[ { "ticker": "DKSH.SW", "company_name": "DKSH Holding AG", "sector": "Distribution / Services", "industry": "Market Expansion Services", "fiscal_year": "2015", "reporting_currency": "CHF", "revenue": "10050.8", "ebitda": "341.8", "ebit": "270.2", "net_income": "199.6", "total_assets": "4095.8", "total_equity": "1539.7", "cash": null, "total_debt": "102.6", "net_debt": null, "operating_cash_flow": "244.9", "capex_reported": null, "capex_calculated": "-39.3", "free_cash_flow_reported": "190.8", "free_cash_flow_calculated": null, "eps": "3.12", "dividend_per_share": "1.30", "ebitda_margin_pct": "3.400724", "ebit_margin_pct": "2.688343", "net_margin_pct": "1.98591156922832", "reported_fcf_margin_pct": "1.898356349743304", "calculated_fcf_margin_pct": null, "roe_pct": null, "roa_pct": null, "debt_to_equity": null, "cash_to_debt": null, "net_debt_to_ebitda": null, "dividend_payout_ratio": null, "revenue_growth_pct": null, "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": null, "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "public_beta_accounting_subset", "notes": "Accounting ratios are calculated from available public beta fundamentals. Free-cash-flow margins follow the reported or calculated FCF field indicated by row metadata; blank values indicate unavailable inputs.", "capex_reported_basis": "missing", "capex_calculated_basis": "cash_flow_capex", "free_cash_flow_reported_basis": "reported", "free_cash_flow_calculated_basis": "missing", "capex_basis_status": "confirmed", "free_cash_flow_basis_status": "confirmed" }, { "ticker": "DKSH.SW", "company_name": "DKSH Holding AG", "sector": "Distribution / Services", "industry": "Market Expansion Services", "fiscal_year": "2016", "reporting_currency": "CHF", "revenue": "10505.2", "ebitda": "332.5", "ebit": "293.0", "net_income": "213.0", "total_assets": "4415.3", "total_equity": "1677.7", "cash": null, "total_debt": "98.8", "net_debt": null, "operating_cash_flow": "166.4", "capex_reported": null, "capex_calculated": "-32.2", "free_cash_flow_reported": "128.8", "free_cash_flow_calculated": null, "eps": "3.21", "dividend_per_share": "1.50", "ebitda_margin_pct": "3.16509918897308", "ebit_margin_pct": "2.789094924418383", "net_margin_pct": "2.027567", "reported_fcf_margin_pct": "1.2260594753074667", "calculated_fcf_margin_pct": null, "roe_pct": null, "roa_pct": null, "debt_to_equity": null, "cash_to_debt": null, "net_debt_to_ebitda": null, "dividend_payout_ratio": null, "revenue_growth_pct": "4.521033151589937", "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": null, "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "public_beta_accounting_subset", "notes": "Accounting ratios are calculated from available public beta fundamentals. Free-cash-flow margins follow the reported or calculated FCF field indicated by row metadata; blank values indicate unavailable inputs.", "capex_reported_basis": "missing", "capex_calculated_basis": "cash_flow_capex", "free_cash_flow_reported_basis": "reported", "free_cash_flow_calculated_basis": "missing", "capex_basis_status": "confirmed", "free_cash_flow_basis_status": "confirmed" }, { "ticker": "DKSH.SW", "company_name": "DKSH Holding AG", "sector": "Distribution / Services", "industry": "Market Expansion Services", "fiscal_year": "2017", "reporting_currency": "CHF", "revenue": "11006.4", "ebitda": "334.9", "ebit": "297.0", "net_income": "213.3", "total_assets": "4645.0", "total_equity": "1633.7", "cash": "443.1", "total_debt": "98.9", "net_debt": "-344.2", "operating_cash_flow": "166.4", "capex_reported": null, "capex_calculated": "-25.8", "free_cash_flow_reported": "139.5", "free_cash_flow_calculated": null, "eps": "3.18", "dividend_per_share": "1.65", "ebitda_margin_pct": "3.042775112661724", "ebit_margin_pct": "2.698430004361099", "net_margin_pct": "1.937963366768426", "reported_fcf_margin_pct": "1.267444395987789", "calculated_fcf_margin_pct": null, "roe_pct": "13.06", "roa_pct": null, "debt_to_equity": "0.06", "cash_to_debt": null, "net_debt_to_ebitda": null, "dividend_payout_ratio": null, "revenue_growth_pct": "4.7709705669573", "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": null, "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "public_beta_accounting_subset", "notes": "Accounting ratios are calculated from available public beta fundamentals. Free-cash-flow margins follow the reported or calculated FCF field indicated by row metadata; blank values indicate unavailable inputs.", "capex_reported_basis": "missing", "capex_calculated_basis": "cash_flow_capex", "free_cash_flow_reported_basis": "reported", "free_cash_flow_calculated_basis": "missing", "capex_basis_status": "confirmed", "free_cash_flow_basis_status": "confirmed" }, { "ticker": "DKSH.SW", "company_name": "DKSH Holding AG", "sector": "Distribution / Services", "industry": "Market Expansion Services", "fiscal_year": "2018", "reporting_currency": "CHF", "revenue": "11344.6", "ebitda": "308.2", "ebit": "263.6", "net_income": "260.3", "total_assets": "4895.4", "total_equity": "1768.6", "cash": null, "total_debt": "140.5", "net_debt": null, "operating_cash_flow": "179.9", "capex_reported": null, "capex_calculated": "-35.3", "free_cash_flow_reported": "144.6", "free_cash_flow_calculated": null, "eps": "3.92", "dividend_per_share": "1.85", "ebitda_margin_pct": "2.716711", "ebit_margin_pct": "2.323572", "net_margin_pct": "2.294484", "reported_fcf_margin_pct": "1.2746152354424132", "calculated_fcf_margin_pct": null, "roe_pct": null, "roa_pct": null, "debt_to_equity": null, "cash_to_debt": null, "net_debt_to_ebitda": null, "dividend_payout_ratio": null, "revenue_growth_pct": "3.0727576682657354", "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": null, "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "public_beta_accounting_subset", "notes": "Accounting ratios are calculated from available public beta fundamentals. Free-cash-flow margins follow the reported or calculated FCF field indicated by row metadata; blank values indicate unavailable inputs.", "capex_reported_basis": "missing", "capex_calculated_basis": "cash_flow_capex", "free_cash_flow_reported_basis": "calculated_ocf_minus_capex", "free_cash_flow_calculated_basis": "missing", "capex_basis_status": "confirmed", "free_cash_flow_basis_status": "confirmed" }, { "ticker": "DKSH.SW", "company_name": "DKSH Holding AG", "sector": "Distribution / Services", "industry": "Market Expansion Services", "fiscal_year": "2019", "reporting_currency": "CHF", "revenue": "11579.2", "ebitda": "401.2", "ebit": "265.4", "net_income": "176.1", "total_assets": "5353.0", "total_equity": "1834.6", "cash": "592.6", "total_debt": "279.7", "net_debt": "-312.9", "operating_cash_flow": "294.2", "capex_reported": null, "capex_calculated": "-45.2", "free_cash_flow_reported": "156.7", "free_cash_flow_calculated": null, "eps": "2.65", "dividend_per_share": "1.90", "ebitda_margin_pct": "3.464833", "ebit_margin_pct": "2.292041", "net_margin_pct": "1.520830454608263", "reported_fcf_margin_pct": "1.353288655520243", "calculated_fcf_margin_pct": null, "roe_pct": null, "roa_pct": null, "debt_to_equity": null, "cash_to_debt": null, "net_debt_to_ebitda": null, "dividend_payout_ratio": null, "revenue_growth_pct": "2.0679442201576137", "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": null, "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "public_beta_accounting_subset", "notes": "Accounting ratios are calculated from available public beta fundamentals. Free-cash-flow margins follow the reported or calculated FCF field indicated by row metadata; blank values indicate unavailable inputs.", "capex_reported_basis": "missing", "capex_calculated_basis": "cash_flow_capex", "free_cash_flow_reported_basis": "reported", "free_cash_flow_calculated_basis": "missing", "capex_basis_status": "confirmed", "free_cash_flow_basis_status": "confirmed" }, { "ticker": "DKSH.SW", "company_name": "DKSH Holding AG", "sector": "Distribution / Services", "industry": "Market Expansion Services", "fiscal_year": "2020", "reporting_currency": "CHF", "revenue": "10742.2", "ebitda": "386.7", "ebit": "257.5", "net_income": "164.8", "total_assets": "5118.0", "total_equity": "1799.6", "cash": "680.8", "total_debt": "338.6", "net_debt": "-342.2", "operating_cash_flow": "325.3", "capex_reported": null, "capex_calculated": "-31.2", "free_cash_flow_reported": "210.2", "free_cash_flow_calculated": null, "eps": "2.42", "dividend_per_share": "1.95", "ebitda_margin_pct": "3.599821265662527", "ebit_margin_pct": "2.397088", "net_margin_pct": "1.534136396641284", "reported_fcf_margin_pct": "1.9567686321237732", "calculated_fcf_margin_pct": null, "roe_pct": "9.16", "roa_pct": null, "debt_to_equity": "0.19", "cash_to_debt": "2.010632013", "net_debt_to_ebitda": "-0.8849237148", "dividend_payout_ratio": null, "revenue_growth_pct": "-7.228478651374881", "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": null, "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "public_beta_accounting_subset", "notes": "Accounting ratios are calculated from available public beta fundamentals. Free-cash-flow margins follow the reported or calculated FCF field indicated by row metadata; blank values indicate unavailable inputs.", "capex_reported_basis": "missing", "capex_calculated_basis": "cash_flow_capex", "free_cash_flow_reported_basis": "reported", "free_cash_flow_calculated_basis": "missing", "capex_basis_status": "confirmed", "free_cash_flow_basis_status": "confirmed" }, { "ticker": "DKSH.SW", "company_name": "DKSH Holding AG", "sector": "Distribution / Services", "industry": "Market Expansion Services", "fiscal_year": "2021", "reporting_currency": "CHF", "revenue": "11106.3", "ebitda": "412.8", "ebit": "284.6", "net_income": "230.1", "total_assets": "5347.4", "total_equity": "1886.4", "cash": "673.7", "total_debt": "306.4", "net_debt": "-367.3", "operating_cash_flow": "393.2", "capex_reported": null, "capex_calculated": "-44.8", "free_cash_flow_reported": "261.6", "free_cash_flow_calculated": null, "eps": "3.45", "dividend_per_share": "2.05", "ebitda_margin_pct": "3.716809378460874", "ebit_margin_pct": "2.56251", "net_margin_pct": "2.071797088139164", "reported_fcf_margin_pct": "2.355419896815321", "calculated_fcf_margin_pct": null, "roe_pct": "12.2", "roa_pct": null, "debt_to_equity": "0.16", "cash_to_debt": "2.198759791", "net_debt_to_ebitda": "-0.8897771328", "dividend_payout_ratio": null, "revenue_growth_pct": "3.3894360559289405", "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": null, "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "public_beta_accounting_subset", "notes": "Accounting ratios are calculated from available public beta fundamentals. Free-cash-flow margins follow the reported or calculated FCF field indicated by row metadata; blank values indicate unavailable inputs.", "capex_reported_basis": "missing", "capex_calculated_basis": "cash_flow_capex", "free_cash_flow_reported_basis": "reported", "free_cash_flow_calculated_basis": "missing", "capex_basis_status": "confirmed", "free_cash_flow_basis_status": "confirmed" }, { "ticker": "DKSH.SW", "company_name": "DKSH Holding AG", "sector": "Distribution / Services", "industry": "Market Expansion Services", "fiscal_year": "2022", "reporting_currency": "CHF", "revenue": "11320.2", "ebitda": "445.7", "ebit": "319.2", "net_income": "207.6", "total_assets": "5878.7", "total_equity": "1826.3", "cash": "636.4", "total_debt": "678.7", "net_debt": "42.3", "operating_cash_flow": "321.9", "capex_reported": null, "capex_calculated": "-36.6", "free_cash_flow_reported": "209.5", "free_cash_flow_calculated": null, "eps": "3.09", "dividend_per_share": "2.15", "ebitda_margin_pct": "3.93721", "ebit_margin_pct": "2.819738167170191", "net_margin_pct": "1.83389", "reported_fcf_margin_pct": "1.8506740163601347", "calculated_fcf_margin_pct": null, "roe_pct": "11.37", "roa_pct": null, "debt_to_equity": "0.37", "cash_to_debt": "0.937674967", "net_debt_to_ebitda": "0.0949071124", "dividend_payout_ratio": null, "revenue_growth_pct": "1.9259339293914437", "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": null, "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "public_beta_accounting_subset", "notes": "Accounting ratios are calculated from available public beta fundamentals. Free-cash-flow margins follow the reported or calculated FCF field indicated by row metadata; blank values indicate unavailable inputs.", "capex_reported_basis": "missing", "capex_calculated_basis": "cash_flow_capex", "free_cash_flow_reported_basis": "reported", "free_cash_flow_calculated_basis": "missing", "capex_basis_status": "confirmed", "free_cash_flow_basis_status": "confirmed" }, { "ticker": "DKSH.SW", "company_name": "DKSH Holding AG", "sector": "Distribution / Services", "industry": "Market Expansion Services", "fiscal_year": "2023", "reporting_currency": "CHF", "revenue": "11066.0", "ebitda": "438.0", "ebit": "305.9", "net_income": "189.9", "total_assets": "5471.2", "total_equity": "1737.9", "cash": "687.2", "total_debt": "680.7", "net_debt": "-6.5", "operating_cash_flow": "393.1", "capex_reported": null, "capex_calculated": "-30.7", "free_cash_flow_reported": "282.3", "free_cash_flow_calculated": null, "eps": "2.8", "dividend_per_share": "2.25", "ebitda_margin_pct": "3.95807", "ebit_margin_pct": "2.764323151997108", "net_margin_pct": "1.716067", "reported_fcf_margin_pct": "2.5510572926079886", "calculated_fcf_margin_pct": null, "roe_pct": "10.93", "roa_pct": null, "debt_to_equity": "0.39", "cash_to_debt": "1.009548993", "net_debt_to_ebitda": "-0.01484018265", "dividend_payout_ratio": null, "revenue_growth_pct": "-2.2455433649582246", "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": null, "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "public_beta_accounting_subset", "notes": "Accounting ratios are calculated from available public beta fundamentals. Free-cash-flow margins follow the reported or calculated FCF field indicated by row metadata; blank values indicate unavailable inputs.", "capex_reported_basis": "missing", "capex_calculated_basis": "cash_flow_capex", "free_cash_flow_reported_basis": "reported", "free_cash_flow_calculated_basis": "missing", "capex_basis_status": "confirmed", "free_cash_flow_basis_status": "confirmed" }, { "ticker": "DKSH.SW", "company_name": "DKSH Holding AG", "sector": "Distribution / Services", "industry": "Market Expansion Services", "fiscal_year": "2024", "reporting_currency": "CHF", "revenue": "11093.6", "ebitda": "460.5", "ebit": "333.9", "net_income": "220.9", "total_assets": "5848.3", "total_equity": "1880.0", "cash": "609.1", "total_debt": "561.0", "net_debt": "-48.1", "operating_cash_flow": "362.9", "capex_reported": null, "capex_calculated": "-33.7", "free_cash_flow_reported": "256.5", "free_cash_flow_calculated": null, "eps": "3.31", "dividend_per_share": "2.35", "ebitda_margin_pct": "4.1510420422586", "ebit_margin_pct": "3.009844", "net_margin_pct": "1.99123819138963", "reported_fcf_margin_pct": "2.312143938847624", "calculated_fcf_margin_pct": null, "roe_pct": "11.75", "roa_pct": null, "debt_to_equity": "0.3", "cash_to_debt": "1.085739750", "net_debt_to_ebitda": "-0.1044516829", "dividend_payout_ratio": null, "revenue_growth_pct": "0.2494126152177811", "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": null, "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "public_beta_accounting_subset", "notes": "Accounting ratios are calculated from available public beta fundamentals. Free-cash-flow margins follow the reported or calculated FCF field indicated by row metadata; blank values indicate unavailable inputs.", "capex_reported_basis": "missing", "capex_calculated_basis": "cash_flow_capex", "free_cash_flow_reported_basis": "reported", "free_cash_flow_calculated_basis": "missing", "capex_basis_status": "confirmed", "free_cash_flow_basis_status": "confirmed" }, { "ticker": "DKSH.SW", "company_name": "DKSH Holding AG", "sector": "Distribution / Services", "industry": "Market Expansion Services", "fiscal_year": "2025", "reporting_currency": "CHF", "revenue": "11070.6", "ebitda": "457.1", "ebit": "335.4", "net_income": "210.9", "total_assets": "5499.7", "total_equity": "1821.1", "cash": "538.4", "total_debt": "513.2", "net_debt": "-25.2", "operating_cash_flow": "320.1", "capex_reported": null, "capex_calculated": "-35.4", "free_cash_flow_reported": "215.5", "free_cash_flow_calculated": null, "eps": "3.12", "dividend_per_share": "2.50", "ebitda_margin_pct": "4.12895416689249", "ebit_margin_pct": "3.029646", "net_margin_pct": "1.905046", "reported_fcf_margin_pct": "1.9465972937329503", "calculated_fcf_margin_pct": null, "roe_pct": "11.58", "roa_pct": null, "debt_to_equity": "0.28", "cash_to_debt": "1.049103663", "net_debt_to_ebitda": "-0.05513016845", "dividend_payout_ratio": null, "revenue_growth_pct": "-0.2073267469531958", "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": null, "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "public_beta_accounting_subset", "notes": "Accounting ratios are calculated from available public beta fundamentals. Free-cash-flow margins follow the reported or calculated FCF field indicated by row metadata; blank values indicate unavailable inputs.", "capex_reported_basis": "missing", "capex_calculated_basis": "cash_flow_capex", "free_cash_flow_reported_basis": "reported", "free_cash_flow_calculated_basis": "missing", "capex_basis_status": "confirmed", "free_cash_flow_basis_status": "confirmed" }, { "ticker": "GEBN.SW", "company_name": "Geberit AG", "sector": "Industrials", "industry": "Building Products", "fiscal_year": "2015", "reporting_currency": "CHF", "revenue": "2593.7", "ebitda": "631.7", "ebit": "498.3", "net_income": "422.4", "total_assets": "3553.8", "total_equity": "1482.2", "cash": "459.6", "total_debt": "1139.2", "net_debt": "679.6", "operating_cash_flow": "612.1", "capex_reported": null, "capex_calculated": "-147.3", "free_cash_flow_reported": "484.0", "free_cash_flow_calculated": "464.8", "eps": "11.33", "dividend_per_share": "8.4", "ebitda_margin_pct": "24.35516829240082", "ebit_margin_pct": "19.211937", "net_margin_pct": "16.285615", "reported_fcf_margin_pct": "18.660600686278293", "calculated_fcf_margin_pct": "17.9203", "roe_pct": "28.5", "roa_pct": null, "debt_to_equity": "0.77", "cash_to_debt": null, "net_debt_to_ebitda": null, "dividend_payout_ratio": null, "revenue_growth_pct": null, "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": null, "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "public_beta_accounting_subset", "notes": "Accounting ratios are calculated from available public beta fundamentals. Free-cash-flow margins follow the reported or calculated FCF field indicated by row metadata; blank values indicate unavailable inputs.", "capex_reported_basis": "missing", "capex_calculated_basis": "cash_flow_capex", "free_cash_flow_reported_basis": "reported", "free_cash_flow_calculated_basis": "calculated_ocf_plus_capex", "capex_basis_status": "confirmed", "free_cash_flow_basis_status": "confirmed" }, { "ticker": "GEBN.SW", "company_name": "Geberit AG", "sector": "Industrials", "industry": "Building Products", "fiscal_year": "2016", "reporting_currency": "CHF", "revenue": "2809.0", "ebitda": "785.2", "ebit": "640.1", "net_income": "548.2", "total_assets": "3601.1", "total_equity": "1635.2", "cash": "509.7", "total_debt": "970.9", "net_debt": "461.2", "operating_cash_flow": "715.2", "capex_reported": null, "capex_calculated": "-139.1", "free_cash_flow_reported": "563.9", "free_cash_flow_calculated": "576.1", "eps": "14.88", "dividend_per_share": "10.0", "ebitda_margin_pct": "27.95300818796725", "ebit_margin_pct": "22.7874688501246", "net_margin_pct": "19.515842", "reported_fcf_margin_pct": "20.074759700961195", "calculated_fcf_margin_pct": "20.5091", "roe_pct": "33.52", "roa_pct": null, "debt_to_equity": "0.59", "cash_to_debt": null, "net_debt_to_ebitda": null, "dividend_payout_ratio": null, "revenue_growth_pct": "8.300882908586193", "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": "23.9458", "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "public_beta_accounting_subset", "notes": "Accounting ratios are calculated from available public beta fundamentals. Free-cash-flow margins follow the reported or calculated FCF field indicated by row metadata; blank values indicate unavailable inputs.", "capex_reported_basis": "missing", "capex_calculated_basis": "cash_flow_capex", "free_cash_flow_reported_basis": "reported", "free_cash_flow_calculated_basis": "calculated_ocf_plus_capex", "capex_basis_status": "confirmed", "free_cash_flow_basis_status": "confirmed" }, { "ticker": "GEBN.SW", "company_name": "Geberit AG", "sector": "Industrials", "industry": "Building Products", "fiscal_year": "2017", "reporting_currency": "CHF", "revenue": "2908.3", "ebitda": "772.0", "ebit": "621.7", "net_income": "527.4", "total_assets": "3742.8", "total_equity": "1837.2", "cash": "412.7", "total_debt": "895.2", "net_debt": "482.5", "operating_cash_flow": "640.4", "capex_reported": null, "capex_calculated": "-159.0", "free_cash_flow_reported": "483.4", "free_cash_flow_calculated": "481.4", "eps": "14.34", "dividend_per_share": "10.4", "ebitda_margin_pct": "26.544717", "ebit_margin_pct": "21.37674930371695", "net_margin_pct": "18.134305", "reported_fcf_margin_pct": "16.621393941477837", "calculated_fcf_margin_pct": "16.5526", "roe_pct": "28.71", "roa_pct": null, "debt_to_equity": "0.49", "cash_to_debt": null, "net_debt_to_ebitda": null, "dividend_payout_ratio": null, "revenue_growth_pct": "3.5350658597365747", "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": "-16.4381", "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "public_beta_accounting_subset", "notes": "Accounting ratios are calculated from available public beta fundamentals. Free-cash-flow margins follow the reported or calculated FCF field indicated by row metadata; blank values indicate unavailable inputs.", "capex_reported_basis": "missing", "capex_calculated_basis": "cash_flow_capex", "free_cash_flow_reported_basis": "reported", "free_cash_flow_calculated_basis": "calculated_ocf_plus_capex", "capex_basis_status": "confirmed", "free_cash_flow_basis_status": "confirmed" }, { "ticker": "GEBN.SW", "company_name": "Geberit AG", "sector": "Industrials", "industry": "Building Products", "fiscal_year": "2018", "reporting_currency": "CHF", "revenue": "3080.5", "ebitda": "867.8", "ebit": "707.6", "net_income": "597.2", "total_assets": "3501.8", "total_equity": "1745.4", "cash": "282.2", "total_debt": "837.4", "net_debt": "555.2", "operating_cash_flow": "747.5", "capex_reported": null, "capex_calculated": "-162.0", "free_cash_flow_reported": "582.0", "free_cash_flow_calculated": "585.5", "eps": "16.4", "dividend_per_share": "10.8", "ebitda_margin_pct": "28.170752", "ebit_margin_pct": "22.970297", "net_margin_pct": "19.386463", "reported_fcf_margin_pct": "18.893036844668075", "calculated_fcf_margin_pct": "19.0067", "roe_pct": "34.22", "roa_pct": null, "debt_to_equity": "0.48", "cash_to_debt": null, "net_debt_to_ebitda": null, "dividend_payout_ratio": null, "revenue_growth_pct": "5.920984767733728", "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": "21.6244", "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "public_beta_accounting_subset", "notes": "Accounting ratios are calculated from available public beta fundamentals. Free-cash-flow margins follow the reported or calculated FCF field indicated by row metadata; blank values indicate unavailable inputs.", "capex_reported_basis": "missing", "capex_calculated_basis": "cash_flow_capex", "free_cash_flow_reported_basis": "reported", "free_cash_flow_calculated_basis": "calculated_ocf_plus_capex", "capex_basis_status": "confirmed", "free_cash_flow_basis_status": "confirmed" }, { "ticker": "GEBN.SW", "company_name": "Geberit AG", "sector": "Industrials", "industry": "Building Products", "fiscal_year": "2019", "reporting_currency": "CHF", "revenue": "3082.9", "ebitda": "903.9", "ebit": "756.6", "net_income": "646.9", "total_assets": "3725.3", "total_equity": "1899.0", "cash": "408.1", "total_debt": "836.9", "net_debt": "428.8", "operating_cash_flow": "834.0", "capex_reported": null, "capex_calculated": "-167", "free_cash_flow_reported": "644.0", "free_cash_flow_calculated": "667", "eps": "17.97", "dividend_per_share": "8.4", "ebitda_margin_pct": "29.31979629569561", "ebit_margin_pct": "24.54182750008109", "net_margin_pct": "20.98349", "reported_fcf_margin_pct": "20.889422", "calculated_fcf_margin_pct": "21.6355", "roe_pct": "34.07", "roa_pct": null, "debt_to_equity": "0.44", "cash_to_debt": null, "net_debt_to_ebitda": null, "dividend_payout_ratio": null, "revenue_growth_pct": "0.0779094302872929", "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": "17.3356", "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "public_beta_accounting_subset", "notes": "Accounting ratios are calculated from available public beta fundamentals. Free-cash-flow margins follow the reported or calculated FCF field indicated by row metadata; blank values indicate unavailable inputs.", "capex_reported_basis": "missing", "capex_calculated_basis": "cash_flow_capex", "free_cash_flow_reported_basis": "reported", "free_cash_flow_calculated_basis": "calculated_ocf_plus_capex", "capex_basis_status": "confirmed", "free_cash_flow_basis_status": "confirmed" }, { "ticker": "GEBN.SW", "company_name": "Geberit AG", "sector": "Industrials", "industry": "Building Products", "fiscal_year": "2020", "reporting_currency": "CHF", "revenue": "2986.1", "ebitda": "925.3", "ebit": "771.5", "net_income": "642.3", "total_assets": "3751.0", "total_equity": "1922.0", "cash": "468.6", "total_debt": "778.8", "net_debt": "310.2", "operating_cash_flow": "900.0", "capex_reported": null, "capex_calculated": "-150", "free_cash_flow_reported": "717.0", "free_cash_flow_calculated": "750", "eps": "17.95", "dividend_per_share": "10.0", "ebitda_margin_pct": "30.98690599778976", "ebit_margin_pct": "25.83637520511704", "net_margin_pct": "21.509661", "reported_fcf_margin_pct": "24.011252", "calculated_fcf_margin_pct": "25.1164", "roe_pct": "33.42", "roa_pct": null, "debt_to_equity": "0.41", "cash_to_debt": null, "net_debt_to_ebitda": null, "dividend_payout_ratio": null, "revenue_growth_pct": "-3.1399007428071", "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": "10.7715", "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "public_beta_accounting_subset", "notes": "Accounting ratios are calculated from available public beta fundamentals. Free-cash-flow margins follow the reported or calculated FCF field indicated by row metadata; blank values indicate unavailable inputs.", "capex_reported_basis": "missing", "capex_calculated_basis": "cash_flow_capex", "free_cash_flow_reported_basis": "reported", "free_cash_flow_calculated_basis": "calculated_ocf_plus_capex", "capex_basis_status": "confirmed", "free_cash_flow_basis_status": "confirmed" }, { "ticker": "GEBN.SW", "company_name": "Geberit AG", "sector": "Industrials", "industry": "Building Products", "fiscal_year": "2021", "reporting_currency": "CHF", "revenue": "3460.5", "ebitda": "1069.3", "ebit": "901.6", "net_income": "755.7", "total_assets": "3751.0", "total_equity": "1987.7", "cash": "511.0", "total_debt": "783.9", "net_debt": "272.9", "operating_cash_flow": "998.9", "capex_reported": null, "capex_calculated": "-169.0", "free_cash_flow_reported": "809.0", "free_cash_flow_calculated": "829.9", "eps": "21.34", "dividend_per_share": "12.5", "ebitda_margin_pct": "30.90015893656986", "ebit_margin_pct": "26.054038", "net_margin_pct": "21.83788469874296", "reported_fcf_margin_pct": "23.378124548475657", "calculated_fcf_margin_pct": "23.9821", "roe_pct": "38.02", "roa_pct": null, "debt_to_equity": "0.39", "cash_to_debt": null, "net_debt_to_ebitda": null, "dividend_payout_ratio": null, "revenue_growth_pct": "15.886942835136145", "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": "9.0539", "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "public_beta_accounting_subset", "notes": "Accounting ratios are calculated from available public beta fundamentals. Free-cash-flow margins follow the reported or calculated FCF field indicated by row metadata; blank values indicate unavailable inputs.", "capex_reported_basis": "missing", "capex_calculated_basis": "cash_flow_capex", "free_cash_flow_reported_basis": "reported", "free_cash_flow_calculated_basis": "calculated_ocf_plus_capex", "capex_basis_status": "confirmed", "free_cash_flow_basis_status": "confirmed" }, { "ticker": "GEBN.SW", "company_name": "Geberit AG", "sector": "Industrials", "industry": "Building Products", "fiscal_year": "2022", "reporting_currency": "CHF", "revenue": "3391.9", "ebitda": "908.6", "ebit": "755.0", "net_income": "706.3", "total_assets": "3429.2", "total_equity": "1497.0", "cash": "205.7", "total_debt": "1029.6", "net_debt": "823.9", "operating_cash_flow": "736.0", "capex_reported": null, "capex_calculated": "-155.0", "free_cash_flow_reported": "562.0", "free_cash_flow_calculated": "581.0", "eps": "20.48", "dividend_per_share": "12.6", "ebitda_margin_pct": "26.787346", "ebit_margin_pct": "22.258911", "net_margin_pct": "20.82313747457177", "reported_fcf_margin_pct": "16.568884695893157", "calculated_fcf_margin_pct": "17.129", "roe_pct": "47.18", "roa_pct": null, "debt_to_equity": "0.69", "cash_to_debt": null, "net_debt_to_ebitda": null, "dividend_payout_ratio": null, "revenue_growth_pct": "-1.9823724895246309", "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": "-29.9916", "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "public_beta_accounting_subset", "notes": "Accounting ratios are calculated from available public beta fundamentals. Free-cash-flow margins follow the reported or calculated FCF field indicated by row metadata; blank values indicate unavailable inputs.", "capex_reported_basis": "missing", "capex_calculated_basis": "cash_flow_capex", "free_cash_flow_reported_basis": "reported", "free_cash_flow_calculated_basis": "calculated_ocf_plus_capex", "capex_basis_status": "confirmed", "free_cash_flow_basis_status": "confirmed" }, { "ticker": "GEBN.SW", "company_name": "Geberit AG", "sector": "Industrials", "industry": "Building Products", "fiscal_year": "2023", "reporting_currency": "CHF", "revenue": "3083.9", "ebitda": "920.9", "ebit": "768.5", "net_income": "617.0", "total_assets": "3556.2", "total_equity": "1320.1", "cash": "356.8", "total_debt": "1321.4", "net_debt": "964.6", "operating_cash_flow": "857.9", "capex_reported": null, "capex_calculated": "-197.0", "free_cash_flow_reported": "625.0", "free_cash_flow_calculated": "660.9", "eps": "18.39", "dividend_per_share": "12.7", "ebitda_margin_pct": "29.861539", "ebit_margin_pct": "24.919744", "net_margin_pct": "20.00713382405396", "reported_fcf_margin_pct": "20.266545607834235", "calculated_fcf_margin_pct": "21.4307", "roe_pct": "46.74", "roa_pct": null, "debt_to_equity": "1.00", "cash_to_debt": null, "net_debt_to_ebitda": null, "dividend_payout_ratio": null, "revenue_growth_pct": "-9.080456381379165", "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": "13.7522", "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "public_beta_accounting_subset", "notes": "Accounting ratios are calculated from available public beta fundamentals. Free-cash-flow margins follow the reported or calculated FCF field indicated by row metadata; blank values indicate unavailable inputs.", "capex_reported_basis": "missing", "capex_calculated_basis": "cash_flow_capex", "free_cash_flow_reported_basis": "reported", "free_cash_flow_calculated_basis": "calculated_ocf_plus_capex", "capex_basis_status": "confirmed", "free_cash_flow_basis_status": "confirmed" }, { "ticker": "GEBN.SW", "company_name": "Geberit AG", "sector": "Industrials", "industry": "Building Products", "fiscal_year": "2024", "reporting_currency": "CHF", "revenue": "3085.5", "ebitda": "912.6", "ebit": "761.8", "net_income": "597.1", "total_assets": "3641.0", "total_equity": "1302.0", "cash": "407.7", "total_debt": "1373.1", "net_debt": "965.4", "operating_cash_flow": "847.6", "capex_reported": null, "capex_calculated": "-182.0", "free_cash_flow_reported": "613.0", "free_cash_flow_calculated": "665.6", "eps": "18.06", "dividend_per_share": "12.8", "ebitda_margin_pct": "29.5770539620807", "ebit_margin_pct": "24.68967752390212", "net_margin_pct": "19.351807", "reported_fcf_margin_pct": "19.86712040187976", "calculated_fcf_margin_pct": "21.5719", "roe_pct": "45.86", "roa_pct": null, "debt_to_equity": "1.05", "cash_to_debt": null, "net_debt_to_ebitda": null, "dividend_payout_ratio": null, "revenue_growth_pct": "0.0518823567560611", "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": "0.7112", "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "public_beta_accounting_subset", "notes": "Accounting ratios are calculated from available public beta fundamentals. Free-cash-flow margins follow the reported or calculated FCF field indicated by row metadata; blank values indicate unavailable inputs.", "capex_reported_basis": "missing", "capex_calculated_basis": "cash_flow_capex", "free_cash_flow_reported_basis": "reported", "free_cash_flow_calculated_basis": "calculated_ocf_plus_capex", "capex_basis_status": "confirmed", "free_cash_flow_basis_status": "confirmed" }, { "ticker": "GEBN.SW", "company_name": "Geberit AG", "sector": "Industrials", "industry": "Building Products", "fiscal_year": "2025", "reporting_currency": "CHF", "revenue": "3162.9", "ebitda": "930.6", "ebit": "767.2", "net_income": "597.8", "total_assets": "3857.9", "total_equity": "1517.1", "cash": "585.8", "total_debt": "1354.8", "net_debt": "769.0", "operating_cash_flow": "866.9", "capex_reported": null, "capex_calculated": "-173.0", "free_cash_flow_reported": "659.0", "free_cash_flow_calculated": "693.9", "eps": "18.15", "dividend_per_share": "12.9", "ebitda_margin_pct": "29.422366", "ebit_margin_pct": "24.25622055708369", "net_margin_pct": "18.90037623699769", "reported_fcf_margin_pct": "20.835309367985076", "calculated_fcf_margin_pct": "21.9387", "roe_pct": "39.4", "roa_pct": null, "debt_to_equity": "0.89", "cash_to_debt": null, "net_debt_to_ebitda": null, "dividend_payout_ratio": null, "revenue_growth_pct": "2.5085075352454966", "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": "4.2518", "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "public_beta_accounting_subset", "notes": "Accounting ratios are calculated from available public beta fundamentals. Free-cash-flow margins follow the reported or calculated FCF field indicated by row metadata; blank values indicate unavailable inputs.", "capex_reported_basis": "missing", "capex_calculated_basis": "cash_flow_capex", "free_cash_flow_reported_basis": "reported", "free_cash_flow_calculated_basis": "calculated_ocf_plus_capex", "capex_basis_status": "confirmed", "free_cash_flow_basis_status": "confirmed" }, { "ticker": "SCMN.SW", "company_name": "Swisscom AG", "sector": "Telecom / Infrastructure", "industry": "Telecommunications", "fiscal_year": "2015", "reporting_currency": "CHF", "revenue": "11678.0", "ebitda": "4098.0", "ebit": "2012.0", "net_income": "1362.0", "total_assets": "21149.0", "total_equity": "5242.0", "cash": "324.0", "total_debt": "8593.0", "net_debt": "8269.0", "operating_cash_flow": "3867.0", "capex_reported": null, "capex_calculated": null, "free_cash_flow_reported": "1306.0", "free_cash_flow_calculated": null, "eps": "26.27", "dividend_per_share": "22.0", "ebitda_margin_pct": "35.09162527830108", "ebit_margin_pct": "17.228978", "net_margin_pct": "11.662956", "reported_fcf_margin_pct": "11.18342181880459", "calculated_fcf_margin_pct": null, "roe_pct": "25.98", "roa_pct": null, "debt_to_equity": "1.64", "cash_to_debt": null, "net_debt_to_ebitda": null, "dividend_payout_ratio": null, "revenue_growth_pct": null, "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": null, "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "public_beta_accounting_subset", "notes": "Accounting ratios are calculated from available public beta fundamentals. Free-cash-flow margins follow the reported or calculated FCF field indicated by row metadata; blank values indicate unavailable inputs.", "capex_reported_basis": "missing", "capex_calculated_basis": "missing", "free_cash_flow_reported_basis": "reported", "free_cash_flow_calculated_basis": "missing", "capex_basis_status": "documented_missing", "free_cash_flow_basis_status": "confirmed" }, { "ticker": "SCMN.SW", "company_name": "Swisscom AG", "sector": "Telecom / Infrastructure", "industry": "Telecommunications", "fiscal_year": "2016", "reporting_currency": "CHF", "revenue": "11643.0", "ebitda": "4293.0", "ebit": "2148.0", "net_income": "1604.0", "total_assets": "21454.0", "total_equity": "6522.0", "cash": "329.0", "total_debt": "8496.0", "net_debt": "8167.0", "operating_cash_flow": "3862.0", "capex_reported": null, "capex_calculated": null, "free_cash_flow_reported": "1306.0", "free_cash_flow_calculated": null, "eps": "30.97", "dividend_per_share": "22.0", "ebitda_margin_pct": "36.87194", "ebit_margin_pct": "18.448853388301984", "net_margin_pct": "13.776518079532766", "reported_fcf_margin_pct": "11.217040281714334", "calculated_fcf_margin_pct": null, "roe_pct": "24.59", "roa_pct": null, "debt_to_equity": "1.3", "cash_to_debt": null, "net_debt_to_ebitda": null, "dividend_payout_ratio": null, "revenue_growth_pct": "-0.2997088542558646", "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": null, "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "public_beta_accounting_subset", "notes": "Accounting ratios are calculated from available public beta fundamentals. Free-cash-flow margins follow the reported or calculated FCF field indicated by row metadata; blank values indicate unavailable inputs.", "capex_reported_basis": "missing", "capex_calculated_basis": "missing", "free_cash_flow_reported_basis": "reported", "free_cash_flow_calculated_basis": "missing", "capex_basis_status": "documented_missing", "free_cash_flow_basis_status": "confirmed" }, { "ticker": "SCMN.SW", "company_name": "Swisscom AG", "sector": "Telecom / Infrastructure", "industry": "Telecommunications", "fiscal_year": "2017", "reporting_currency": "CHF", "revenue": "11662.0", "ebitda": "4295.0", "ebit": "2131.0", "net_income": "1568.0", "total_assets": "22058.0", "total_equity": "7645.0", "cash": "525.0", "total_debt": "8286.0", "net_debt": "7761.0", "operating_cash_flow": "4091.0", "capex_reported": null, "capex_calculated": null, "free_cash_flow_reported": "1715.0", "free_cash_flow_calculated": null, "eps": "30.31", "dividend_per_share": "22.0", "ebitda_margin_pct": "36.8290173212142", "ebit_margin_pct": "18.27302349511233", "net_margin_pct": "13.445378151260504", "reported_fcf_margin_pct": "14.705882352941178", "calculated_fcf_margin_pct": null, "roe_pct": "20.51", "roa_pct": null, "debt_to_equity": "1.08", "cash_to_debt": null, "net_debt_to_ebitda": null, "dividend_payout_ratio": null, "revenue_growth_pct": "0.1631881817401037", "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": null, "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "public_beta_accounting_subset", "notes": "Accounting ratios are calculated from available public beta fundamentals. Free-cash-flow margins follow the reported or calculated FCF field indicated by row metadata; blank values indicate unavailable inputs.", "capex_reported_basis": "missing", "capex_calculated_basis": "missing", "free_cash_flow_reported_basis": "reported", "free_cash_flow_calculated_basis": "missing", "capex_basis_status": "documented_missing", "free_cash_flow_basis_status": "confirmed" }, { "ticker": "SCMN.SW", "company_name": "Swisscom AG", "sector": "Telecom / Infrastructure", "industry": "Telecommunications", "fiscal_year": "2018", "reporting_currency": "CHF", "revenue": "11714.0", "ebitda": "4213.0", "ebit": "2069.0", "net_income": "1521.0", "total_assets": "22586.0", "total_equity": "8208.0", "cash": "474.0", "total_debt": "8167.0", "net_debt": "7693.0", "operating_cash_flow": "3720.0", "capex_reported": null, "capex_calculated": "-2404.0", "free_cash_flow_reported": "1318.0", "free_cash_flow_calculated": "1316.0", "eps": "29.48", "dividend_per_share": "22.0", "ebitda_margin_pct": "35.96551135393546", "ebit_margin_pct": "17.66262591770531", "net_margin_pct": "12.984463", "reported_fcf_margin_pct": "11.25149393887656", "calculated_fcf_margin_pct": "11.2344", "roe_pct": "18.53", "roa_pct": null, "debt_to_equity": "1.0", "cash_to_debt": null, "net_debt_to_ebitda": null, "dividend_payout_ratio": null, "revenue_growth_pct": "0.4458926427713949", "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": null, "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "public_beta_accounting_subset", "notes": "Accounting ratios are calculated from available public beta fundamentals. Free-cash-flow margins follow the reported or calculated FCF field indicated by row metadata; blank values indicate unavailable inputs.", "capex_reported_basis": "missing", "capex_calculated_basis": "cash_flow_capex", "free_cash_flow_reported_basis": "reported", "free_cash_flow_calculated_basis": "calculated_ocf_plus_capex", "capex_basis_status": "confirmed", "free_cash_flow_basis_status": "confirmed" }, { "ticker": "SCMN.SW", "company_name": "Swisscom AG", "sector": "Telecom / Infrastructure", "industry": "Telecommunications", "fiscal_year": "2019", "reporting_currency": "CHF", "revenue": "11453.0", "ebitda": "4358.0", "ebit": "1910.0", "net_income": "1669.0", "total_assets": "22586.0", "total_equity": "8875.0", "cash": "328.0", "total_debt": "7460.0", "net_debt": "7132.0", "operating_cash_flow": "3981.0", "capex_reported": null, "capex_calculated": "-2438.0", "free_cash_flow_reported": "1543.0", "free_cash_flow_calculated": "1543.0", "eps": null, "dividend_per_share": "22.0", "ebitda_margin_pct": "38.05116563345848", "ebit_margin_pct": "16.676853226228936", "net_margin_pct": "14.572601065223086", "reported_fcf_margin_pct": "13.472452632498037", "calculated_fcf_margin_pct": "13.4725", "roe_pct": "18.81", "roa_pct": null, "debt_to_equity": "0.84", "cash_to_debt": null, "net_debt_to_ebitda": null, "dividend_payout_ratio": null, "revenue_growth_pct": "-2.228103124466452", "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": "17.2492", "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "public_beta_accounting_subset", "notes": "Accounting ratios are calculated from available public beta fundamentals. Free-cash-flow margins follow the reported or calculated FCF field indicated by row metadata; blank values indicate unavailable inputs.", "capex_reported_basis": "missing", "capex_calculated_basis": "cash_flow_capex", "free_cash_flow_reported_basis": "calculated_ocf_minus_capex", "free_cash_flow_calculated_basis": "calculated_ocf_plus_capex", "capex_basis_status": "confirmed", "free_cash_flow_basis_status": "confirmed" }, { "ticker": "SCMN.SW", "company_name": "Swisscom AG", "sector": "Telecom / Infrastructure", "industry": "Telecommunications", "fiscal_year": "2020", "reporting_currency": "CHF", "revenue": "11100.0", "ebitda": "4382.0", "ebit": "1947.0", "net_income": "1528.0", "total_assets": "24262.0", "total_equity": "9491.0", "cash": "340.0", "total_debt": "7042.0", "net_debt": "6702.0", "operating_cash_flow": "4069.0", "capex_reported": null, "capex_calculated": "-2229.0", "free_cash_flow_reported": "1840.0", "free_cash_flow_calculated": "1840.0", "eps": "29.54", "dividend_per_share": "22.0", "ebitda_margin_pct": "39.47747747747748", "ebit_margin_pct": "17.54054054054054", "net_margin_pct": "13.765766", "reported_fcf_margin_pct": "16.576576576576578", "calculated_fcf_margin_pct": "16.5766", "roe_pct": "16.1", "roa_pct": null, "debt_to_equity": "0.74", "cash_to_debt": null, "net_debt_to_ebitda": null, "dividend_payout_ratio": null, "revenue_growth_pct": "-3.082161878983669", "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": "19.2482", "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "public_beta_accounting_subset", "notes": "Accounting ratios are calculated from available public beta fundamentals. Free-cash-flow margins follow the reported or calculated FCF field indicated by row metadata; blank values indicate unavailable inputs.", "capex_reported_basis": "missing", "capex_calculated_basis": "cash_flow_capex", "free_cash_flow_reported_basis": "calculated_ocf_minus_capex", "free_cash_flow_calculated_basis": "calculated_ocf_plus_capex", "capex_basis_status": "confirmed", "free_cash_flow_basis_status": "confirmed" }, { "ticker": "SCMN.SW", "company_name": "Swisscom AG", "sector": "Telecom / Infrastructure", "industry": "Telecommunications", "fiscal_year": "2021", "reporting_currency": "CHF", "revenue": "11183.0", "ebitda": "4478.0", "ebit": "2066.0", "net_income": "1833.0", "total_assets": "24801.0", "total_equity": "10813.0", "cash": "401.0", "total_debt": "6445.0", "net_debt": "6044.0", "operating_cash_flow": "4044.0", "capex_reported": null, "capex_calculated": "-2286.0", "free_cash_flow_reported": "1758.0", "free_cash_flow_calculated": "1758.0", "eps": "35.37", "dividend_per_share": "22.0", "ebitda_margin_pct": "40.0429222927658", "ebit_margin_pct": "18.47447017794867", "net_margin_pct": "16.390951", "reported_fcf_margin_pct": "15.720289725476167", "calculated_fcf_margin_pct": "15.7203", "roe_pct": "16.95", "roa_pct": null, "debt_to_equity": "0.6", "cash_to_debt": null, "net_debt_to_ebitda": null, "dividend_payout_ratio": null, "revenue_growth_pct": "0.7477477477477512", "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": "-4.4565", "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "public_beta_accounting_subset", "notes": "Accounting ratios are calculated from available public beta fundamentals. Free-cash-flow margins follow the reported or calculated FCF field indicated by row metadata; blank values indicate unavailable inputs.", "capex_reported_basis": "missing", "capex_calculated_basis": "cash_flow_capex", "free_cash_flow_reported_basis": "calculated_ocf_minus_capex", "free_cash_flow_calculated_basis": "calculated_ocf_plus_capex", "capex_basis_status": "confirmed", "free_cash_flow_basis_status": "confirmed" }, { "ticker": "SCMN.SW", "company_name": "Swisscom AG", "sector": "Telecom / Infrastructure", "industry": "Telecommunications", "fiscal_year": "2022", "reporting_currency": "CHF", "revenue": "11112.0", "ebitda": "4406.0", "ebit": "2040.0", "net_income": "1603.0", "total_assets": "24620.0", "total_equity": "11171.0", "cash": "121.0", "total_debt": "6002.0", "net_debt": "5881.0", "operating_cash_flow": "3876.0", "capex_reported": null, "capex_calculated": "-2309.0", "free_cash_flow_reported": "1349.0", "free_cash_flow_calculated": "1567.0", "eps": "30.93", "dividend_per_share": "22.0", "ebitda_margin_pct": "39.6508279337653", "ebit_margin_pct": "18.3585313174946", "net_margin_pct": "14.425846", "reported_fcf_margin_pct": "12.140028797696184", "calculated_fcf_margin_pct": "14.1019", "roe_pct": "14.35", "roa_pct": null, "debt_to_equity": "0.54", "cash_to_debt": null, "net_debt_to_ebitda": null, "dividend_payout_ratio": null, "revenue_growth_pct": "-0.6348922471608676", "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": "-10.8646", "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "public_beta_accounting_subset", "notes": "Accounting ratios are calculated from available public beta fundamentals. Free-cash-flow margins follow the reported or calculated FCF field indicated by row metadata; blank values indicate unavailable inputs.", "capex_reported_basis": "missing", "capex_calculated_basis": "cash_flow_capex", "free_cash_flow_reported_basis": "reported", "free_cash_flow_calculated_basis": "calculated_ocf_plus_capex", "capex_basis_status": "confirmed", "free_cash_flow_basis_status": "confirmed" }, { "ticker": "SCMN.SW", "company_name": "Swisscom AG", "sector": "Telecom / Infrastructure", "industry": "Telecommunications", "fiscal_year": "2023", "reporting_currency": "CHF", "revenue": "11072.0", "ebitda": "4622.0", "ebit": "2205.0", "net_income": "1711.0", "total_assets": "24750.0", "total_equity": "11622.0", "cash": "148.0", "total_debt": "7580.0", "net_debt": "7432.0", "operating_cash_flow": "4029.0", "capex_reported": null, "capex_calculated": "-2292.0", "free_cash_flow_reported": "1480.0", "free_cash_flow_calculated": "1737.0", "eps": null, "dividend_per_share": "22.0", "ebitda_margin_pct": "41.744942", "ebit_margin_pct": "19.915101", "net_margin_pct": "15.453396", "reported_fcf_margin_pct": "13.367052023121389", "calculated_fcf_margin_pct": "15.6882", "roe_pct": "14.72", "roa_pct": null, "debt_to_equity": "0.65", "cash_to_debt": null, "net_debt_to_ebitda": null, "dividend_payout_ratio": null, "revenue_growth_pct": "-0.3599712023038104", "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": "10.8488", "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "public_beta_accounting_subset", "notes": "Accounting ratios are calculated from available public beta fundamentals. Free-cash-flow margins follow the reported or calculated FCF field indicated by row metadata; blank values indicate unavailable inputs.", "capex_reported_basis": "missing", "capex_calculated_basis": "cash_flow_capex", "free_cash_flow_reported_basis": "reported", "free_cash_flow_calculated_basis": "calculated_ocf_plus_capex", "capex_basis_status": "confirmed", "free_cash_flow_basis_status": "confirmed" }, { "ticker": "SCMN.SW", "company_name": "Swisscom AG", "sector": "Telecom / Infrastructure", "industry": "Telecommunications", "fiscal_year": "2024", "reporting_currency": "CHF", "revenue": "11036.0", "ebitda": "4355.0", "ebit": "1951.0", "net_income": "1541.0", "total_assets": "37211.0", "total_equity": "12155.0", "cash": "1523.0", "total_debt": "17535.0", "net_debt": "16012.0", "operating_cash_flow": "3977.0", "capex_reported": null, "capex_calculated": "-2312.0", "free_cash_flow_reported": "1437.0", "free_cash_flow_calculated": "1665.0", "eps": "29.77", "dividend_per_share": "22.0", "ebitda_margin_pct": "39.46176150779268", "ebit_margin_pct": "17.67850670532802", "net_margin_pct": "13.96339253352664", "reported_fcf_margin_pct": "13.021022109459947", "calculated_fcf_margin_pct": "15.087", "roe_pct": "12.68", "roa_pct": null, "debt_to_equity": "1.44", "cash_to_debt": null, "net_debt_to_ebitda": null, "dividend_payout_ratio": null, "revenue_growth_pct": "-0.3251445086705162", "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": "-4.1451", "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "public_beta_accounting_subset", "notes": "Accounting ratios are calculated from available public beta fundamentals. Free-cash-flow margins follow the reported or calculated FCF field indicated by row metadata; blank values indicate unavailable inputs.", "capex_reported_basis": "missing", "capex_calculated_basis": "cash_flow_capex", "free_cash_flow_reported_basis": "reported", "free_cash_flow_calculated_basis": "calculated_ocf_plus_capex", "capex_basis_status": "confirmed", "free_cash_flow_basis_status": "confirmed" }, { "ticker": "SCMN.SW", "company_name": "Swisscom AG", "sector": "Telecom / Infrastructure", "industry": "Telecommunications", "fiscal_year": "2025", "reporting_currency": "CHF", "revenue": "15048.0", "ebitda": "6617.0", "ebit": "1925.0", "net_income": "1270.0", "total_assets": "36023.0", "total_equity": "12238.0", "cash": "258.0", "total_debt": "16718.0", "net_debt": "16460.0", "operating_cash_flow": "6012.0", "capex_reported": "3064.0", "capex_calculated": "-3008.0", "free_cash_flow_reported": "1433.0", "free_cash_flow_calculated": "3004.0", "eps": null, "dividend_per_share": "26.0", "ebitda_margin_pct": "43.972621", "ebit_margin_pct": "12.792397660818713", "net_margin_pct": "8.43965975544923", "reported_fcf_margin_pct": "9.522860180754918", "calculated_fcf_margin_pct": "19.9628", "roe_pct": "10.38", "roa_pct": null, "debt_to_equity": "1.37", "cash_to_debt": null, "net_debt_to_ebitda": null, "dividend_payout_ratio": null, "revenue_growth_pct": "36.3537513591881", "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": "80.4204", "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "public_beta_accounting_subset", "notes": "Accounting ratios are calculated from available public beta fundamentals. Free-cash-flow margins follow the reported or calculated FCF field indicated by row metadata; blank values indicate unavailable inputs.", "capex_reported_basis": "reported", "capex_calculated_basis": "cash_flow_capex", "free_cash_flow_reported_basis": "reported", "free_cash_flow_calculated_basis": "calculated_ocf_plus_capex", "capex_basis_status": "confirmed", "free_cash_flow_basis_status": "confirmed" }, { "ticker": "SIKA.SW", "company_name": "Sika AG", "sector": "Chemicals / Construction Materials", "industry": "Specialty Chemicals", "fiscal_year": "2015", "reporting_currency": "CHF", "revenue": "5489.2", "ebitda": "837.3", "ebit": "673.3", "net_income": "465.1", "total_assets": "4923.8", "total_equity": "2552.1", "cash": "1074.4", "total_debt": "948.3", "net_debt": "-126.1", "operating_cash_flow": "585.8", "capex_reported": null, "capex_calculated": "-135.6", "free_cash_flow_reported": "379.5", "free_cash_flow_calculated": "450.2", "eps": "30.23", "dividend_per_share": "13.0", "ebitda_margin_pct": "15.253589", "ebit_margin_pct": "12.265904", "net_margin_pct": "8.473002", "reported_fcf_margin_pct": "6.9135757487429865", "calculated_fcf_margin_pct": "8.2", "roe_pct": "18.22", "roa_pct": null, "debt_to_equity": "0.37", "cash_to_debt": null, "net_debt_to_ebitda": null, "dividend_payout_ratio": null, "revenue_growth_pct": null, "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": null, "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "public_beta_accounting_subset", "notes": "Accounting ratios are calculated from available public beta fundamentals. Free-cash-flow margins follow the reported or calculated FCF field indicated by row metadata; blank values indicate unavailable inputs.", "capex_reported_basis": "missing", "capex_calculated_basis": "cash_flow_capex", "free_cash_flow_reported_basis": "reported", "free_cash_flow_calculated_basis": "calculated_ocf_minus_ppe_capex", "capex_basis_status": "confirmed", "free_cash_flow_basis_status": "confirmed" }, { "ticker": "SIKA.SW", "company_name": "Sika AG", "sector": "Chemicals / Construction Materials", "industry": "Specialty Chemicals", "fiscal_year": "2016", "reporting_currency": "CHF", "revenue": "5747.7", "ebitda": "965.7", "ebit": "795.3", "net_income": "566.6", "total_assets": "5099.2", "total_equity": "2947.7", "cash": "1155.0", "total_debt": "698.7", "net_debt": "-456.3", "operating_cash_flow": "735.7", "capex_reported": null, "capex_calculated": "-149.5", "free_cash_flow_reported": "563.0", "free_cash_flow_calculated": "586.2", "eps": "36.97", "dividend_per_share": "17.0", "ebitda_margin_pct": "16.801503", "ebit_margin_pct": "13.836839", "net_margin_pct": "9.857856", "reported_fcf_margin_pct": "9.795222436800808", "calculated_fcf_margin_pct": "10.2", "roe_pct": "19.22", "roa_pct": null, "debt_to_equity": "0.24", "cash_to_debt": null, "net_debt_to_ebitda": null, "dividend_payout_ratio": null, "revenue_growth_pct": "4.7092472491437665", "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": null, "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "public_beta_accounting_subset", "notes": "Accounting ratios are calculated from available public beta fundamentals. Free-cash-flow margins follow the reported or calculated FCF field indicated by row metadata; blank values indicate unavailable inputs.", "capex_reported_basis": "missing", "capex_calculated_basis": "cash_flow_capex", "free_cash_flow_reported_basis": "reported", "free_cash_flow_calculated_basis": "calculated_ocf_minus_ppe_capex", "capex_basis_status": "confirmed", "free_cash_flow_basis_status": "confirmed" }, { "ticker": "SIKA.SW", "company_name": "Sika AG", "sector": "Chemicals / Construction Materials", "industry": "Specialty Chemicals", "fiscal_year": "2017", "reporting_currency": "CHF", "revenue": "6248.3", "ebitda": "1068.5", "ebit": "896.3", "net_income": "649.0", "total_assets": "5792.2", "total_equity": "3411.1", "cash": "1037.9", "total_debt": "752.0", "net_debt": "-285.9", "operating_cash_flow": "651.9", "capex_reported": null, "capex_calculated": "-158.5", "free_cash_flow_reported": "173.7", "free_cash_flow_calculated": "493.4", "eps": "42.25", "dividend_per_share": "18.5", "ebitda_margin_pct": "17.100651", "ebit_margin_pct": "14.344702", "net_margin_pct": "10.386825", "reported_fcf_margin_pct": "2.779956148072275", "calculated_fcf_margin_pct": "7.9", "roe_pct": "19.03", "roa_pct": null, "debt_to_equity": "0.22", "cash_to_debt": null, "net_debt_to_ebitda": null, "dividend_payout_ratio": null, "revenue_growth_pct": "8.709570784835673", "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": null, "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "public_beta_accounting_subset", "notes": "Accounting ratios are calculated from available public beta fundamentals. Free-cash-flow margins follow the reported or calculated FCF field indicated by row metadata; blank values indicate unavailable inputs.", "capex_reported_basis": "missing", "capex_calculated_basis": "cash_flow_capex", "free_cash_flow_reported_basis": "reported", "free_cash_flow_calculated_basis": "calculated_ocf_minus_ppe_capex", "capex_basis_status": "confirmed", "free_cash_flow_basis_status": "confirmed" }, { "ticker": "SIKA.SW", "company_name": "Sika AG", "sector": "Chemicals / Construction Materials", "industry": "Specialty Chemicals", "fiscal_year": "2018", "reporting_currency": "CHF", "revenue": "7085.4", "ebitda": "1149.9", "ebit": "945.9", "net_income": "687.1", "total_assets": "6382.2", "total_equity": "1675.4", "cash": "914.0", "total_debt": "3032.5", "net_debt": "2118.5", "operating_cash_flow": "744.0", "capex_reported": null, "capex_calculated": "-233.4", "free_cash_flow_reported": "38.8", "free_cash_flow_calculated": "510.6", "eps": "4.69", "dividend_per_share": "2.05", "ebitda_margin_pct": "16.229147", "ebit_margin_pct": "13.349987", "net_margin_pct": "9.697406", "reported_fcf_margin_pct": "0.5476049340898185", "calculated_fcf_margin_pct": "7.21", "roe_pct": "41.01", "roa_pct": null, "debt_to_equity": "1.81", "cash_to_debt": null, "net_debt_to_ebitda": null, "dividend_payout_ratio": null, "revenue_growth_pct": "13.397244050381696", "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": null, "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "public_beta_accounting_subset", "notes": "Accounting ratios are calculated from available public beta fundamentals. Free-cash-flow margins follow the reported or calculated FCF field indicated by row metadata; blank values indicate unavailable inputs.", "capex_reported_basis": "missing", "capex_calculated_basis": "cash_flow_capex", "free_cash_flow_reported_basis": "reported", "free_cash_flow_calculated_basis": "calculated_ocf_minus_ppe_capex", "capex_basis_status": "confirmed", "free_cash_flow_basis_status": "confirmed" }, { "ticker": "SIKA.SW", "company_name": "Sika AG", "sector": "Chemicals / Construction Materials", "industry": "Specialty Chemicals", "fiscal_year": "2019", "reporting_currency": "CHF", "revenue": "8109.2", "ebitda": "1387.6", "ebit": "1055.1", "net_income": "758.5", "total_assets": "9945.2", "total_equity": "3161.2", "cash": "995.1", "total_debt": "4412.9", "net_debt": "3417.8", "operating_cash_flow": "1213.9", "capex_reported": null, "capex_calculated": "-179.7", "free_cash_flow_reported": "-717.0", "free_cash_flow_calculated": "1034.2", "eps": "5.3", "dividend_per_share": "2.3", "ebitda_margin_pct": "17.111429", "ebit_margin_pct": "13.011148", "net_margin_pct": "9.353574", "reported_fcf_margin_pct": "-8.84180930301386", "calculated_fcf_margin_pct": "12.75", "roe_pct": "23.99", "roa_pct": null, "debt_to_equity": "1.4", "cash_to_debt": null, "net_debt_to_ebitda": null, "dividend_payout_ratio": null, "revenue_growth_pct": "14.44943122477207", "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": null, "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "public_beta_accounting_subset", "notes": "Accounting ratios are calculated from available public beta fundamentals. Free-cash-flow margins follow the reported or calculated FCF field indicated by row metadata; blank values indicate unavailable inputs.", "capex_reported_basis": "missing", "capex_calculated_basis": "cash_flow_capex", "free_cash_flow_reported_basis": "reported", "free_cash_flow_calculated_basis": "calculated_ocf_minus_ppe_capex", "capex_basis_status": "confirmed", "free_cash_flow_basis_status": "confirmed" }, { "ticker": "SIKA.SW", "company_name": "Sika AG", "sector": "Chemicals / Construction Materials", "industry": "Specialty Chemicals", "fiscal_year": "2020", "reporting_currency": "CHF", "revenue": "7877.5", "ebitda": "1497.6", "ebit": "1130.5", "net_income": "825.1", "total_assets": "9794.0", "total_equity": "3288.0", "cash": "1318.7", "total_debt": "4186.6", "net_debt": "2867.9", "operating_cash_flow": "1373.4", "capex_reported": null, "capex_calculated": "-120.1", "free_cash_flow_reported": "1120.3", "free_cash_flow_calculated": "1253.3", "eps": "5.82", "dividend_per_share": "2.5", "ebitda_margin_pct": "19.011108", "ebit_margin_pct": "14.351", "net_margin_pct": "10.474135", "reported_fcf_margin_pct": "14.22151697873691", "calculated_fcf_margin_pct": "15.91", "roe_pct": "25.09", "roa_pct": null, "debt_to_equity": "1.27", "cash_to_debt": null, "net_debt_to_ebitda": null, "dividend_payout_ratio": null, "revenue_growth_pct": "-2.857248557194292", "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": null, "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "public_beta_accounting_subset", "notes": "Accounting ratios are calculated from available public beta fundamentals. Free-cash-flow margins follow the reported or calculated FCF field indicated by row metadata; blank values indicate unavailable inputs.", "capex_reported_basis": "missing", "capex_calculated_basis": "cash_flow_capex", "free_cash_flow_reported_basis": "reported", "free_cash_flow_calculated_basis": "calculated_ocf_minus_ppe_capex", "capex_basis_status": "confirmed", "free_cash_flow_basis_status": "confirmed" }, { "ticker": "SIKA.SW", "company_name": "Sika AG", "sector": "Chemicals / Construction Materials", "industry": "Specialty Chemicals", "fiscal_year": "2021", "reporting_currency": "CHF", "revenue": "9252.3", "ebitda": "1758.0", "ebit": "1391.4", "net_income": "1048.5", "total_assets": "10699.9", "total_equity": "4395.9", "cash": "1175.0", "total_debt": "3728.8", "net_debt": "2553.8", "operating_cash_flow": "1064.1", "capex_reported": null, "capex_calculated": "-157.3", "free_cash_flow_reported": "594.9", "free_cash_flow_calculated": "906.8", "eps": "7.39", "dividend_per_share": "2.9", "ebitda_margin_pct": "19.000681", "ebit_margin_pct": "15.038423", "net_margin_pct": "11.332317", "reported_fcf_margin_pct": "6.429752602055705", "calculated_fcf_margin_pct": "9.8", "roe_pct": "23.85", "roa_pct": null, "debt_to_equity": "0.85", "cash_to_debt": null, "net_debt_to_ebitda": null, "dividend_payout_ratio": null, "revenue_growth_pct": "17.452237384957137", "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": null, "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "public_beta_accounting_subset", "notes": "Accounting ratios are calculated from available public beta fundamentals. Free-cash-flow margins follow the reported or calculated FCF field indicated by row metadata; blank values indicate unavailable inputs.", "capex_reported_basis": "missing", "capex_calculated_basis": "cash_flow_capex", "free_cash_flow_reported_basis": "reported", "free_cash_flow_calculated_basis": "calculated_ocf_minus_ppe_capex", "capex_basis_status": "confirmed", "free_cash_flow_basis_status": "confirmed" }, { "ticker": "SIKA.SW", "company_name": "Sika AG", "sector": "Chemicals / Construction Materials", "industry": "Specialty Chemicals", "fiscal_year": "2022", "reporting_currency": "CHF", "revenue": "10491.8", "ebitda": "1964.2", "ebit": "1579.7", "net_income": "1162.5", "total_assets": "11319.2", "total_equity": "4967.1", "cash": "1873.3", "total_debt": "3937.2", "net_debt": "2063.9", "operating_cash_flow": "1099.8", "capex_reported": null, "capex_calculated": "-238.0", "free_cash_flow_reported": "930.8", "free_cash_flow_calculated": "861.8", "eps": "7.57", "dividend_per_share": "3.2", "ebitda_margin_pct": "18.721287", "ebit_margin_pct": "15.05652", "net_margin_pct": "11.080082", "reported_fcf_margin_pct": "8.87169027240321", "calculated_fcf_margin_pct": "8.21", "roe_pct": "23.4", "roa_pct": null, "debt_to_equity": "0.79", "cash_to_debt": null, "net_debt_to_ebitda": null, "dividend_payout_ratio": null, "revenue_growth_pct": "13.396668936372569", "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": null, "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "public_beta_accounting_subset", "notes": "Accounting ratios are calculated from available public beta fundamentals. Free-cash-flow margins follow the reported or calculated FCF field indicated by row metadata; blank values indicate unavailable inputs.", "capex_reported_basis": "missing", "capex_calculated_basis": "cash_flow_capex", "free_cash_flow_reported_basis": "reported", "free_cash_flow_calculated_basis": "calculated_ocf_minus_ppe_capex", "capex_basis_status": "confirmed", "free_cash_flow_basis_status": "confirmed" }, { "ticker": "SIKA.SW", "company_name": "Sika AG", "sector": "Chemicals / Construction Materials", "industry": "Specialty Chemicals", "fiscal_year": "2023", "reporting_currency": "CHF", "revenue": "11238.6", "ebitda": "2044.7", "ebit": "1549.1", "net_income": "1062.6", "total_assets": "15049.2", "total_equity": "5933.2", "cash": "643.9", "total_debt": "5949.9", "net_debt": "5306", "operating_cash_flow": "1714.2", "capex_reported": null, "capex_calculated": "-256.8", "free_cash_flow_reported": "-1801.3", "free_cash_flow_calculated": "1457.4", "eps": "6.82", "dividend_per_share": "3.3", "ebitda_margin_pct": "18.193547", "ebit_margin_pct": "13.783745", "net_margin_pct": "9.454914", "reported_fcf_margin_pct": "-16.027797", "calculated_fcf_margin_pct": "12.97", "roe_pct": "17.91", "roa_pct": null, "debt_to_equity": "1.0", "cash_to_debt": null, "net_debt_to_ebitda": null, "dividend_payout_ratio": null, "revenue_growth_pct": "7.11793972435617", "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": null, "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "public_beta_accounting_subset", "notes": "Accounting ratios are calculated from available public beta fundamentals. Free-cash-flow margins follow the reported or calculated FCF field indicated by row metadata; blank values indicate unavailable inputs.", "capex_reported_basis": "missing", "capex_calculated_basis": "cash_flow_capex", "free_cash_flow_reported_basis": "reported", "free_cash_flow_calculated_basis": "operating_cash_flow_plus_capex_calculated", "capex_basis_status": "confirmed", "free_cash_flow_basis_status": "confirmed" }, { "ticker": "SIKA.SW", "company_name": "Sika AG", "sector": "Chemicals / Construction Materials", "industry": "Specialty Chemicals", "fiscal_year": "2024", "reporting_currency": "CHF", "revenue": "11763.1", "ebitda": "2269.5", "ebit": "1713.9", "net_income": "1247.6", "total_assets": "15977.2", "total_equity": "7046.8", "cash": "707.5", "total_debt": "5762.2", "net_debt": "5054.7", "operating_cash_flow": "1742.8", "capex_reported": null, "capex_calculated": "-331.1", "free_cash_flow_reported": "1137.7", "free_cash_flow_calculated": "1411.7", "eps": "7.76", "dividend_per_share": "3.6", "ebitda_margin_pct": "19.293384", "ebit_margin_pct": "14.570139", "net_margin_pct": "10.606048", "reported_fcf_margin_pct": "9.67177019663184", "calculated_fcf_margin_pct": "12.0", "roe_pct": "17.7", "roa_pct": null, "debt_to_equity": "0.82", "cash_to_debt": null, "net_debt_to_ebitda": null, "dividend_payout_ratio": null, "revenue_growth_pct": "4.666951399640529", "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": null, "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "public_beta_accounting_subset", "notes": "Accounting ratios are calculated from available public beta fundamentals. Free-cash-flow margins follow the reported or calculated FCF field indicated by row metadata; blank values indicate unavailable inputs.", "capex_reported_basis": "missing", "capex_calculated_basis": "cash_flow_capex", "free_cash_flow_reported_basis": "reported", "free_cash_flow_calculated_basis": "calculated_ocf_minus_ppe_capex", "capex_basis_status": "confirmed", "free_cash_flow_basis_status": "confirmed" }, { "ticker": "SIKA.SW", "company_name": "Sika AG", "sector": "Chemicals / Construction Materials", "industry": "Specialty Chemicals", "fiscal_year": "2025", "reporting_currency": "CHF", "revenue": "11201.3", "ebitda": "2064.7", "ebit": "1493.2", "net_income": "1045.3", "total_assets": "15148.3", "total_equity": "6666.7", "cash": "801.8", "total_debt": "5549.2", "net_debt": "4747.4", "operating_cash_flow": "1707.9", "capex_reported": null, "capex_calculated": "-348.1", "free_cash_flow_reported": "1156.0", "free_cash_flow_calculated": "1359.8", "eps": "6.51", "dividend_per_share": "3.7", "ebitda_margin_pct": "18.432682", "ebit_margin_pct": "13.330596", "net_margin_pct": "9.331953", "reported_fcf_margin_pct": "10.320230687509486", "calculated_fcf_margin_pct": "12.14", "roe_pct": "15.68", "roa_pct": null, "debt_to_equity": "0.83", "cash_to_debt": null, "net_debt_to_ebitda": null, "dividend_payout_ratio": null, "revenue_growth_pct": "-4.775951917436738", "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": null, "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "public_beta_accounting_subset", "notes": "Accounting ratios are calculated from available public beta fundamentals. Free-cash-flow margins follow the reported or calculated FCF field indicated by row metadata; blank values indicate unavailable inputs.", "capex_reported_basis": "missing", "capex_calculated_basis": "cash_flow_capex", "free_cash_flow_reported_basis": "reported", "free_cash_flow_calculated_basis": "calculated_ocf_minus_ppe_capex", "capex_basis_status": "confirmed", "free_cash_flow_basis_status": "confirmed" }, { "ticker": "BANB.SW", "company_name": "Bachem Holding AG", "sector": "Health Care", "industry": "Peptides / Pharmaceutical Ingredients / CDMO", "fiscal_year": "2015", "reporting_currency": "CHF", "revenue": "208.604", "ebitda": "56.8", "ebit": "38.495", "net_income": "31.838", "total_assets": "443.832", "total_equity": "353.363", "cash": "23.249", "total_debt": "17.423", "net_debt": "-5.826", "operating_cash_flow": "61.434", "capex_reported": null, "capex_calculated": "-25.38", "free_cash_flow_reported": null, "free_cash_flow_calculated": "36.054", "eps": "2.35", "dividend_per_share": "2.25", "ebitda_margin_pct": "27.228625", "ebit_margin_pct": "18.453625", "net_margin_pct": "15.262411", "reported_fcf_margin_pct": null, "calculated_fcf_margin_pct": "17.283465", "roe_pct": "9.009998", "roa_pct": "7.173435", "debt_to_equity": "0.049306", "cash_to_debt": "1.334386", "net_debt_to_ebitda": "-0.10257", "dividend_payout_ratio": "0.957447", "revenue_growth_pct": null, "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": null, "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated from locked annual report snapshot only; capex_reported is not backfilled from capex_calculated. EPS growth and dividend payout ratio use as-reported share-level values; interpret FY2021-FY2022 across the 1:5 share split with caution. FY2015-FY2020 source is third_party_archive because official Bachem direct PDFs were not located during Phase 0A. Year-over-year growth fields are blank because no FY2014 locked row exists. 3-year revenue CAGR is blank because the year-minus-3 locked row is unavailable. 5-year revenue CAGR is blank because the year-minus-5 locked row is unavailable.", "capex_reported_basis": "missing", "capex_calculated_basis": "calculated_from_cash_flow", "free_cash_flow_reported_basis": "missing", "free_cash_flow_calculated_basis": "calculated_ocf_plus_capex", "capex_basis_status": "documented_missing", "free_cash_flow_basis_status": "documented_missing" }, { "ticker": "BANB.SW", "company_name": "Bachem Holding AG", "sector": "Health Care", "industry": "Peptides / Pharmaceutical Ingredients / CDMO", "fiscal_year": "2016", "reporting_currency": "CHF", "revenue": "236.478", "ebitda": "64.8", "ebit": "45.056", "net_income": "41.205", "total_assets": "496.509", "total_equity": "365.364", "cash": "19.206", "total_debt": "55.436", "net_debt": "36.23", "operating_cash_flow": "40.409", "capex_reported": null, "capex_calculated": "-51.261", "free_cash_flow_reported": null, "free_cash_flow_calculated": "-10.852", "eps": "3.04", "dividend_per_share": "2.5", "ebitda_margin_pct": "27.402126", "ebit_margin_pct": "19.052935", "net_margin_pct": "17.424454", "reported_fcf_margin_pct": null, "calculated_fcf_margin_pct": "-4.58901", "roe_pct": "11.277794", "roa_pct": "8.298943", "debt_to_equity": "0.151728", "cash_to_debt": "0.346454", "net_debt_to_ebitda": "0.559105", "dividend_payout_ratio": "0.822368", "revenue_growth_pct": "13.36216", "ebit_growth_pct": "17.043772", "eps_growth_pct": "29.361702", "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": "-130.099296", "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated from locked annual report snapshot only; capex_reported is not backfilled from capex_calculated. EPS growth and dividend payout ratio use as-reported share-level values; interpret FY2021-FY2022 across the 1:5 share split with caution. FY2015-FY2020 source is third_party_archive because official Bachem direct PDFs were not located during Phase 0A. 3-year revenue CAGR is blank because the year-minus-3 locked row is unavailable. 5-year revenue CAGR is blank because the year-minus-5 locked row is unavailable.", "capex_reported_basis": "missing", "capex_calculated_basis": "calculated_from_cash_flow", "free_cash_flow_reported_basis": "missing", "free_cash_flow_calculated_basis": "calculated_ocf_plus_capex", "capex_basis_status": "documented_missing", "free_cash_flow_basis_status": "documented_missing" }, { "ticker": "BANB.SW", "company_name": "Bachem Holding AG", "sector": "Health Care", "industry": "Peptides / Pharmaceutical Ingredients / CDMO", "fiscal_year": "2017", "reporting_currency": "CHF", "revenue": "261.612", "ebitda": "71.5", "ebit": "50.61", "net_income": "41.77", "total_assets": "544.655", "total_equity": "374.172", "cash": "17.283", "total_debt": "94.934", "net_debt": "77.651", "operating_cash_flow": "35.745", "capex_reported": null, "capex_calculated": "-50.429", "free_cash_flow_reported": null, "free_cash_flow_calculated": "-14.684", "eps": "3.08", "dividend_per_share": "2.75", "ebitda_margin_pct": "27.330551", "ebit_margin_pct": "19.345443", "net_margin_pct": "15.966393", "reported_fcf_margin_pct": null, "calculated_fcf_margin_pct": "-5.612892", "roe_pct": "11.163315", "roa_pct": "7.669075", "debt_to_equity": "0.253718", "cash_to_debt": "0.182053", "net_debt_to_ebitda": "1.086028", "dividend_payout_ratio": "0.892857", "revenue_growth_pct": "10.628473", "ebit_growth_pct": "12.326882", "eps_growth_pct": "1.315789", "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": "35.311463", "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated from locked annual report snapshot only; capex_reported is not backfilled from capex_calculated. EPS growth and dividend payout ratio use as-reported share-level values; interpret FY2021-FY2022 across the 1:5 share split with caution. FY2015-FY2020 source is third_party_archive because official Bachem direct PDFs were not located during Phase 0A. 3-year revenue CAGR is blank because the year-minus-3 locked row is unavailable. 5-year revenue CAGR is blank because the year-minus-5 locked row is unavailable.", "capex_reported_basis": "missing", "capex_calculated_basis": "calculated_from_cash_flow", "free_cash_flow_reported_basis": "missing", "free_cash_flow_calculated_basis": "calculated_ocf_plus_capex", "capex_basis_status": "documented_missing", "free_cash_flow_basis_status": "documented_missing" }, { "ticker": "BANB.SW", "company_name": "Bachem Holding AG", "sector": "Health Care", "industry": "Peptides / Pharmaceutical Ingredients / CDMO", "fiscal_year": "2018", "reporting_currency": "CHF", "revenue": "282.5", "ebitda": "77.9", "ebit": "54.809", "net_income": "46.644", "total_assets": "614.7", "total_equity": "384.212", "cash": "22.302", "total_debt": "150.46", "net_debt": "128.158", "operating_cash_flow": "25.776", "capex_reported": null, "capex_calculated": "-38.002", "free_cash_flow_reported": null, "free_cash_flow_calculated": "-12.226", "eps": "3.43", "dividend_per_share": "2.75", "ebitda_margin_pct": "27.575221", "ebit_margin_pct": "19.401416", "net_margin_pct": "16.51115", "reported_fcf_margin_pct": null, "calculated_fcf_margin_pct": "-4.327788", "roe_pct": "12.140173", "roa_pct": "7.588092", "debt_to_equity": "0.391607", "cash_to_debt": "0.148225", "net_debt_to_ebitda": "1.64516", "dividend_payout_ratio": "0.801749", "revenue_growth_pct": "7.984343", "ebit_growth_pct": "8.296779", "eps_growth_pct": "11.363636", "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": "-16.739308", "revenue_cagr_3y_pct": "10.636545", "revenue_cagr_5y_pct": null, "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated from locked annual report snapshot only; capex_reported is not backfilled from capex_calculated. EPS growth and dividend payout ratio use as-reported share-level values; interpret FY2021-FY2022 across the 1:5 share split with caution. FY2015-FY2020 source is third_party_archive because official Bachem direct PDFs were not located during Phase 0A. 5-year revenue CAGR is blank because the year-minus-5 locked row is unavailable.", "capex_reported_basis": "missing", "capex_calculated_basis": "calculated_from_cash_flow", "free_cash_flow_reported_basis": "missing", "free_cash_flow_calculated_basis": "calculated_ocf_plus_capex", "capex_basis_status": "documented_missing", "free_cash_flow_basis_status": "documented_missing" }, { "ticker": "BANB.SW", "company_name": "Bachem Holding AG", "sector": "Health Care", "industry": "Peptides / Pharmaceutical Ingredients / CDMO", "fiscal_year": "2019", "reporting_currency": "CHF", "revenue": "313.715", "ebitda": "87.2", "ebit": "62.36", "net_income": "54.164", "total_assets": "647.144", "total_equity": "447.818", "cash": "21.431", "total_debt": "107.101", "net_debt": "85.67", "operating_cash_flow": "64.267", "capex_reported": null, "capex_calculated": "-30.589", "free_cash_flow_reported": null, "free_cash_flow_calculated": "33.678", "eps": "3.91", "dividend_per_share": "3.0", "ebitda_margin_pct": "27.795929", "ebit_margin_pct": "19.877915", "net_margin_pct": "17.265352", "reported_fcf_margin_pct": null, "calculated_fcf_margin_pct": "10.735221", "roe_pct": "12.095092", "roa_pct": "8.369698", "debt_to_equity": "0.239162", "cash_to_debt": "0.200101", "net_debt_to_ebitda": "0.982454", "dividend_payout_ratio": "0.767263", "revenue_growth_pct": "11.049558", "ebit_growth_pct": "13.776934", "eps_growth_pct": "13.994169", "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": "-375.46213", "revenue_cagr_3y_pct": "9.879038", "revenue_cagr_5y_pct": null, "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated from locked annual report snapshot only; capex_reported is not backfilled from capex_calculated. EPS growth and dividend payout ratio use as-reported share-level values; interpret FY2021-FY2022 across the 1:5 share split with caution. FY2015-FY2020 source is third_party_archive because official Bachem direct PDFs were not located during Phase 0A. 5-year revenue CAGR is blank because the year-minus-5 locked row is unavailable.", "capex_reported_basis": "missing", "capex_calculated_basis": "calculated_from_cash_flow", "free_cash_flow_reported_basis": "missing", "free_cash_flow_calculated_basis": "calculated_ocf_plus_capex", "capex_basis_status": "documented_missing", "free_cash_flow_basis_status": "documented_missing" }, { "ticker": "BANB.SW", "company_name": "Bachem Holding AG", "sector": "Health Care", "industry": "Peptides / Pharmaceutical Ingredients / CDMO", "fiscal_year": "2020", "reporting_currency": "CHF", "revenue": "401.995", "ebitda": "122.6", "ebit": "96.663", "net_income": "78.062", "total_assets": "710.884", "total_equity": "475.714", "cash": "23.496", "total_debt": "107.551", "net_debt": "84.055", "operating_cash_flow": "115.04", "capex_reported": null, "capex_calculated": "-69.097", "free_cash_flow_reported": null, "free_cash_flow_calculated": "45.943", "eps": "5.58", "dividend_per_share": "3.25", "ebitda_margin_pct": "30.497892", "ebit_margin_pct": "24.045821", "net_margin_pct": "19.418649", "reported_fcf_margin_pct": null, "calculated_fcf_margin_pct": "11.428749", "roe_pct": "16.409439", "roa_pct": "10.980976", "debt_to_equity": "0.226083", "cash_to_debt": "0.218464", "net_debt_to_ebitda": "0.685604", "dividend_payout_ratio": "0.582437", "revenue_growth_pct": "28.140191", "ebit_growth_pct": "55.008018", "eps_growth_pct": "42.710997", "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": "36.418433", "revenue_cagr_3y_pct": "15.395179", "revenue_cagr_5y_pct": "14.019624", "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated from locked annual report snapshot only; capex_reported is not backfilled from capex_calculated. EPS growth and dividend payout ratio use as-reported share-level values; interpret FY2021-FY2022 across the 1:5 share split with caution. FY2015-FY2020 source is third_party_archive because official Bachem direct PDFs were not located during Phase 0A.", "capex_reported_basis": "missing", "capex_calculated_basis": "calculated_from_cash_flow", "free_cash_flow_reported_basis": "missing", "free_cash_flow_calculated_basis": "calculated_ocf_plus_capex", "capex_basis_status": "documented_missing", "free_cash_flow_basis_status": "documented_missing" }, { "ticker": "BANB.SW", "company_name": "Bachem Holding AG", "sector": "Health Care", "industry": "Peptides / Pharmaceutical Ingredients / CDMO", "fiscal_year": "2021", "reporting_currency": "CHF", "revenue": "503.234", "ebitda": "157.4", "ebit": "128.927", "net_income": "114.682", "total_assets": "1298.496", "total_equity": "1120.998", "cash": "89.191", "total_debt": "20.863", "net_debt": "-68.328", "operating_cash_flow": "97.555", "capex_reported": null, "capex_calculated": "-116.826", "free_cash_flow_reported": null, "free_cash_flow_calculated": "-19.271", "eps": "8.09", "dividend_per_share": "3.5", "ebitda_margin_pct": "31.277696", "ebit_margin_pct": "25.619692", "net_margin_pct": "22.789001", "reported_fcf_margin_pct": null, "calculated_fcf_margin_pct": "-3.829431", "roe_pct": "10.230348", "roa_pct": "8.83191", "debt_to_equity": "0.018611", "cash_to_debt": "4.27508", "net_debt_to_ebitda": "-0.434104", "dividend_payout_ratio": "0.432633", "revenue_growth_pct": "25.184144", "ebit_growth_pct": "33.377818", "eps_growth_pct": "44.982079", "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": "-141.945454", "revenue_cagr_3y_pct": "21.222669", "revenue_cagr_5y_pct": "16.30432", "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated from locked annual report snapshot only; capex_reported is not backfilled from capex_calculated. EPS growth and dividend payout ratio use as-reported share-level values; interpret FY2021-FY2022 across the 1:5 share split with caution. FY2021-FY2025 source is official_company_source annual report PDF.", "capex_reported_basis": "missing", "capex_calculated_basis": "calculated_from_cash_flow", "free_cash_flow_reported_basis": "missing", "free_cash_flow_calculated_basis": "calculated_ocf_plus_capex", "capex_basis_status": "documented_missing", "free_cash_flow_basis_status": "documented_missing" }, { "ticker": "BANB.SW", "company_name": "Bachem Holding AG", "sector": "Health Care", "industry": "Peptides / Pharmaceutical Ingredients / CDMO", "fiscal_year": "2022", "reporting_currency": "CHF", "revenue": "531.741", "ebitda": "160.5", "ebit": "127.224", "net_income": "100.684", "total_assets": "1383.869", "total_equity": "1169.661", "cash": "31.451", "total_debt": "0.691", "net_debt": "-30.76", "operating_cash_flow": "92.648", "capex_reported": null, "capex_calculated": "-142.344", "free_cash_flow_reported": null, "free_cash_flow_calculated": "-49.696", "eps": "1.37", "dividend_per_share": "0.75", "ebitda_margin_pct": "30.183868", "ebit_margin_pct": "23.925934", "net_margin_pct": "18.934782", "reported_fcf_margin_pct": null, "calculated_fcf_margin_pct": "-9.345903", "roe_pct": "8.607964", "roa_pct": "7.275544", "debt_to_equity": "0.000591", "cash_to_debt": "45.515195", "net_debt_to_ebitda": "-0.191651", "dividend_payout_ratio": "0.547445", "revenue_growth_pct": "5.66476", "ebit_growth_pct": "-1.320903", "eps_growth_pct": "-83.065513", "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": "157.879716", "revenue_cagr_3y_pct": "19.230753", "revenue_cagr_5y_pct": "15.241393", "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated from locked annual report snapshot only; capex_reported is not backfilled from capex_calculated. EPS growth and dividend payout ratio use as-reported share-level values; interpret FY2021-FY2022 across the 1:5 share split with caution. FY2021-FY2025 source is official_company_source annual report PDF.", "capex_reported_basis": "missing", "capex_calculated_basis": "calculated_from_cash_flow", "free_cash_flow_reported_basis": "missing", "free_cash_flow_calculated_basis": "calculated_ocf_plus_capex", "capex_basis_status": "documented_missing", "free_cash_flow_basis_status": "documented_missing" }, { "ticker": "BANB.SW", "company_name": "Bachem Holding AG", "sector": "Health Care", "industry": "Peptides / Pharmaceutical Ingredients / CDMO", "fiscal_year": "2023", "reporting_currency": "CHF", "revenue": "577.316", "ebitda": "166.7", "ebit": "129.38", "net_income": "111.859", "total_assets": "1682.88", "total_equity": "1320.523", "cash": "157.725", "total_debt": "0.401", "net_debt": "-157.324", "operating_cash_flow": "249.864", "capex_reported": null, "capex_calculated": "-268.402", "free_cash_flow_reported": null, "free_cash_flow_calculated": "-18.538", "eps": "1.5", "dividend_per_share": "0.8", "ebitda_margin_pct": "28.875001", "ebit_margin_pct": "22.410604", "net_margin_pct": "19.375697", "reported_fcf_margin_pct": null, "calculated_fcf_margin_pct": "-3.211066", "roe_pct": "8.47081", "roa_pct": "6.646879", "debt_to_equity": "0.000304", "cash_to_debt": "393.329177", "net_debt_to_ebitda": "-0.943755", "dividend_payout_ratio": "0.533333", "revenue_growth_pct": "8.570902", "ebit_growth_pct": "1.694649", "eps_growth_pct": "9.489051", "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": "-62.697199", "revenue_cagr_3y_pct": "12.823001", "revenue_cagr_5y_pct": "15.366317", "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated from locked annual report snapshot only; capex_reported is not backfilled from capex_calculated. EPS growth and dividend payout ratio use as-reported share-level values; interpret FY2021-FY2022 across the 1:5 share split with caution. FY2021-FY2025 source is official_company_source annual report PDF.", "capex_reported_basis": "missing", "capex_calculated_basis": "calculated_from_cash_flow", "free_cash_flow_reported_basis": "missing", "free_cash_flow_calculated_basis": "calculated_ocf_plus_capex", "capex_basis_status": "documented_missing", "free_cash_flow_basis_status": "documented_missing" }, { "ticker": "BANB.SW", "company_name": "Bachem Holding AG", "sector": "Health Care", "industry": "Peptides / Pharmaceutical Ingredients / CDMO", "fiscal_year": "2024", "reporting_currency": "CHF", "revenue": "605.259", "ebitda": "176.3", "ebit": "133.048", "net_income": "120.248", "total_assets": "1922.971", "total_equity": "1391.089", "cash": "95.197", "total_debt": "0.29", "net_debt": "-94.907", "operating_cash_flow": "146.322", "capex_reported": null, "capex_calculated": "-284.618", "free_cash_flow_reported": null, "free_cash_flow_calculated": "-138.296", "eps": "1.6", "dividend_per_share": "0.85", "ebitda_margin_pct": "29.128026", "ebit_margin_pct": "21.981994", "net_margin_pct": "19.867197", "reported_fcf_margin_pct": null, "calculated_fcf_margin_pct": "-22.849061", "roe_pct": "8.644163", "roa_pct": "6.25324", "debt_to_equity": "0.000208", "cash_to_debt": "328.265517", "net_debt_to_ebitda": "-0.538327", "dividend_payout_ratio": "0.53125", "revenue_growth_pct": "4.840157", "ebit_growth_pct": "2.83506", "eps_growth_pct": "6.666667", "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": "646.013594", "revenue_cagr_3y_pct": "6.346637", "revenue_cagr_5y_pct": "14.046298", "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated from locked annual report snapshot only; capex_reported is not backfilled from capex_calculated. EPS growth and dividend payout ratio use as-reported share-level values; interpret FY2021-FY2022 across the 1:5 share split with caution. FY2021-FY2025 source is official_company_source annual report PDF.", "capex_reported_basis": "missing", "capex_calculated_basis": "calculated_from_cash_flow", "free_cash_flow_reported_basis": "missing", "free_cash_flow_calculated_basis": "calculated_ocf_plus_capex", "capex_basis_status": "documented_missing", "free_cash_flow_basis_status": "documented_missing" }, { "ticker": "BANB.SW", "company_name": "Bachem Holding AG", "sector": "Health Care", "industry": "Peptides / Pharmaceutical Ingredients / CDMO", "fiscal_year": "2025", "reporting_currency": "CHF", "revenue": "695.07", "ebitda": "214.7", "ebit": "167.303", "net_income": "148.793", "total_assets": "2108.725", "total_equity": "1458.317", "cash": "30.988", "total_debt": "57.392", "net_debt": "26.404", "operating_cash_flow": "271.573", "capex_reported": "-332.6", "capex_calculated": "-329.396", "free_cash_flow_reported": null, "free_cash_flow_calculated": "-57.823", "eps": "1.98", "dividend_per_share": "0.9", "ebitda_margin_pct": "30.888975", "ebit_margin_pct": "24.06995", "net_margin_pct": "21.406909", "reported_fcf_margin_pct": null, "calculated_fcf_margin_pct": "-8.319018", "roe_pct": "10.203063", "roa_pct": "7.056065", "debt_to_equity": "0.039355", "cash_to_debt": "0.539936", "net_debt_to_ebitda": "0.122981", "dividend_payout_ratio": "0.454545", "revenue_growth_pct": "14.838441", "ebit_growth_pct": "25.746347", "eps_growth_pct": "23.75", "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": "-58.188957", "revenue_cagr_3y_pct": "9.33926", "revenue_cagr_5y_pct": "11.573634", "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated from locked annual report snapshot only; capex_reported is not backfilled from capex_calculated. EPS growth and dividend payout ratio use as-reported share-level values; interpret FY2021-FY2022 across the 1:5 share split with caution. FY2021-FY2025 source is official_company_source annual report PDF.", "capex_reported_basis": "reported", "capex_calculated_basis": "calculated_from_cash_flow", "free_cash_flow_reported_basis": "missing", "free_cash_flow_calculated_basis": "calculated_ocf_plus_capex", "capex_basis_status": "confirmed", "free_cash_flow_basis_status": "documented_missing" }, { "ticker": "SFZN.SW", "company_name": "Siegfried Holding AG", "sector": "Health Care", "industry": "Pharmaceutical manufacturing", "fiscal_year": "2015", "reporting_currency": null, "revenue": null, "ebitda": null, "ebit": null, "net_income": null, "total_assets": null, "total_equity": null, "cash": null, "total_debt": null, "net_debt": null, "operating_cash_flow": null, "capex_reported": null, "capex_calculated": null, "free_cash_flow_reported": null, "free_cash_flow_calculated": null, "eps": null, "dividend_per_share": null, "ebitda_margin_pct": null, "ebit_margin_pct": null, "net_margin_pct": null, "reported_fcf_margin_pct": null, "calculated_fcf_margin_pct": null, "roe_pct": null, "roa_pct": null, "debt_to_equity": null, "cash_to_debt": null, "net_debt_to_ebitda": null, "dividend_payout_ratio": null, "revenue_growth_pct": null, "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": null, "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "documented_missing", "notes": "Documented-missing public placeholder; no value is published for this field or period.", "capex_reported_basis": "missing", "capex_calculated_basis": "missing", "free_cash_flow_reported_basis": "missing", "free_cash_flow_calculated_basis": "missing", "capex_basis_status": "documented_missing", "free_cash_flow_basis_status": "documented_missing" }, { "ticker": "SFZN.SW", "company_name": "Siegfried Holding AG", "sector": "Health Care", "industry": "Pharmaceutical manufacturing", "fiscal_year": "2016", "reporting_currency": "CHF", "revenue": "717.729", "ebitda": "96.7", "ebit": "46.714", "net_income": "27.906", "total_assets": "1021.357", "total_equity": "660.736", "cash": "31.636", "total_debt": "101.107", "net_debt": "69.471", "operating_cash_flow": "57.113", "capex_reported": "68.4", "capex_calculated": "-68.425", "free_cash_flow_reported": "-11.2", "free_cash_flow_calculated": "-11.312", "eps": "7.18", "dividend_per_share": null, "ebitda_margin_pct": "13.473052", "ebit_margin_pct": "6.508585", "net_margin_pct": "3.888097", "reported_fcf_margin_pct": "-1.560478", "calculated_fcf_margin_pct": "-1.576082", "roe_pct": "4.223472", "roa_pct": "2.732247", "debt_to_equity": "0.153022", "cash_to_debt": "0.312896", "net_debt_to_ebitda": "0.718418", "dividend_payout_ratio": null, "revenue_growth_pct": null, "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": null, "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated only from published annual-report fields; blanks indicate missing denominators or documented missing/source-limited inputs.", "capex_reported_basis": "reported", "capex_calculated_basis": "cash_flow_capex", "free_cash_flow_reported_basis": "reported", "free_cash_flow_calculated_basis": "calculated_ocf_plus_capex", "capex_basis_status": "confirmed", "free_cash_flow_basis_status": "confirmed" }, { "ticker": "SFZN.SW", "company_name": "Siegfried Holding AG", "sector": "Health Care", "industry": "Pharmaceutical manufacturing", "fiscal_year": "2017", "reporting_currency": "CHF", "revenue": "750.468", "ebitda": "113.9", "ebit": "64.576", "net_income": "39.732", "total_assets": "1068.606", "total_equity": "673.384", "cash": "34.137", "total_debt": "100.0", "net_debt": "65.863", "operating_cash_flow": "84.422", "capex_reported": "52.8", "capex_calculated": "-52.84", "free_cash_flow_reported": "32.1", "free_cash_flow_calculated": "31.582", "eps": "10.01", "dividend_per_share": null, "ebitda_margin_pct": "15.177196", "ebit_margin_pct": "8.604764", "net_margin_pct": "5.294296", "reported_fcf_margin_pct": "4.277331", "calculated_fcf_margin_pct": "4.208307", "roe_pct": "5.900348", "roa_pct": "3.718115", "debt_to_equity": "0.148504", "cash_to_debt": "0.34137", "net_debt_to_ebitda": "0.578253", "dividend_payout_ratio": null, "revenue_growth_pct": "4.561471", "ebit_growth_pct": "38.236931", "eps_growth_pct": "39.415042", "reported_fcf_growth_pct": "-386.607143", "calculated_fcf_growth_pct": "-379.19024", "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated only from published annual-report fields; blanks indicate missing denominators or documented missing/source-limited inputs.", "capex_reported_basis": "reported", "capex_calculated_basis": "cash_flow_capex", "free_cash_flow_reported_basis": "reported", "free_cash_flow_calculated_basis": "calculated_ocf_plus_capex", "capex_basis_status": "confirmed", "free_cash_flow_basis_status": "confirmed" }, { "ticker": "SFZN.SW", "company_name": "Siegfried Holding AG", "sector": "Health Care", "industry": "Pharmaceutical manufacturing", "fiscal_year": "2018", "reporting_currency": "CHF", "revenue": "794.297", "ebitda": "125.9", "ebit": "76.28", "net_income": "56.31", "total_assets": "1103.109", "total_equity": "678.777", "cash": "39.88", "total_debt": "110.0", "net_debt": "70.12", "operating_cash_flow": "106.001", "capex_reported": "60.1", "capex_calculated": "-60.053", "free_cash_flow_reported": "46.0", "free_cash_flow_calculated": "45.948", "eps": "13.52", "dividend_per_share": null, "ebitda_margin_pct": "15.850494", "ebit_margin_pct": "9.603461", "net_margin_pct": "7.089288", "reported_fcf_margin_pct": "5.791285", "calculated_fcf_margin_pct": "5.784738", "roe_pct": "8.295803", "roa_pct": "5.104663", "debt_to_equity": "0.162056", "cash_to_debt": "0.362545", "net_debt_to_ebitda": "0.55695", "dividend_payout_ratio": null, "revenue_growth_pct": "5.840222", "ebit_growth_pct": "18.124381", "eps_growth_pct": "35.064935", "reported_fcf_growth_pct": "43.302181", "calculated_fcf_growth_pct": "45.487936", "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated only from published annual-report fields; blanks indicate missing denominators or documented missing/source-limited inputs.", "capex_reported_basis": "reported", "capex_calculated_basis": "cash_flow_capex", "free_cash_flow_reported_basis": "reported", "free_cash_flow_calculated_basis": "calculated_ocf_plus_capex", "capex_basis_status": "confirmed", "free_cash_flow_basis_status": "confirmed" }, { "ticker": "SFZN.SW", "company_name": "Siegfried Holding AG", "sector": "Health Care", "industry": "Pharmaceutical manufacturing", "fiscal_year": "2019", "reporting_currency": "CHF", "revenue": "833.5", "ebitda": null, "ebit": null, "net_income": "53.147", "total_assets": "1168.7", "total_equity": "691.7", "cash": "25.443", "total_debt": "135.0", "net_debt": "109.557", "operating_cash_flow": "65.643", "capex_reported": "61.9", "capex_calculated": "-61.901", "free_cash_flow_reported": "3.8", "free_cash_flow_calculated": "3.742", "eps": null, "dividend_per_share": null, "ebitda_margin_pct": null, "ebit_margin_pct": null, "net_margin_pct": "6.376365", "reported_fcf_margin_pct": "0.455909", "calculated_fcf_margin_pct": "0.44895", "roe_pct": "7.683533", "roa_pct": "4.547531", "debt_to_equity": "0.195171", "cash_to_debt": "0.188467", "net_debt_to_ebitda": null, "dividend_payout_ratio": null, "revenue_growth_pct": "4.935559", "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": "-91.73913", "calculated_fcf_growth_pct": "-91.856011", "revenue_cagr_3y_pct": "5.111049", "revenue_cagr_5y_pct": null, "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated only from published annual-report fields; blanks indicate missing denominators or documented missing/source-limited inputs.", "capex_reported_basis": "reported", "capex_calculated_basis": "cash_flow_capex", "free_cash_flow_reported_basis": "reported", "free_cash_flow_calculated_basis": "calculated_ocf_plus_capex", "capex_basis_status": "confirmed", "free_cash_flow_basis_status": "confirmed" }, { "ticker": "SFZN.SW", "company_name": "Siegfried Holding AG", "sector": "Health Care", "industry": "Pharmaceutical manufacturing", "fiscal_year": "2020", "reporting_currency": null, "revenue": null, "ebitda": null, "ebit": null, "net_income": null, "total_assets": null, "total_equity": null, "cash": null, "total_debt": null, "net_debt": null, "operating_cash_flow": null, "capex_reported": null, "capex_calculated": null, "free_cash_flow_reported": null, "free_cash_flow_calculated": null, "eps": null, "dividend_per_share": null, "ebitda_margin_pct": null, "ebit_margin_pct": null, "net_margin_pct": null, "reported_fcf_margin_pct": null, "calculated_fcf_margin_pct": null, "roe_pct": null, "roa_pct": null, "debt_to_equity": null, "cash_to_debt": null, "net_debt_to_ebitda": null, "dividend_payout_ratio": null, "revenue_growth_pct": null, "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": null, "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "documented_missing", "notes": "Documented-missing public placeholder; no value is published for this field or period.", "capex_reported_basis": "missing", "capex_calculated_basis": "missing", "free_cash_flow_reported_basis": "missing", "free_cash_flow_calculated_basis": "missing", "capex_basis_status": "documented_missing", "free_cash_flow_basis_status": "documented_missing" }, { "ticker": "SFZN.SW", "company_name": "Siegfried Holding AG", "sector": "Health Care", "industry": "Pharmaceutical manufacturing", "fiscal_year": "2021", "reporting_currency": "CHF", "revenue": "1102.423", "ebitda": "214.8", "ebit": "131.953", "net_income": "95.6", "total_assets": "1669.158", "total_equity": "688.217", "cash": "72.621", "total_debt": "480.0", "net_debt": "407.379", "operating_cash_flow": "119.749", "capex_reported": "113.4", "capex_calculated": "-113.397", "free_cash_flow_reported": "6.5", "free_cash_flow_calculated": "6.352", "eps": "22.73", "dividend_per_share": "3.2", "ebitda_margin_pct": "19.484354", "ebit_margin_pct": "11.969362", "net_margin_pct": "8.671807", "reported_fcf_margin_pct": "0.58961", "calculated_fcf_margin_pct": "0.576185", "roe_pct": "13.890968", "roa_pct": "5.727439", "debt_to_equity": "0.697454", "cash_to_debt": "0.151294", "net_debt_to_ebitda": "1.89655", "dividend_payout_ratio": "0.140783", "revenue_growth_pct": null, "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": null, "revenue_cagr_3y_pct": "11.546286", "revenue_cagr_5y_pct": "8.962624", "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated only from published annual-report fields; blanks indicate missing denominators or documented missing/source-limited inputs.", "capex_reported_basis": "reported", "capex_calculated_basis": "cash_flow_capex", "free_cash_flow_reported_basis": "reported", "free_cash_flow_calculated_basis": "calculated_ocf_plus_capex", "capex_basis_status": "confirmed", "free_cash_flow_basis_status": "confirmed" }, { "ticker": "SFZN.SW", "company_name": "Siegfried Holding AG", "sector": "Health Care", "industry": "Pharmaceutical manufacturing", "fiscal_year": "2022", "reporting_currency": "CHF", "revenue": "1229.518", "ebitda": "312.5", "ebit": "230.777", "net_income": "156.49", "total_assets": "1793.2", "total_equity": "790.928", "cash": "91.483", "total_debt": "510.0", "net_debt": "418.517", "operating_cash_flow": "142.34", "capex_reported": "115.2", "capex_calculated": "-115.208", "free_cash_flow_reported": "27.2", "free_cash_flow_calculated": "27.132", "eps": "37.07", "dividend_per_share": "3.4", "ebitda_margin_pct": "25.416464", "ebit_margin_pct": "18.769713", "net_margin_pct": "12.727752", "reported_fcf_margin_pct": "2.212249", "calculated_fcf_margin_pct": "2.206718", "roe_pct": "19.785619", "roa_pct": "8.726857", "debt_to_equity": "0.644812", "cash_to_debt": "0.179378", "net_debt_to_ebitda": "1.339254", "dividend_payout_ratio": "0.091718", "revenue_growth_pct": "11.528696", "ebit_growth_pct": "74.893333", "eps_growth_pct": "63.088429", "reported_fcf_growth_pct": "318.461538", "calculated_fcf_growth_pct": "327.141058", "revenue_cagr_3y_pct": "13.835162", "revenue_cagr_5y_pct": "10.377497", "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated only from published annual-report fields; blanks indicate missing denominators or documented missing/source-limited inputs.", "capex_reported_basis": "reported", "capex_calculated_basis": "cash_flow_capex", "free_cash_flow_reported_basis": "reported", "free_cash_flow_calculated_basis": "calculated_ocf_plus_capex", "capex_basis_status": "confirmed", "free_cash_flow_basis_status": "confirmed" }, { "ticker": "SFZN.SW", "company_name": "Siegfried Holding AG", "sector": "Health Care", "industry": "Pharmaceutical manufacturing", "fiscal_year": "2023", "reporting_currency": "CHF", "revenue": "1271.494", "ebitda": "253.4", "ebit": "172.068", "net_income": "112.774", "total_assets": "1861.505", "total_equity": "838.133", "cash": "56.363", "total_debt": "445.0", "net_debt": "388.637", "operating_cash_flow": "208.608", "capex_reported": "137.1", "capex_calculated": "-137.094", "free_cash_flow_reported": "71.8", "free_cash_flow_calculated": "71.514", "eps": "26.61", "dividend_per_share": "3.6", "ebitda_margin_pct": "19.929312", "ebit_margin_pct": "13.532742", "net_margin_pct": "8.869409", "reported_fcf_margin_pct": "5.6469", "calculated_fcf_margin_pct": "5.624407", "roe_pct": "13.455382", "roa_pct": "6.058216", "debt_to_equity": "0.530942", "cash_to_debt": "0.126658", "net_debt_to_ebitda": "1.53369", "dividend_payout_ratio": "0.135287", "revenue_growth_pct": "3.414021", "ebit_growth_pct": "-25.43971", "eps_growth_pct": "-28.216887", "reported_fcf_growth_pct": "163.970588", "calculated_fcf_growth_pct": "163.578063", "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": "9.86675", "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated only from published annual-report fields; blanks indicate missing denominators or documented missing/source-limited inputs.", "capex_reported_basis": "reported", "capex_calculated_basis": "cash_flow_capex", "free_cash_flow_reported_basis": "reported", "free_cash_flow_calculated_basis": "calculated_ocf_plus_capex", "capex_basis_status": "confirmed", "free_cash_flow_basis_status": "confirmed" }, { "ticker": "SFZN.SW", "company_name": "Siegfried Holding AG", "sector": "Health Care", "industry": "Pharmaceutical manufacturing", "fiscal_year": "2024", "reporting_currency": "CHF", "revenue": "1294.573", "ebitda": "284.0", "ebit": "199.26", "net_income": "160.064", "total_assets": "1933.722", "total_equity": "979.907", "cash": "38.756", "total_debt": "490.1", "net_debt": "451.344", "operating_cash_flow": "168.777", "capex_reported": "180.8", "capex_calculated": "-180.847", "free_cash_flow_reported": "-11.6", "free_cash_flow_calculated": "-12.07", "eps": "37.14", "dividend_per_share": "3.8", "ebitda_margin_pct": "21.937735", "ebit_margin_pct": "15.391948", "net_margin_pct": "12.364231", "reported_fcf_margin_pct": "-0.896048", "calculated_fcf_margin_pct": "-0.932354", "roe_pct": "16.334611", "roa_pct": "8.277508", "debt_to_equity": "0.50015", "cash_to_debt": "0.079078", "net_debt_to_ebitda": "1.589239", "dividend_payout_ratio": "0.102316", "revenue_growth_pct": "1.815109", "ebit_growth_pct": "15.803055", "eps_growth_pct": "39.57159", "reported_fcf_growth_pct": "-116.155989", "calculated_fcf_growth_pct": "-116.877814", "revenue_cagr_3y_pct": "5.501692", "revenue_cagr_5y_pct": "9.205419", "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated only from published annual-report fields; blanks indicate missing denominators or documented missing/source-limited inputs.", "capex_reported_basis": "reported", "capex_calculated_basis": "cash_flow_capex", "free_cash_flow_reported_basis": "reported", "free_cash_flow_calculated_basis": "calculated_ocf_plus_capex", "capex_basis_status": "confirmed", "free_cash_flow_basis_status": "confirmed" }, { "ticker": "SFZN.SW", "company_name": "Siegfried Holding AG", "sector": "Health Care", "industry": "Pharmaceutical manufacturing", "fiscal_year": "2025", "reporting_currency": "CHF", "revenue": "1327.834", "ebitda": "318.5", "ebit": "223.764", "net_income": "168.659", "total_assets": "2153.543", "total_equity": "1127.555", "cash": "103.082", "total_debt": "575.2", "net_debt": "472.118", "operating_cash_flow": "228.159", "capex_reported": "231.5", "capex_calculated": "-231.469", "free_cash_flow_reported": "-3.1", "free_cash_flow_calculated": "-3.31", "eps": "3.85", "dividend_per_share": "0.4", "ebitda_margin_pct": "23.986432", "ebit_margin_pct": "16.851805", "net_margin_pct": "12.701814", "reported_fcf_margin_pct": "-0.233463", "calculated_fcf_margin_pct": "-0.249278", "roe_pct": "14.95794", "roa_pct": "7.831699", "debt_to_equity": "0.51013", "cash_to_debt": "0.179211", "net_debt_to_ebitda": "1.482317", "dividend_payout_ratio": "0.103896", "revenue_growth_pct": "2.569264", "ebit_growth_pct": "12.297501", "eps_growth_pct": "-89.633818", "reported_fcf_growth_pct": "-73.275862", "calculated_fcf_growth_pct": "-72.576636", "revenue_cagr_3y_pct": "2.597386", "revenue_cagr_5y_pct": null, "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated only from published annual-report fields; blanks indicate missing denominators or documented missing/source-limited inputs.", "capex_reported_basis": "reported", "capex_calculated_basis": "cash_flow_capex", "free_cash_flow_reported_basis": "reported", "free_cash_flow_calculated_basis": "calculated_ocf_plus_capex", "capex_basis_status": "confirmed", "free_cash_flow_basis_status": "confirmed" }, { "ticker": "BARN.SW", "company_name": "Barry Callebaut AG", "sector": "Consumer Staples", "industry": "Food Products / Chocolate & Cocoa", "fiscal_year": "2015", "reporting_currency": "CHF", "revenue": "6241.865", "ebitda": null, "ebit": "414.821", "net_income": "239.871", "total_assets": "5429.388", "total_equity": "1787.114", "cash": "125.151", "total_debt": "1855.332", "net_debt": "1730.181", "operating_cash_flow": "226.682", "capex_reported": "249.2", "capex_calculated": "-249.185", "free_cash_flow_reported": null, "free_cash_flow_calculated": "-22.503", "eps": "43.25", "dividend_per_share": "14.5", "ebitda_margin_pct": null, "ebit_margin_pct": "6.645786", "net_margin_pct": "3.842938", "reported_fcf_margin_pct": null, "calculated_fcf_margin_pct": "-0.360517", "roe_pct": "13.422255", "roa_pct": "4.418012", "debt_to_equity": "1.038172", "cash_to_debt": "0.067455", "net_debt_to_ebitda": null, "dividend_payout_ratio": "0.33526", "revenue_growth_pct": null, "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": null, "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "documented_missing", "notes": "Documented-missing public placeholder; no value is published for this field or period.", "capex_reported_basis": "annual_report_reported_metric", "capex_calculated_basis": "operating_cash_flow_statement_cash_outflow", "free_cash_flow_reported_basis": null, "free_cash_flow_calculated_basis": "operating_cash_flow_plus_capex_calculated", "capex_basis_status": "confirmed_separate_basis", "free_cash_flow_basis_status": "confirmed_separate_basis" }, { "ticker": "BARN.SW", "company_name": "Barry Callebaut AG", "sector": "Consumer Staples", "industry": "Food Products / Chocolate & Cocoa", "fiscal_year": "2016", "reporting_currency": "CHF", "revenue": "6676.766", "ebitda": null, "ebit": "401.694", "net_income": "218.961", "total_assets": "5640.803", "total_equity": "1971.211", "cash": "456.8", "total_debt": "1909.681", "net_debt": "1452.881", "operating_cash_flow": "621.483", "capex_reported": "201.0", "capex_calculated": "-201.017", "free_cash_flow_reported": "404.0", "free_cash_flow_calculated": "420.466", "eps": "39.57", "dividend_per_share": "15.5", "ebitda_margin_pct": null, "ebit_margin_pct": "6.016296", "net_margin_pct": "3.279447", "reported_fcf_margin_pct": "6.050834", "calculated_fcf_margin_pct": "6.29745", "roe_pct": "11.107943", "roa_pct": "3.881735", "debt_to_equity": "0.968786", "cash_to_debt": "0.239202", "net_debt_to_ebitda": null, "dividend_payout_ratio": "0.391711", "revenue_growth_pct": "6.967485", "ebit_growth_pct": "-3.164497", "eps_growth_pct": "-8.508671", "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": "-1968.488646", "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "documented_missing", "notes": "Documented-missing public placeholder; no value is published for this field or period.", "capex_reported_basis": "annual_report_reported_metric", "capex_calculated_basis": "operating_cash_flow_statement_cash_outflow", "free_cash_flow_reported_basis": "annual_report_reported_metric", "free_cash_flow_calculated_basis": "operating_cash_flow_plus_capex_calculated", "capex_basis_status": "confirmed_separate_basis", "free_cash_flow_basis_status": "confirmed_separate_basis" }, { "ticker": "BARN.SW", "company_name": "Barry Callebaut AG", "sector": "Consumer Staples", "industry": "Food Products / Chocolate & Cocoa", "fiscal_year": "2017", "reporting_currency": "CHF", "revenue": "6805.156", "ebitda": null, "ebit": "488.164", "net_income": "302.923", "total_assets": "5534.073", "total_equity": "2193.645", "cash": "399.292", "total_debt": "1510.279", "net_debt": "1110.987", "operating_cash_flow": "683.993", "capex_reported": "220.4", "capex_calculated": "-220.437", "free_cash_flow_reported": "475.6", "free_cash_flow_calculated": "463.556", "eps": "55.12", "dividend_per_share": "20.0", "ebitda_margin_pct": null, "ebit_margin_pct": "7.173443", "net_margin_pct": "4.451375", "reported_fcf_margin_pct": "6.988818", "calculated_fcf_margin_pct": "6.811835", "roe_pct": "13.809117", "roa_pct": "5.47378", "debt_to_equity": "0.688479", "cash_to_debt": "0.264383", "net_debt_to_ebitda": null, "dividend_payout_ratio": "0.362845", "revenue_growth_pct": "1.922937", "ebit_growth_pct": "21.526336", "eps_growth_pct": "39.297448", "reported_fcf_growth_pct": "17.722772", "calculated_fcf_growth_pct": "10.248153", "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "documented_missing", "notes": "Documented-missing public placeholder; no value is published for this field or period.", "capex_reported_basis": "annual_report_reported_metric", "capex_calculated_basis": "operating_cash_flow_statement_cash_outflow", "free_cash_flow_reported_basis": "annual_report_reported_metric", "free_cash_flow_calculated_basis": "operating_cash_flow_plus_capex_calculated", "capex_basis_status": "confirmed_separate_basis", "free_cash_flow_basis_status": "confirmed_separate_basis" }, { "ticker": "BARN.SW", "company_name": "Barry Callebaut AG", "sector": "Consumer Staples", "industry": "Food Products / Chocolate & Cocoa", "fiscal_year": "2018", "reporting_currency": "CHF", "revenue": "6948.411", "ebitda": null, "ebit": "554.024", "net_income": "357.359", "total_assets": "5832.042", "total_equity": "2285.511", "cash": "404.183", "total_debt": "1480.112", "net_debt": "1075.929", "operating_cash_flow": "515.507", "capex_reported": "217.9", "capex_calculated": "-217.932", "free_cash_flow_reported": "311.9", "free_cash_flow_calculated": "297.575", "eps": "64.93", "dividend_per_share": "24.0", "ebitda_margin_pct": null, "ebit_margin_pct": "7.973391", "net_margin_pct": "5.143032", "reported_fcf_margin_pct": "4.488796", "calculated_fcf_margin_pct": "4.282634", "roe_pct": "15.635847", "roa_pct": "6.127511", "debt_to_equity": "0.647607", "cash_to_debt": "0.273076", "net_debt_to_ebitda": null, "dividend_payout_ratio": "0.369629", "revenue_growth_pct": "2.105095", "ebit_growth_pct": "13.491368", "eps_growth_pct": "17.797533", "reported_fcf_growth_pct": "-34.41968", "calculated_fcf_growth_pct": "-35.80603", "revenue_cagr_3y_pct": "3.639118", "revenue_cagr_5y_pct": null, "ratio_status": "documented_missing", "notes": "Documented-missing public placeholder; no value is published for this field or period.", "capex_reported_basis": "annual_report_reported_metric", "capex_calculated_basis": "operating_cash_flow_statement_cash_outflow", "free_cash_flow_reported_basis": "annual_report_reported_metric", "free_cash_flow_calculated_basis": "operating_cash_flow_plus_capex_calculated", "capex_basis_status": "confirmed_separate_basis", "free_cash_flow_basis_status": "confirmed_separate_basis" }, { "ticker": "BARN.SW", "company_name": "Barry Callebaut AG", "sector": "Consumer Staples", "industry": "Food Products / Chocolate & Cocoa", "fiscal_year": "2019", "reporting_currency": "CHF", "revenue": "7309.036", "ebitda": null, "ebit": "601.188", "net_income": "368.731", "total_assets": "6508.132", "total_equity": "2413.612", "cash": "557.827", "total_debt": "1864.094", "net_debt": "1306.267", "operating_cash_flow": "555.748", "capex_reported": "279.6", "capex_calculated": "-279.576", "free_cash_flow_reported": "289.7", "free_cash_flow_calculated": "276.172", "eps": "67.57", "dividend_per_share": "26.0", "ebitda_margin_pct": null, "ebit_margin_pct": "8.225271", "net_margin_pct": "5.044865", "reported_fcf_margin_pct": "3.963587", "calculated_fcf_margin_pct": "3.778501", "roe_pct": "15.277145", "roa_pct": "5.665696", "debt_to_equity": "0.772325", "cash_to_debt": "0.299248", "net_debt_to_ebitda": null, "dividend_payout_ratio": "0.384786", "revenue_growth_pct": "5.190036", "ebit_growth_pct": "8.512989", "eps_growth_pct": "4.065917", "reported_fcf_growth_pct": "-7.117666", "calculated_fcf_growth_pct": "-7.192472", "revenue_cagr_3y_pct": "3.061861", "revenue_cagr_5y_pct": null, "ratio_status": "documented_missing", "notes": "Documented-missing public placeholder; no value is published for this field or period.", "capex_reported_basis": "annual_report_reported_metric", "capex_calculated_basis": "operating_cash_flow_statement_cash_outflow", "free_cash_flow_reported_basis": "annual_report_reported_metric", "free_cash_flow_calculated_basis": "operating_cash_flow_plus_capex_calculated", "capex_basis_status": "confirmed_separate_basis", "free_cash_flow_basis_status": "confirmed_separate_basis" }, { "ticker": "BARN.SW", "company_name": "Barry Callebaut AG", "sector": "Consumer Staples", "industry": "Food Products / Chocolate & Cocoa", "fiscal_year": "2020", "reporting_currency": "CHF", "revenue": "6893.146", "ebitda": null, "ebit": "483.152", "net_income": "311.494", "total_assets": "7141.11", "total_equity": "2355.267", "cash": "1385.976", "total_debt": "2758.174", "net_debt": "1372.198", "operating_cash_flow": "593.548", "capex_reported": "280.9", "capex_calculated": "-280.894", "free_cash_flow_reported": "317.0", "free_cash_flow_calculated": "312.654", "eps": "57.7", "dividend_per_share": "22.0", "ebitda_margin_pct": null, "ebit_margin_pct": "7.009165", "net_margin_pct": "4.518895", "reported_fcf_margin_pct": "4.598771", "calculated_fcf_margin_pct": "4.535723", "roe_pct": "13.225422", "roa_pct": "4.361983", "debt_to_equity": "1.171066", "cash_to_debt": "0.502498", "net_debt_to_ebitda": null, "dividend_payout_ratio": "0.381282", "revenue_growth_pct": "-5.69008", "ebit_growth_pct": "-19.633792", "eps_growth_pct": "-14.607074", "reported_fcf_growth_pct": "9.423542", "calculated_fcf_growth_pct": "13.209884", "revenue_cagr_3y_pct": "0.429152", "revenue_cagr_5y_pct": "2.004803", "ratio_status": "documented_missing", "notes": "Documented-missing public placeholder; no value is published for this field or period.", "capex_reported_basis": "annual_report_reported_metric", "capex_calculated_basis": "operating_cash_flow_statement_cash_outflow", "free_cash_flow_reported_basis": "annual_report_reported_metric", "free_cash_flow_calculated_basis": "operating_cash_flow_plus_capex_calculated", "capex_basis_status": "confirmed_separate_basis", "free_cash_flow_basis_status": "confirmed_separate_basis" }, { "ticker": "BARN.SW", "company_name": "Barry Callebaut AG", "sector": "Consumer Staples", "industry": "Food Products / Chocolate & Cocoa", "fiscal_year": "2021", "reporting_currency": "CHF", "revenue": "7207.595", "ebitda": null, "ebit": "566.688", "net_income": "384.505", "total_assets": "7244.018", "total_equity": "2685.217", "cash": "1095.831", "total_debt": "2378.584", "net_debt": "1282.753", "operating_cash_flow": "615.637", "capex_reported": "275.2", "capex_calculated": "-275.244", "free_cash_flow_reported": "355.0", "free_cash_flow_calculated": "340.393", "eps": "70.04", "dividend_per_share": "28.0", "ebitda_margin_pct": null, "ebit_margin_pct": "7.862373", "net_margin_pct": "5.33472", "reported_fcf_margin_pct": "4.92536", "calculated_fcf_margin_pct": "4.722699", "roe_pct": "14.319327", "roa_pct": "5.307897", "debt_to_equity": "0.885807", "cash_to_debt": "0.460707", "net_debt_to_ebitda": null, "dividend_payout_ratio": "0.399772", "revenue_growth_pct": "4.561763", "ebit_growth_pct": "17.289797", "eps_growth_pct": "21.386482", "reported_fcf_growth_pct": "11.987382", "calculated_fcf_growth_pct": "8.872108", "revenue_cagr_3y_pct": "1.228226", "revenue_cagr_5y_pct": "1.541797", "ratio_status": "documented_missing", "notes": "Documented-missing public placeholder; no value is published for this field or period.", "capex_reported_basis": "annual_report_reported_metric", "capex_calculated_basis": "operating_cash_flow_statement_cash_outflow", "free_cash_flow_reported_basis": "annual_report_reported_metric", "free_cash_flow_calculated_basis": "operating_cash_flow_plus_capex_calculated", "capex_basis_status": "confirmed_separate_basis", "free_cash_flow_basis_status": "confirmed_separate_basis" }, { "ticker": "BARN.SW", "company_name": "Barry Callebaut AG", "sector": "Consumer Staples", "industry": "Food Products / Chocolate & Cocoa", "fiscal_year": "2022", "reporting_currency": "CHF", "revenue": "8091.855", "ebitda": null, "ebit": "553.486", "net_income": "360.94", "total_assets": "7760.879", "total_equity": "2904.346", "cash": "878.197", "total_debt": "2079.056", "net_debt": "1200.859", "operating_cash_flow": "521.651", "capex_reported": "275.9", "capex_calculated": "-275.89", "free_cash_flow_reported": "266.2", "free_cash_flow_calculated": "245.761", "eps": "65.81", "dividend_per_share": "28.0", "ebitda_margin_pct": null, "ebit_margin_pct": "6.840039", "net_margin_pct": "4.460535", "reported_fcf_margin_pct": "3.289728", "calculated_fcf_margin_pct": "3.03714", "roe_pct": "12.427583", "roa_pct": "4.650762", "debt_to_equity": "0.715843", "cash_to_debt": "0.422402", "net_debt_to_ebitda": null, "dividend_payout_ratio": "0.425467", "revenue_growth_pct": "12.268447", "ebit_growth_pct": "-2.329677", "eps_growth_pct": "-6.039406", "reported_fcf_growth_pct": "-25.014085", "calculated_fcf_growth_pct": "-27.800807", "revenue_cagr_3y_pct": "3.449723", "revenue_cagr_5y_pct": "3.524228", "ratio_status": "documented_missing", "notes": "Documented-missing public placeholder; no value is published for this field or period.", "capex_reported_basis": "annual_report_reported_metric", "capex_calculated_basis": "operating_cash_flow_statement_cash_outflow", "free_cash_flow_reported_basis": "annual_report_reported_metric", "free_cash_flow_calculated_basis": "operating_cash_flow_plus_capex_calculated", "capex_basis_status": "confirmed_separate_basis", "free_cash_flow_basis_status": "confirmed_separate_basis" }, { "ticker": "BARN.SW", "company_name": "Barry Callebaut AG", "sector": "Consumer Staples", "industry": "Food Products / Chocolate & Cocoa", "fiscal_year": "2023", "reporting_currency": "CHF", "revenue": "8470.525", "ebitda": null, "ebit": "659.35", "net_income": "443.135", "total_assets": "8432.748", "total_equity": "2897.144", "cash": "488.203", "total_debt": "1797.012", "net_debt": "1308.809", "operating_cash_flow": "330.563", "capex_reported": "241.2", "capex_calculated": "-241.165", "free_cash_flow_reported": "113.0", "free_cash_flow_calculated": "89.398", "eps": "81.04", "dividend_per_share": "29.0", "ebitda_margin_pct": null, "ebit_margin_pct": "7.784051", "net_margin_pct": "5.231494", "reported_fcf_margin_pct": "1.334038", "calculated_fcf_margin_pct": "1.055401", "roe_pct": "15.295581", "roa_pct": "5.25493", "debt_to_equity": "0.62027", "cash_to_debt": "0.271675", "net_debt_to_ebitda": null, "dividend_payout_ratio": "0.357848", "revenue_growth_pct": "4.679644", "ebit_growth_pct": "19.126771", "eps_growth_pct": "23.14238", "reported_fcf_growth_pct": "-57.550714", "calculated_fcf_growth_pct": "-63.624009", "revenue_cagr_3y_pct": "7.11023", "revenue_cagr_5y_pct": "4.041107", "ratio_status": "documented_missing", "notes": "Documented-missing public placeholder; no value is published for this field or period.", "capex_reported_basis": "annual_report_reported_metric", "capex_calculated_basis": "operating_cash_flow_statement_cash_outflow", "free_cash_flow_reported_basis": "annual_report_reported_metric", "free_cash_flow_calculated_basis": "operating_cash_flow_plus_capex_calculated", "capex_basis_status": "confirmed_separate_basis", "free_cash_flow_basis_status": "confirmed_separate_basis" }, { "ticker": "BARN.SW", "company_name": "Barry Callebaut AG", "sector": "Consumer Staples", "industry": "Food Products / Chocolate & Cocoa", "fiscal_year": "2024", "reporting_currency": "CHF", "revenue": "10386.283", "ebitda": "692.2", "ebit": "446.127", "net_income": "190.933", "total_assets": "15159.279", "total_equity": "2841.62", "cash": "978.214", "total_debt": "4796.381", "net_debt": "3818.167", "operating_cash_flow": "-2064.007", "capex_reported": "285.1", "capex_calculated": "-285.081", "free_cash_flow_reported": "-2330.7", "free_cash_flow_calculated": "-2349.088", "eps": "34.64", "dividend_per_share": "29.0", "ebitda_margin_pct": "6.664559", "ebit_margin_pct": "4.295348", "net_margin_pct": "1.838319", "reported_fcf_margin_pct": "-22.440174", "calculated_fcf_margin_pct": "-22.617215", "roe_pct": "6.71916", "roa_pct": "1.259512", "debt_to_equity": "1.687904", "cash_to_debt": "0.203948", "net_debt_to_ebitda": "5.515988", "dividend_payout_ratio": "0.837182", "revenue_growth_pct": "22.616756", "ebit_growth_pct": "-32.338364", "eps_growth_pct": "-57.255676", "reported_fcf_growth_pct": "-2162.566372", "calculated_fcf_growth_pct": "-2727.673997", "revenue_cagr_3y_pct": "12.95096", "revenue_cagr_5y_pct": "7.280308", "ratio_status": "documented_missing", "notes": "Documented-missing public placeholder; no value is published for this field or period.", "capex_reported_basis": "annual_report_reported_metric", "capex_calculated_basis": "operating_cash_flow_statement_cash_outflow", "free_cash_flow_reported_basis": "annual_report_reported_metric", "free_cash_flow_calculated_basis": "operating_cash_flow_plus_capex_calculated", "capex_basis_status": "confirmed_separate_basis", "free_cash_flow_basis_status": "confirmed_separate_basis" }, { "ticker": "BARN.SW", "company_name": "Barry Callebaut AG", "sector": "Consumer Staples", "industry": "Food Products / Chocolate & Cocoa", "fiscal_year": "2025", "reporting_currency": "CHF", "revenue": "14788.581", "ebitda": "880.3", "ebit": "635.109", "net_income": "188.378", "total_assets": "12643.918", "total_equity": "2626.953", "cash": "1905.367", "total_debt": "6206.792", "net_debt": "4301.425", "operating_cash_flow": "-42.516", "capex_reported": "295.0", "capex_calculated": "-294.967", "free_cash_flow_reported": "-312.0", "free_cash_flow_calculated": "-337.483", "eps": "33.9", "dividend_per_share": "29.0", "ebitda_margin_pct": "5.952566", "ebit_margin_pct": "4.294591", "net_margin_pct": "1.273807", "reported_fcf_margin_pct": "-2.109736", "calculated_fcf_margin_pct": "-2.282051", "roe_pct": "7.17097", "roa_pct": "1.48987", "debt_to_equity": "2.362734", "cash_to_debt": "0.306981", "net_debt_to_ebitda": "4.886317", "dividend_payout_ratio": "0.855457", "revenue_growth_pct": "42.385693", "ebit_growth_pct": "42.360583", "eps_growth_pct": "-2.136259", "reported_fcf_growth_pct": "-86.613464", "calculated_fcf_growth_pct": "-85.633446", "revenue_cagr_3y_pct": "22.262368", "revenue_cagr_5y_pct": "16.49353", "ratio_status": "documented_missing", "notes": "Documented-missing public placeholder; no value is published for this field or period.", "capex_reported_basis": "annual_report_reported_metric", "capex_calculated_basis": "operating_cash_flow_statement_cash_outflow", "free_cash_flow_reported_basis": "annual_report_reported_metric", "free_cash_flow_calculated_basis": "operating_cash_flow_plus_capex_calculated", "capex_basis_status": "confirmed_separate_basis", "free_cash_flow_basis_status": "confirmed_separate_basis" }, { "ticker": "MIKN.SW", "company_name": "Mikron Holding AG", "sector": "Industrials", "industry": "Agricultural / Industrial Machinery", "fiscal_year": "2015", "reporting_currency": "CHF", "revenue": "228.588", "ebitda": "10.0", "ebit": "1.054", "net_income": "0.922", "total_assets": "243.873", "total_equity": "154.571", "cash": "34.237", "total_debt": "22.771", "net_debt": "-11.466", "operating_cash_flow": "15.516", "capex_reported": null, "capex_calculated": "-12.571", "free_cash_flow_reported": null, "free_cash_flow_calculated": "2.945", "eps": "0.06", "dividend_per_share": "0.05", "ebitda_margin_pct": "4.374683", "ebit_margin_pct": "0.461092", "net_margin_pct": "0.403346", "reported_fcf_margin_pct": null, "calculated_fcf_margin_pct": "1.288344", "roe_pct": "0.59649", "roa_pct": "0.378066", "debt_to_equity": "0.147317", "cash_to_debt": "1.503535", "net_debt_to_ebitda": "-1.1466", "dividend_payout_ratio": "0.833333", "revenue_growth_pct": null, "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": null, "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated only from published annual-report fields; blanks indicate missing denominators or documented missing/source-limited inputs.", "capex_reported_basis": "source_unavailable", "capex_calculated_basis": "operating_cash_flow_statement_cash_outflow", "free_cash_flow_reported_basis": "source_unavailable", "free_cash_flow_calculated_basis": "operating_cash_flow_plus_capex_calculated", "capex_basis_status": "confirmed_separate_basis", "free_cash_flow_basis_status": "confirmed_separate_basis" }, { "ticker": "MIKN.SW", "company_name": "Mikron Holding AG", "sector": "Industrials", "industry": "Agricultural / Industrial Machinery", "fiscal_year": "2016", "reporting_currency": "CHF", "revenue": "255.986", "ebitda": "12.6", "ebit": "2.773", "net_income": "2.337", "total_assets": "251.755", "total_equity": "156.348", "cash": "38.723", "total_debt": "23.479", "net_debt": "-15.244", "operating_cash_flow": "12.799", "capex_reported": null, "capex_calculated": "-6.842", "free_cash_flow_reported": null, "free_cash_flow_calculated": "5.957", "eps": "0.14", "dividend_per_share": "0.05", "ebitda_margin_pct": "4.922144", "ebit_margin_pct": "1.083262", "net_margin_pct": "0.912941", "reported_fcf_margin_pct": null, "calculated_fcf_margin_pct": "2.32708", "roe_pct": "1.494742", "roa_pct": "0.928283", "debt_to_equity": "0.150171", "cash_to_debt": "1.649261", "net_debt_to_ebitda": "-1.209841", "dividend_payout_ratio": "0.357143", "revenue_growth_pct": "11.985756", "ebit_growth_pct": "163.092979", "eps_growth_pct": "133.333333", "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": "102.275042", "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated only from published annual-report fields; blanks indicate missing denominators or documented missing/source-limited inputs.", "capex_reported_basis": "source_unavailable", "capex_calculated_basis": "operating_cash_flow_statement_cash_outflow", "free_cash_flow_reported_basis": "source_unavailable", "free_cash_flow_calculated_basis": "operating_cash_flow_plus_capex_calculated", "capex_basis_status": "confirmed_separate_basis", "free_cash_flow_basis_status": "confirmed_separate_basis" }, { "ticker": "MIKN.SW", "company_name": "Mikron Holding AG", "sector": "Industrials", "industry": "Agricultural / Industrial Machinery", "fiscal_year": "2017", "reporting_currency": "CHF", "revenue": "248.51", "ebitda": "11.2", "ebit": "1.332", "net_income": "1.156", "total_assets": "265.699", "total_equity": "157.345", "cash": "42.161", "total_debt": "23.282", "net_debt": "-18.879", "operating_cash_flow": "15.648", "capex_reported": null, "capex_calculated": "-8.566", "free_cash_flow_reported": null, "free_cash_flow_calculated": "7.082", "eps": "0.07", "dividend_per_share": "0.05", "ebitda_margin_pct": "4.506861", "ebit_margin_pct": "0.535995", "net_margin_pct": "0.465172", "reported_fcf_margin_pct": null, "calculated_fcf_margin_pct": "2.849785", "roe_pct": "0.734691", "roa_pct": "0.435079", "debt_to_equity": "0.147968", "cash_to_debt": "1.810884", "net_debt_to_ebitda": "-1.685625", "dividend_payout_ratio": "0.714286", "revenue_growth_pct": "-2.920472", "ebit_growth_pct": "-51.96538", "eps_growth_pct": "-50", "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": "18.885345", "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated only from published annual-report fields; blanks indicate missing denominators or documented missing/source-limited inputs.", "capex_reported_basis": "source_unavailable", "capex_calculated_basis": "operating_cash_flow_statement_cash_outflow", "free_cash_flow_reported_basis": "source_unavailable", "free_cash_flow_calculated_basis": "operating_cash_flow_plus_capex_calculated", "capex_basis_status": "confirmed_separate_basis", "free_cash_flow_basis_status": "confirmed_separate_basis" }, { "ticker": "MIKN.SW", "company_name": "Mikron Holding AG", "sector": "Industrials", "industry": "Agricultural / Industrial Machinery", "fiscal_year": "2018", "reporting_currency": "CHF", "revenue": "314.692", "ebitda": "22.2", "ebit": "12.737", "net_income": "12.243", "total_assets": "289.521", "total_equity": "164.309", "cash": "27.567", "total_debt": "10.572", "net_debt": "-16.995", "operating_cash_flow": "20.107", "capex_reported": null, "capex_calculated": "-11.948", "free_cash_flow_reported": null, "free_cash_flow_calculated": "8.159", "eps": "0.74", "dividend_per_share": "0.2", "ebitda_margin_pct": "7.054517", "ebit_margin_pct": "4.04745", "net_margin_pct": "3.890471", "reported_fcf_margin_pct": null, "calculated_fcf_margin_pct": "2.592694", "roe_pct": "7.451205", "roa_pct": "4.228709", "debt_to_equity": "0.064342", "cash_to_debt": "2.607548", "net_debt_to_ebitda": "-0.765541", "dividend_payout_ratio": "0.27027", "revenue_growth_pct": "26.631524", "ebit_growth_pct": "856.231231", "eps_growth_pct": "957.142857", "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": "15.207568", "revenue_cagr_3y_pct": "11.244212", "revenue_cagr_5y_pct": null, "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated only from published annual-report fields; blanks indicate missing denominators or documented missing/source-limited inputs.", "capex_reported_basis": "source_unavailable", "capex_calculated_basis": "operating_cash_flow_statement_cash_outflow", "free_cash_flow_reported_basis": "source_unavailable", "free_cash_flow_calculated_basis": "operating_cash_flow_plus_capex_calculated", "capex_basis_status": "confirmed_separate_basis", "free_cash_flow_basis_status": "confirmed_separate_basis" }, { "ticker": "MIKN.SW", "company_name": "Mikron Holding AG", "sector": "Industrials", "industry": "Agricultural / Industrial Machinery", "fiscal_year": "2019", "reporting_currency": "CHF", "revenue": "327.553", "ebitda": "22.87", "ebit": "13.956", "net_income": "8.766", "total_assets": "289.512", "total_equity": "169.22", "cash": "37.992", "total_debt": "21.59", "net_debt": "-16.402", "operating_cash_flow": "7.281", "capex_reported": null, "capex_calculated": "-11.311", "free_cash_flow_reported": "7.229", "free_cash_flow_calculated": "-4.03", "eps": "0.54", "dividend_per_share": "0.06", "ebitda_margin_pct": "6.982076", "ebit_margin_pct": "4.260685", "net_margin_pct": "2.676208", "reported_fcf_margin_pct": "2.206971", "calculated_fcf_margin_pct": "-1.230335", "roe_pct": "5.180239", "roa_pct": "3.027854", "debt_to_equity": "0.127585", "cash_to_debt": "1.759704", "net_debt_to_ebitda": "-0.717184", "dividend_payout_ratio": "0.111111", "revenue_growth_pct": "4.086853", "ebit_growth_pct": "9.570543", "eps_growth_pct": "-27.027027", "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": "-149.393308", "revenue_cagr_3y_pct": "8.564655", "revenue_cagr_5y_pct": null, "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated only from published annual-report fields; blanks indicate missing denominators or documented missing/source-limited inputs.", "capex_reported_basis": "source_unavailable", "capex_calculated_basis": "operating_cash_flow_statement_cash_outflow", "free_cash_flow_reported_basis": "annual_report_reported_metric", "free_cash_flow_calculated_basis": "operating_cash_flow_plus_capex_calculated", "capex_basis_status": "confirmed_separate_basis", "free_cash_flow_basis_status": "confirmed_separate_basis" }, { "ticker": "MIKN.SW", "company_name": "Mikron Holding AG", "sector": "Industrials", "industry": "Agricultural / Industrial Machinery", "fiscal_year": "2020", "reporting_currency": "CHF", "revenue": "257.819", "ebitda": "-8.876", "ebit": "-20.085", "net_income": "-22.075", "total_assets": "277.126", "total_equity": "145.519", "cash": "38.42", "total_debt": "24.126", "net_debt": "-14.294", "operating_cash_flow": "9.175", "capex_reported": null, "capex_calculated": "-15.328", "free_cash_flow_reported": "-1.825", "free_cash_flow_calculated": "-6.153", "eps": "-1.35", "dividend_per_share": "0.0", "ebitda_margin_pct": "-3.442725", "ebit_margin_pct": "-7.790349", "net_margin_pct": "-8.562208", "reported_fcf_margin_pct": "-0.707861", "calculated_fcf_margin_pct": "-2.386558", "roe_pct": "-15.16984", "roa_pct": "-7.965691", "debt_to_equity": "0.165793", "cash_to_debt": "1.592473", "net_debt_to_ebitda": "1.61041", "dividend_payout_ratio": "0", "revenue_growth_pct": "-21.289379", "ebit_growth_pct": "-243.916595", "eps_growth_pct": "-350", "reported_fcf_growth_pct": "-125.245539", "calculated_fcf_growth_pct": "52.679901", "revenue_cagr_3y_pct": "1.233367", "revenue_cagr_5y_pct": "2.435926", "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated only from published annual-report fields; blanks indicate missing denominators or documented missing/source-limited inputs.", "capex_reported_basis": "source_unavailable", "capex_calculated_basis": "operating_cash_flow_statement_cash_outflow", "free_cash_flow_reported_basis": "annual_report_reported_metric", "free_cash_flow_calculated_basis": "operating_cash_flow_plus_capex_calculated", "capex_basis_status": "confirmed_separate_basis", "free_cash_flow_basis_status": "confirmed_separate_basis" }, { "ticker": "MIKN.SW", "company_name": "Mikron Holding AG", "sector": "Industrials", "industry": "Agricultural / Industrial Machinery", "fiscal_year": "2021", "reporting_currency": "CHF", "revenue": "289.455", "ebitda": "27.09", "ebit": "18.009", "net_income": "17.01", "total_assets": "300.039", "total_equity": "165.07", "cash": "54.107", "total_debt": "7.713", "net_debt": "-46.394", "operating_cash_flow": "50.741", "capex_reported": null, "capex_calculated": "-20.355", "free_cash_flow_reported": "32.953", "free_cash_flow_calculated": "30.386", "eps": "1.04", "dividend_per_share": "0.24", "ebitda_margin_pct": "9.358968", "ebit_margin_pct": "6.221692", "net_margin_pct": "5.876561", "reported_fcf_margin_pct": "11.384498", "calculated_fcf_margin_pct": "10.497659", "roe_pct": "10.304719", "roa_pct": "5.669263", "debt_to_equity": "0.046726", "cash_to_debt": "7.01504", "net_debt_to_ebitda": "-1.712588", "dividend_payout_ratio": "0.230769", "revenue_growth_pct": "12.270624", "ebit_growth_pct": "-189.663928", "eps_growth_pct": "-177.037037", "reported_fcf_growth_pct": "-1905.643836", "calculated_fcf_growth_pct": "-593.840403", "revenue_cagr_3y_pct": "-2.74802", "revenue_cagr_5y_pct": "2.487988", "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated only from published annual-report fields; blanks indicate missing denominators or documented missing/source-limited inputs.", "capex_reported_basis": "source_unavailable", "capex_calculated_basis": "operating_cash_flow_statement_cash_outflow", "free_cash_flow_reported_basis": "annual_report_reported_metric", "free_cash_flow_calculated_basis": "operating_cash_flow_plus_capex_calculated", "capex_basis_status": "confirmed_separate_basis", "free_cash_flow_basis_status": "confirmed_separate_basis" }, { "ticker": "MIKN.SW", "company_name": "Mikron Holding AG", "sector": "Industrials", "industry": "Agricultural / Industrial Machinery", "fiscal_year": "2022", "reporting_currency": "CHF", "revenue": "309.442", "ebitda": "35.476", "ebit": "25.75", "net_income": "24.201", "total_assets": "345.922", "total_equity": "186.022", "cash": "29.203", "total_debt": "5.575", "net_debt": "-23.628", "operating_cash_flow": "27.648", "capex_reported": null, "capex_calculated": "-11.29", "free_cash_flow_reported": "-18.287", "free_cash_flow_calculated": "16.358", "eps": "1.47", "dividend_per_share": "0.4", "ebitda_margin_pct": "11.464507", "ebit_margin_pct": "8.32143", "net_margin_pct": "7.820852", "reported_fcf_margin_pct": "-5.90967", "calculated_fcf_margin_pct": "5.28629", "roe_pct": "13.009752", "roa_pct": "6.996086", "debt_to_equity": "0.02997", "cash_to_debt": "5.238206", "net_debt_to_ebitda": "-0.666028", "dividend_payout_ratio": "0.272109", "revenue_growth_pct": "6.905046", "ebit_growth_pct": "42.984064", "eps_growth_pct": "41.346154", "reported_fcf_growth_pct": "-155.494189", "calculated_fcf_growth_pct": "-46.165997", "revenue_cagr_3y_pct": "-1.878113", "revenue_cagr_5y_pct": "4.483347", "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated only from published annual-report fields; blanks indicate missing denominators or documented missing/source-limited inputs.", "capex_reported_basis": "source_unavailable", "capex_calculated_basis": "operating_cash_flow_statement_cash_outflow", "free_cash_flow_reported_basis": "annual_report_reported_metric", "free_cash_flow_calculated_basis": "operating_cash_flow_plus_capex_calculated", "capex_basis_status": "confirmed_separate_basis", "free_cash_flow_basis_status": "confirmed_separate_basis" }, { "ticker": "MIKN.SW", "company_name": "Mikron Holding AG", "sector": "Industrials", "industry": "Agricultural / Industrial Machinery", "fiscal_year": "2023", "reporting_currency": "CHF", "revenue": "370.241", "ebitda": "44.346", "ebit": "33.432", "net_income": "28.789", "total_assets": "374.21", "total_equity": "203.805", "cash": "33.96", "total_debt": "3.793", "net_debt": "-30.167", "operating_cash_flow": "10.474", "capex_reported": null, "capex_calculated": "-9.007", "free_cash_flow_reported": "15.999", "free_cash_flow_calculated": "1.467", "eps": "1.73", "dividend_per_share": "0.5", "ebitda_margin_pct": "11.977604", "ebit_margin_pct": "9.029794", "net_margin_pct": "7.775746", "reported_fcf_margin_pct": "4.321239", "calculated_fcf_margin_pct": "0.396228", "roe_pct": "14.125757", "roa_pct": "7.693274", "debt_to_equity": "0.018611", "cash_to_debt": "8.953335", "net_debt_to_ebitda": "-0.680264", "dividend_payout_ratio": "0.289017", "revenue_growth_pct": "19.647947", "ebit_growth_pct": "29.83301", "eps_growth_pct": "17.687075", "reported_fcf_growth_pct": "-187.48838", "calculated_fcf_growth_pct": "-91.031911", "revenue_cagr_3y_pct": "12.820979", "revenue_cagr_5y_pct": "3.304624", "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated only from published annual-report fields; blanks indicate missing denominators or documented missing/source-limited inputs.", "capex_reported_basis": "source_unavailable", "capex_calculated_basis": "operating_cash_flow_statement_cash_outflow", "free_cash_flow_reported_basis": "annual_report_reported_metric", "free_cash_flow_calculated_basis": "operating_cash_flow_plus_capex_calculated", "capex_basis_status": "confirmed_separate_basis", "free_cash_flow_basis_status": "confirmed_separate_basis" }, { "ticker": "MIKN.SW", "company_name": "Mikron Holding AG", "sector": "Industrials", "industry": "Agricultural / Industrial Machinery", "fiscal_year": "2024", "reporting_currency": "CHF", "revenue": "374.064", "ebitda": "41.272", "ebit": "31.941", "net_income": "27.876", "total_assets": "399.117", "total_equity": "226.186", "cash": "113.289", "total_debt": "2.775", "net_debt": "-110.514", "operating_cash_flow": "69.419", "capex_reported": "20.6", "capex_calculated": "-21.263", "free_cash_flow_reported": "48.865", "free_cash_flow_calculated": "48.156", "eps": "1.68", "dividend_per_share": "0.5", "ebitda_margin_pct": "11.033406", "ebit_margin_pct": "8.538913", "net_margin_pct": "7.452201", "reported_fcf_margin_pct": "13.063273", "calculated_fcf_margin_pct": "12.873733", "roe_pct": "12.32437", "roa_pct": "6.984418", "debt_to_equity": "0.012269", "cash_to_debt": "40.824865", "net_debt_to_ebitda": "-2.677699", "dividend_payout_ratio": "0.297619", "revenue_growth_pct": "1.032571", "ebit_growth_pct": "-4.459799", "eps_growth_pct": "-2.890173", "reported_fcf_growth_pct": "205.425339", "calculated_fcf_growth_pct": "3182.617587", "revenue_cagr_3y_pct": "8.923508", "revenue_cagr_5y_pct": "2.691114", "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated only from published annual-report fields; blanks indicate missing denominators or documented missing/source-limited inputs.", "capex_reported_basis": "annual_report_reported_metric", "capex_calculated_basis": "operating_cash_flow_statement_cash_outflow", "free_cash_flow_reported_basis": "annual_report_reported_metric", "free_cash_flow_calculated_basis": "operating_cash_flow_plus_capex_calculated", "capex_basis_status": "confirmed_separate_basis", "free_cash_flow_basis_status": "confirmed_separate_basis" }, { "ticker": "MIKN.SW", "company_name": "Mikron Holding AG", "sector": "Industrials", "industry": "Agricultural / Industrial Machinery", "fiscal_year": "2025", "reporting_currency": "CHF", "revenue": "381.934", "ebitda": "49.204", "ebit": "39.495", "net_income": "32.526", "total_assets": "379.112", "total_equity": "236.635", "cash": "65.061", "total_debt": "2.058", "net_debt": "-63.003", "operating_cash_flow": "12.648", "capex_reported": "24.5", "capex_calculated": "-25.747", "free_cash_flow_reported": "-11.858", "free_cash_flow_calculated": "-13.099", "eps": "1.95", "dividend_per_share": "0.6", "ebitda_margin_pct": "12.882854", "ebit_margin_pct": "10.340792", "net_margin_pct": "8.516131", "reported_fcf_margin_pct": "-3.104725", "calculated_fcf_margin_pct": "-3.42965", "roe_pct": "13.745219", "roa_pct": "8.579523", "debt_to_equity": "0.008697", "cash_to_debt": "31.613703", "net_debt_to_ebitda": "-1.280445", "dividend_payout_ratio": "0.307692", "revenue_growth_pct": "2.103918", "ebit_growth_pct": "23.649854", "eps_growth_pct": "16.071429", "reported_fcf_growth_pct": "-124.266858", "calculated_fcf_growth_pct": "-127.201179", "revenue_cagr_3y_pct": "7.267877", "revenue_cagr_5y_pct": "8.176937", "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated only from published annual-report fields; blanks indicate missing denominators or documented missing/source-limited inputs.", "capex_reported_basis": "annual_report_reported_metric", "capex_calculated_basis": "operating_cash_flow_statement_cash_outflow", "free_cash_flow_reported_basis": "annual_report_reported_metric", "free_cash_flow_calculated_basis": "operating_cash_flow_plus_capex_calculated", "capex_basis_status": "confirmed_separate_basis", "free_cash_flow_basis_status": "confirmed_separate_basis" }, { "ticker": "KLIN.SW", "company_name": "Klingelnberg AG", "sector": "Industrials", "industry": "Agricultural / Industrial Machinery", "fiscal_year": "2015", "reporting_currency": null, "revenue": null, "ebitda": null, "ebit": null, "net_income": null, "total_assets": null, "total_equity": null, "cash": null, "total_debt": null, "net_debt": null, "operating_cash_flow": null, "capex_reported": null, "capex_calculated": null, "free_cash_flow_reported": null, "free_cash_flow_calculated": null, "eps": null, "dividend_per_share": null, "ebitda_margin_pct": null, "ebit_margin_pct": null, "net_margin_pct": null, "reported_fcf_margin_pct": null, "calculated_fcf_margin_pct": null, "roe_pct": null, "roa_pct": null, "debt_to_equity": null, "cash_to_debt": null, "net_debt_to_ebitda": null, "dividend_payout_ratio": null, "revenue_growth_pct": null, "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": null, "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "documented_missing", "notes": "Documented-missing public placeholder; no value is published for this field or period.", "capex_reported_basis": "documented_missing_no_validated_extraction_row", "capex_calculated_basis": "not_available", "free_cash_flow_reported_basis": "not_available", "free_cash_flow_calculated_basis": "not_available", "capex_basis_status": "source_unavailable", "free_cash_flow_basis_status": "source_unavailable" }, { "ticker": "KLIN.SW", "company_name": "Klingelnberg AG", "sector": "Industrials", "industry": "Agricultural / Industrial Machinery", "fiscal_year": "2016", "reporting_currency": null, "revenue": null, "ebitda": null, "ebit": null, "net_income": null, "total_assets": null, "total_equity": null, "cash": null, "total_debt": null, "net_debt": null, "operating_cash_flow": null, "capex_reported": null, "capex_calculated": null, "free_cash_flow_reported": null, "free_cash_flow_calculated": null, "eps": null, "dividend_per_share": null, "ebitda_margin_pct": null, "ebit_margin_pct": null, "net_margin_pct": null, "reported_fcf_margin_pct": null, "calculated_fcf_margin_pct": null, "roe_pct": null, "roa_pct": null, "debt_to_equity": null, "cash_to_debt": null, "net_debt_to_ebitda": null, "dividend_payout_ratio": null, "revenue_growth_pct": null, "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": null, "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "documented_missing", "notes": "Documented-missing public placeholder; no value is published for this field or period.", "capex_reported_basis": "documented_missing_no_validated_extraction_row", "capex_calculated_basis": "not_available", "free_cash_flow_reported_basis": "not_available", "free_cash_flow_calculated_basis": "not_available", "capex_basis_status": "source_unavailable", "free_cash_flow_basis_status": "source_unavailable" }, { "ticker": "KLIN.SW", "company_name": "Klingelnberg AG", "sector": "Industrials", "industry": "Agricultural / Industrial Machinery", "fiscal_year": "2017", "reporting_currency": null, "revenue": null, "ebitda": null, "ebit": null, "net_income": null, "total_assets": null, "total_equity": null, "cash": null, "total_debt": null, "net_debt": null, "operating_cash_flow": null, "capex_reported": null, "capex_calculated": null, "free_cash_flow_reported": null, "free_cash_flow_calculated": null, "eps": null, "dividend_per_share": null, "ebitda_margin_pct": null, "ebit_margin_pct": null, "net_margin_pct": null, "reported_fcf_margin_pct": null, "calculated_fcf_margin_pct": null, "roe_pct": null, "roa_pct": null, "debt_to_equity": null, "cash_to_debt": null, "net_debt_to_ebitda": null, "dividend_payout_ratio": null, "revenue_growth_pct": null, "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": null, "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "documented_missing", "notes": "Documented-missing public placeholder; no value is published for this field or period.", "capex_reported_basis": "documented_missing_no_validated_extraction_row", "capex_calculated_basis": "not_available", "free_cash_flow_reported_basis": "not_available", "free_cash_flow_calculated_basis": "not_available", "capex_basis_status": "source_unavailable", "free_cash_flow_basis_status": "source_unavailable" }, { "ticker": "KLIN.SW", "company_name": "Klingelnberg AG", "sector": "Industrials", "industry": "Agricultural / Industrial Machinery", "fiscal_year": "2018", "reporting_currency": "EUR", "revenue": "257.027", "ebitda": "28.614", "ebit": "22.058", "net_income": "14.232", "total_assets": "235.035", "total_equity": "120.261", "cash": "8.632", "total_debt": "28.330", "net_debt": "19.698", "operating_cash_flow": "6.409", "capex_reported": null, "capex_calculated": "-6.233", "free_cash_flow_reported": null, "free_cash_flow_calculated": "0.176", "eps": null, "dividend_per_share": null, "ebitda_margin_pct": "11.132683", "ebit_margin_pct": "8.581978", "net_margin_pct": "5.537161", "reported_fcf_margin_pct": null, "calculated_fcf_margin_pct": "0.068475", "roe_pct": "11.834260", "roa_pct": "6.055268", "debt_to_equity": "0.235571", "cash_to_debt": "0.304695", "net_debt_to_ebitda": "0.688404", "dividend_payout_ratio": null, "revenue_growth_pct": null, "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": null, "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios use only verified FY2018 statement values and deterministic formulas. Growth, reported-FCF and per-share ratios remain blank because their required inputs are absent.", "capex_reported_basis": "documented_missing_no_eligible_standalone_reported_capex_kpi", "capex_calculated_basis": "operating_cash_flow_statement_cash_outflow", "free_cash_flow_reported_basis": "source_unavailable", "free_cash_flow_calculated_basis": "operating_cash_flow_plus_capex_calculated", "capex_basis_status": "confirmed_separate_basis", "free_cash_flow_basis_status": "confirmed_separate_basis" }, { "ticker": "KLIN.SW", "company_name": "Klingelnberg AG", "sector": "Industrials", "industry": "Agricultural / Industrial Machinery", "fiscal_year": "2019", "reporting_currency": "EUR", "revenue": "278.214", "ebitda": "36.353", "ebit": "29.979", "net_income": "19.216", "total_assets": "255.372", "total_equity": "162.968", "cash": "28.695", "total_debt": "6.457", "net_debt": "-22.238", "operating_cash_flow": "27.587", "capex_reported": null, "capex_calculated": "-7.768", "free_cash_flow_reported": "22.000", "free_cash_flow_calculated": "19.819", "eps": "2.20", "dividend_per_share": "1.00", "ebitda_margin_pct": "13.06656", "ebit_margin_pct": "10.775518", "net_margin_pct": "6.906913", "reported_fcf_margin_pct": "7.907582", "calculated_fcf_margin_pct": "7.123653", "roe_pct": "11.791272", "roa_pct": "7.524709", "debt_to_equity": "0.039621", "cash_to_debt": "4.444014", "net_debt_to_ebitda": "-0.611724", "dividend_payout_ratio": null, "revenue_growth_pct": null, "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": null, "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated only from published annual-report fields; blanks indicate missing denominators or documented missing/source-limited inputs. dividend_payout_ratio blank: fx_required because dividend_per_share uses market currency CHF/share while eps uses reporting currency EUR/share; no FX rate was invented or applied.", "capex_reported_basis": "documented_missing_no_eligible_standalone_reported_capex_kpi", "capex_calculated_basis": "operating_cash_flow_statement_cash_outflow", "free_cash_flow_reported_basis": "annual_report_reported_metric", "free_cash_flow_calculated_basis": "operating_cash_flow_plus_capex_calculated", "capex_basis_status": "confirmed_separate_basis", "free_cash_flow_basis_status": "confirmed_separate_basis" }, { "ticker": "KLIN.SW", "company_name": "Klingelnberg AG", "sector": "Industrials", "industry": "Agricultural / Industrial Machinery", "fiscal_year": "2020", "reporting_currency": "EUR", "revenue": "212.093", "ebitda": "-12.942", "ebit": "-18.776", "net_income": "-25.356", "total_assets": "244.896", "total_equity": "131.569", "cash": "38.744", "total_debt": "30.060", "net_debt": "-8.684", "operating_cash_flow": "-2.222", "capex_reported": null, "capex_calculated": "-5.630", "free_cash_flow_reported": "-6.472", "free_cash_flow_calculated": "-7.852", "eps": "-2.87", "dividend_per_share": "0.00", "ebitda_margin_pct": "-6.10204", "ebit_margin_pct": "-8.85272", "net_margin_pct": "-11.955133", "reported_fcf_margin_pct": "-3.051492", "calculated_fcf_margin_pct": "-3.70215", "roe_pct": "-19.272017", "roa_pct": "-10.353783", "debt_to_equity": "0.228473", "cash_to_debt": "1.288889", "net_debt_to_ebitda": "0.670994", "dividend_payout_ratio": "0", "revenue_growth_pct": "-23.766238", "ebit_growth_pct": "-162.630508", "eps_growth_pct": "-230.454545", "reported_fcf_growth_pct": "-129.418182", "calculated_fcf_growth_pct": "-139.618548", "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated only from published annual-report fields; blanks indicate missing denominators or documented missing/source-limited inputs.", "capex_reported_basis": "documented_missing_no_eligible_standalone_reported_capex_kpi", "capex_calculated_basis": "operating_cash_flow_statement_cash_outflow", "free_cash_flow_reported_basis": "annual_report_reported_metric", "free_cash_flow_calculated_basis": "operating_cash_flow_plus_capex_calculated", "capex_basis_status": "confirmed_separate_basis", "free_cash_flow_basis_status": "confirmed_separate_basis" }, { "ticker": "KLIN.SW", "company_name": "Klingelnberg AG", "sector": "Industrials", "industry": "Agricultural / Industrial Machinery", "fiscal_year": "2021", "reporting_currency": "EUR", "revenue": "158.719", "ebitda": "-6.560", "ebit": "-11.562", "net_income": "-7.292", "total_assets": "216.941", "total_equity": "120.527", "cash": "22.577", "total_debt": "7.048", "net_debt": "-15.529", "operating_cash_flow": "7.617", "capex_reported": null, "capex_calculated": "-3.732", "free_cash_flow_reported": "7.350", "free_cash_flow_calculated": "3.885", "eps": "-0.82", "dividend_per_share": "0.00", "ebitda_margin_pct": "-4.133091", "ebit_margin_pct": "-7.284572", "net_margin_pct": "-4.594283", "reported_fcf_margin_pct": "4.630826", "calculated_fcf_margin_pct": "2.447722", "roe_pct": "-6.050097", "roa_pct": "-3.361283", "debt_to_equity": "0.058477", "cash_to_debt": "3.20332", "net_debt_to_ebitda": "2.367226", "dividend_payout_ratio": "0", "revenue_growth_pct": "-25.165376", "ebit_growth_pct": "-38.421389", "eps_growth_pct": "-71.428571", "reported_fcf_growth_pct": "-213.566131", "calculated_fcf_growth_pct": "-149.47784", "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated only from published annual-report fields; blanks indicate missing denominators or documented missing/source-limited inputs.", "capex_reported_basis": "documented_missing_no_eligible_standalone_reported_capex_kpi", "capex_calculated_basis": "operating_cash_flow_statement_cash_outflow", "free_cash_flow_reported_basis": "annual_report_reported_metric", "free_cash_flow_calculated_basis": "operating_cash_flow_plus_capex_calculated", "capex_basis_status": "confirmed_separate_basis", "free_cash_flow_basis_status": "confirmed_separate_basis" }, { "ticker": "KLIN.SW", "company_name": "Klingelnberg AG", "sector": "Industrials", "industry": "Agricultural / Industrial Machinery", "fiscal_year": "2022", "reporting_currency": "EUR", "revenue": "158.608", "ebitda": "-11.112", "ebit": "-15.675", "net_income": "-21.677", "total_assets": "273.562", "total_equity": "104.723", "cash": "7.720", "total_debt": "47.831", "net_debt": "40.111", "operating_cash_flow": "-54.537", "capex_reported": null, "capex_calculated": "-11.575", "free_cash_flow_reported": "-55.626", "free_cash_flow_calculated": "-66.112", "eps": "-2.45", "dividend_per_share": "0.00", "ebitda_margin_pct": "-7.005952", "ebit_margin_pct": "-9.882856", "net_margin_pct": "-13.667028", "reported_fcf_margin_pct": "-35.071371", "calculated_fcf_margin_pct": "-41.682639", "roe_pct": "-20.699369", "roa_pct": "-7.923981", "debt_to_equity": "0.456738", "cash_to_debt": "0.161402", "net_debt_to_ebitda": "-3.609701", "dividend_payout_ratio": "0", "revenue_growth_pct": "-0.069935", "ebit_growth_pct": "35.57343", "eps_growth_pct": "198.780488", "reported_fcf_growth_pct": "-856.816327", "calculated_fcf_growth_pct": "-1801.724582", "revenue_cagr_3y_pct": "-17.082022", "revenue_cagr_5y_pct": null, "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated only from published annual-report fields; blanks indicate missing denominators or documented missing/source-limited inputs.", "capex_reported_basis": "documented_missing_no_eligible_standalone_reported_capex_kpi", "capex_calculated_basis": "operating_cash_flow_statement_cash_outflow", "free_cash_flow_reported_basis": "annual_report_reported_metric", "free_cash_flow_calculated_basis": "operating_cash_flow_plus_capex_calculated", "capex_basis_status": "confirmed_separate_basis", "free_cash_flow_basis_status": "confirmed_separate_basis" }, { "ticker": "KLIN.SW", "company_name": "Klingelnberg AG", "sector": "Industrials", "industry": "Agricultural / Industrial Machinery", "fiscal_year": "2023", "reporting_currency": "EUR", "revenue": "308.961", "ebitda": "28.113", "ebit": "23.790", "net_income": "20.755", "total_assets": "284.444", "total_equity": "126.609", "cash": "8.718", "total_debt": "50.480", "net_debt": "41.762", "operating_cash_flow": "15.703", "capex_reported": null, "capex_calculated": "-18.318", "free_cash_flow_reported": "-1.877", "free_cash_flow_calculated": "-2.615", "eps": "2.35", "dividend_per_share": "0.40", "ebitda_margin_pct": "9.099207", "ebit_margin_pct": "7.700001", "net_margin_pct": "6.717676", "reported_fcf_margin_pct": "-0.60752", "calculated_fcf_margin_pct": "-0.846385", "roe_pct": "16.392989", "roa_pct": "7.296691", "debt_to_equity": "0.398708", "cash_to_debt": "0.172702", "net_debt_to_ebitda": "1.485505", "dividend_payout_ratio": null, "revenue_growth_pct": "94.795344", "ebit_growth_pct": "-251.770335", "eps_growth_pct": "-195.918367", "reported_fcf_growth_pct": "-96.625679", "calculated_fcf_growth_pct": "-96.044591", "revenue_cagr_3y_pct": "13.35981", "revenue_cagr_5y_pct": null, "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated only from published annual-report fields; blanks indicate missing denominators or documented missing/source-limited inputs. dividend_payout_ratio blank: fx_required because dividend_per_share uses market currency CHF/share while eps uses reporting currency EUR/share; no FX rate was invented or applied.", "capex_reported_basis": "documented_missing_no_eligible_standalone_reported_capex_kpi", "capex_calculated_basis": "operating_cash_flow_statement_cash_outflow", "free_cash_flow_reported_basis": "annual_report_reported_metric", "free_cash_flow_calculated_basis": "operating_cash_flow_plus_capex_calculated", "capex_basis_status": "confirmed_separate_basis", "free_cash_flow_basis_status": "confirmed_separate_basis" }, { "ticker": "KLIN.SW", "company_name": "Klingelnberg AG", "sector": "Industrials", "industry": "Agricultural / Industrial Machinery", "fiscal_year": "2024", "reporting_currency": "EUR", "revenue": "303.497", "ebitda": "30.207", "ebit": "25.067", "net_income": "17.205", "total_assets": "296.124", "total_equity": "140.752", "cash": "16.506", "total_debt": "43.788", "net_debt": "27.282", "operating_cash_flow": "23.486", "capex_reported": null, "capex_calculated": "-8.286", "free_cash_flow_reported": "16.172", "free_cash_flow_calculated": "15.200", "eps": "1.95", "dividend_per_share": "0.50", "ebitda_margin_pct": "9.952981", "ebit_margin_pct": "8.25939", "net_margin_pct": "5.668919", "reported_fcf_margin_pct": "5.328553", "calculated_fcf_margin_pct": "5.008287", "roe_pct": "12.223627", "roa_pct": "5.810066", "debt_to_equity": "0.3111", "cash_to_debt": "0.376953", "net_debt_to_ebitda": "0.903168", "dividend_payout_ratio": null, "revenue_growth_pct": "-1.768508", "ebit_growth_pct": "5.367802", "eps_growth_pct": "-17.021277", "reported_fcf_growth_pct": "-961.58764", "calculated_fcf_growth_pct": "-681.26195", "revenue_cagr_3y_pct": "24.120017", "revenue_cagr_5y_pct": "1.754842", "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated only from published annual-report fields; blanks indicate missing denominators or documented missing/source-limited inputs. dividend_payout_ratio blank: fx_required because dividend_per_share uses market currency CHF/share while eps uses reporting currency EUR/share; no FX rate was invented or applied.", "capex_reported_basis": "documented_missing_no_eligible_standalone_reported_capex_kpi", "capex_calculated_basis": "operating_cash_flow_statement_cash_outflow", "free_cash_flow_reported_basis": "annual_report_reported_metric", "free_cash_flow_calculated_basis": "operating_cash_flow_plus_capex_calculated", "capex_basis_status": "confirmed_separate_basis", "free_cash_flow_basis_status": "confirmed_separate_basis" }, { "ticker": "KLIN.SW", "company_name": "Klingelnberg AG", "sector": "Industrials", "industry": "Agricultural / Industrial Machinery", "fiscal_year": "2025", "reporting_currency": "EUR", "revenue": "309.069", "ebitda": "21.841", "ebit": "16.216", "net_income": "9.985", "total_assets": "280.089", "total_equity": "143.373", "cash": "16.008", "total_debt": "41.622", "net_debt": "25.614", "operating_cash_flow": "18.970", "capex_reported": null, "capex_calculated": "-9.024", "free_cash_flow_reported": "6.494", "free_cash_flow_calculated": "9.946", "eps": "1.13", "dividend_per_share": "0.50", "ebitda_margin_pct": "7.066707", "ebit_margin_pct": "5.246725", "net_margin_pct": "3.23067", "reported_fcf_margin_pct": "2.101149", "calculated_fcf_margin_pct": "3.218052", "roe_pct": "6.964352", "roa_pct": "3.564938", "debt_to_equity": "0.290306", "cash_to_debt": "0.384604", "net_debt_to_ebitda": "1.172749", "dividend_payout_ratio": null, "revenue_growth_pct": "1.835932", "ebit_growth_pct": "-35.309371", "eps_growth_pct": "-42.051282", "reported_fcf_growth_pct": "-59.844175", "calculated_fcf_growth_pct": "-34.565789", "revenue_cagr_3y_pct": "24.904126", "revenue_cagr_5y_pct": "7.821612", "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated only from published annual-report fields; blanks indicate missing denominators or documented missing/source-limited inputs. dividend_payout_ratio blank: fx_required because dividend_per_share uses market currency CHF/share while eps uses reporting currency EUR/share; no FX rate was invented or applied.", "capex_reported_basis": "documented_missing_no_eligible_standalone_reported_capex_kpi", "capex_calculated_basis": "operating_cash_flow_statement_cash_outflow", "free_cash_flow_reported_basis": "annual_report_reported_metric", "free_cash_flow_calculated_basis": "operating_cash_flow_plus_capex_calculated", "capex_basis_status": "confirmed_separate_basis", "free_cash_flow_basis_status": "confirmed_separate_basis" }, { "ticker": "KLIN.SW", "company_name": "Klingelnberg AG", "sector": "Industrials", "industry": "Agricultural / Industrial Machinery", "fiscal_year": "2026", "reporting_currency": "EUR", "revenue": "285.390", "ebitda": "16.094", "ebit": "10.262", "net_income": "5.793", "total_assets": "290.497", "total_equity": "141.556", "cash": "24.848", "total_debt": "53.650", "net_debt": "28.802", "operating_cash_flow": "9.810", "capex_reported": null, "capex_calculated": "-8.573", "free_cash_flow_reported": "2.689", "free_cash_flow_calculated": "1.237", "eps": "0.66", "dividend_per_share": "0.00", "ebitda_margin_pct": "5.639301", "ebit_margin_pct": "3.595781", "net_margin_pct": "2.029854", "reported_fcf_margin_pct": "0.942219", "calculated_fcf_margin_pct": "0.433442", "roe_pct": "4.092373", "roa_pct": "1.994169", "debt_to_equity": "0.379002", "cash_to_debt": "0.46315", "net_debt_to_ebitda": "1.789611", "dividend_payout_ratio": null, "revenue_growth_pct": "-7.661396", "ebit_growth_pct": "-36.716823", "eps_growth_pct": "-41.59292", "reported_fcf_growth_pct": "-58.592547", "calculated_fcf_growth_pct": "-87.562839", "revenue_cagr_3y_pct": "-2.610599", "revenue_cagr_5y_pct": "12.450649", "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated only from published annual-report fields; blanks indicate missing denominators or documented missing/source-limited inputs. dividend_payout_ratio blank: fx_required because dividend_per_share uses market currency CHF/share while eps uses reporting currency EUR/share; no FX rate was invented or applied.", "capex_reported_basis": "documented_missing_no_eligible_standalone_reported_capex_kpi", "capex_calculated_basis": "operating_cash_flow_statement_cash_outflow", "free_cash_flow_reported_basis": "annual_report_reported_metric", "free_cash_flow_calculated_basis": "operating_cash_flow_plus_capex_calculated", "capex_basis_status": "confirmed_separate_basis", "free_cash_flow_basis_status": "confirmed_separate_basis" }, { "ticker": "PPGN.SW", "company_name": "PolyPeptide Group AG", "sector": "Health Care", "industry": "Peptides / Pharmaceutical Ingredients / CDMO", "fiscal_year": "2015", "reporting_currency": null, "revenue": null, "ebitda": null, "ebit": null, "net_income": null, "total_assets": null, "total_equity": null, "cash": null, "total_debt": null, "net_debt": null, "operating_cash_flow": null, "capex_reported": null, "capex_calculated": null, "free_cash_flow_reported": null, "free_cash_flow_calculated": null, "eps": null, "dividend_per_share": null, "ebitda_margin_pct": null, "ebit_margin_pct": null, "net_margin_pct": null, "reported_fcf_margin_pct": null, "calculated_fcf_margin_pct": null, "roe_pct": null, "roa_pct": null, "debt_to_equity": null, "cash_to_debt": null, "net_debt_to_ebitda": null, "dividend_payout_ratio": null, "revenue_growth_pct": null, "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": null, "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "documented_missing", "notes": "Documented-missing public placeholder; no value is published for this field or period.", "capex_reported_basis": "source_unavailable", "capex_calculated_basis": "source_unavailable", "free_cash_flow_reported_basis": "source_unavailable", "free_cash_flow_calculated_basis": "source_unavailable", "capex_basis_status": "documented_missing", "free_cash_flow_basis_status": "documented_missing" }, { "ticker": "PPGN.SW", "company_name": "PolyPeptide Group AG", "sector": "Health Care", "industry": "Peptides / Pharmaceutical Ingredients / CDMO", "fiscal_year": "2016", "reporting_currency": null, "revenue": null, "ebitda": null, "ebit": null, "net_income": null, "total_assets": null, "total_equity": null, "cash": null, "total_debt": null, "net_debt": null, "operating_cash_flow": null, "capex_reported": null, "capex_calculated": null, "free_cash_flow_reported": null, "free_cash_flow_calculated": null, "eps": null, "dividend_per_share": null, "ebitda_margin_pct": null, "ebit_margin_pct": null, "net_margin_pct": null, "reported_fcf_margin_pct": null, "calculated_fcf_margin_pct": null, "roe_pct": null, "roa_pct": null, "debt_to_equity": null, "cash_to_debt": null, "net_debt_to_ebitda": null, "dividend_payout_ratio": null, "revenue_growth_pct": null, "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": null, "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "documented_missing", "notes": "Documented-missing public placeholder; no value is published for this field or period.", "capex_reported_basis": "source_unavailable", "capex_calculated_basis": "source_unavailable", "free_cash_flow_reported_basis": "source_unavailable", "free_cash_flow_calculated_basis": "source_unavailable", "capex_basis_status": "documented_missing", "free_cash_flow_basis_status": "documented_missing" }, { "ticker": "PPGN.SW", "company_name": "PolyPeptide Group AG", "sector": "Health Care", "industry": "Peptides / Pharmaceutical Ingredients / CDMO", "fiscal_year": "2017", "reporting_currency": null, "revenue": null, "ebitda": null, "ebit": null, "net_income": null, "total_assets": null, "total_equity": null, "cash": null, "total_debt": null, "net_debt": null, "operating_cash_flow": null, "capex_reported": null, "capex_calculated": null, "free_cash_flow_reported": null, "free_cash_flow_calculated": null, "eps": null, "dividend_per_share": null, "ebitda_margin_pct": null, "ebit_margin_pct": null, "net_margin_pct": null, "reported_fcf_margin_pct": null, "calculated_fcf_margin_pct": null, "roe_pct": null, "roa_pct": null, "debt_to_equity": null, "cash_to_debt": null, "net_debt_to_ebitda": null, "dividend_payout_ratio": null, "revenue_growth_pct": null, "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": null, "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "documented_missing", "notes": "Documented-missing public placeholder; no value is published for this field or period.", "capex_reported_basis": "source_unavailable", "capex_calculated_basis": "source_unavailable", "free_cash_flow_reported_basis": "source_unavailable", "free_cash_flow_calculated_basis": "source_unavailable", "capex_basis_status": "documented_missing", "free_cash_flow_basis_status": "documented_missing" }, { "ticker": "PPGN.SW", "company_name": "PolyPeptide Group AG", "sector": "Health Care", "industry": "Peptides / Pharmaceutical Ingredients / CDMO", "fiscal_year": "2018", "reporting_currency": null, "revenue": null, "ebitda": null, "ebit": null, "net_income": null, "total_assets": null, "total_equity": null, "cash": null, "total_debt": null, "net_debt": null, "operating_cash_flow": null, "capex_reported": null, "capex_calculated": null, "free_cash_flow_reported": null, "free_cash_flow_calculated": null, "eps": null, "dividend_per_share": null, "ebitda_margin_pct": null, "ebit_margin_pct": null, "net_margin_pct": null, "reported_fcf_margin_pct": null, "calculated_fcf_margin_pct": null, "roe_pct": null, "roa_pct": null, "debt_to_equity": null, "cash_to_debt": null, "net_debt_to_ebitda": null, "dividend_payout_ratio": null, "revenue_growth_pct": null, "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": null, "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "documented_missing", "notes": "Documented-missing public placeholder; no value is published for this field or period.", "capex_reported_basis": "source_unavailable", "capex_calculated_basis": "source_unavailable", "free_cash_flow_reported_basis": "source_unavailable", "free_cash_flow_calculated_basis": "source_unavailable", "capex_basis_status": "documented_missing", "free_cash_flow_basis_status": "documented_missing" }, { "ticker": "PPGN.SW", "company_name": "PolyPeptide Group AG", "sector": "Health Care", "industry": "Peptides / Pharmaceutical Ingredients / CDMO", "fiscal_year": "2019", "reporting_currency": "EUR", "revenue": "202.613", "ebitda": "49.357", "ebit": "33.549", "net_income": "25.737", "total_assets": "305.142", "total_equity": "149.416", "cash": "17.508", "total_debt": "64.204", "net_debt": "46.696", "operating_cash_flow": "55.600", "capex_reported": null, "capex_calculated": "-19.705", "free_cash_flow_reported": null, "free_cash_flow_calculated": "35.895", "eps": null, "dividend_per_share": null, "ebitda_margin_pct": "24.360234", "ebit_margin_pct": "16.558168", "net_margin_pct": "12.702541", "reported_fcf_margin_pct": null, "calculated_fcf_margin_pct": "17.71604", "roe_pct": "17.225063", "roa_pct": "8.434434", "debt_to_equity": "0.4297", "cash_to_debt": "0.272693", "net_debt_to_ebitda": "0.946087", "dividend_payout_ratio": null, "revenue_growth_pct": null, "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": null, "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated only from published annual-report fields; blanks indicate missing denominators or documented missing/source-limited inputs.", "capex_reported_basis": "not_available", "capex_calculated_basis": "operating_cash_flow_statement_cash_outflow", "free_cash_flow_reported_basis": "not_available", "free_cash_flow_calculated_basis": "operating_cash_flow_plus_capex_calculated", "capex_basis_status": "confirmed_separate_basis", "free_cash_flow_basis_status": "confirmed_separate_basis" }, { "ticker": "PPGN.SW", "company_name": "PolyPeptide Group AG", "sector": "Health Care", "industry": "Peptides / Pharmaceutical Ingredients / CDMO", "fiscal_year": "2020", "reporting_currency": "EUR", "revenue": "223.033", "ebitda": "61.923", "ebit": "44.378", "net_income": "31.335", "total_assets": "375.975", "total_equity": "177.660", "cash": "17.208", "total_debt": "64.329", "net_debt": "47.121", "operating_cash_flow": "49.740", "capex_reported": null, "capex_calculated": "-43.201", "free_cash_flow_reported": null, "free_cash_flow_calculated": "6.539", "eps": null, "dividend_per_share": null, "ebitda_margin_pct": "27.764053", "ebit_margin_pct": "19.897504", "net_margin_pct": "14.04949", "reported_fcf_margin_pct": null, "calculated_fcf_margin_pct": "2.931853", "roe_pct": "17.637622", "roa_pct": "8.334331", "debt_to_equity": "0.362091", "cash_to_debt": "0.2675", "net_debt_to_ebitda": "0.760961", "dividend_payout_ratio": null, "revenue_growth_pct": "10.078327", "ebit_growth_pct": "32.27816", "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": "-81.782978", "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated only from published annual-report fields; blanks indicate missing denominators or documented missing/source-limited inputs.", "capex_reported_basis": "not_available", "capex_calculated_basis": "operating_cash_flow_statement_cash_outflow", "free_cash_flow_reported_basis": "not_available", "free_cash_flow_calculated_basis": "operating_cash_flow_plus_capex_calculated", "capex_basis_status": "confirmed_separate_basis", "free_cash_flow_basis_status": "confirmed_separate_basis" }, { "ticker": "PPGN.SW", "company_name": "PolyPeptide Group AG", "sector": "Health Care", "industry": "Peptides / Pharmaceutical Ingredients / CDMO", "fiscal_year": "2021", "reporting_currency": "EUR", "revenue": "282.126", "ebitda": "84.848", "ebit": "64.165", "net_income": "47.258", "total_assets": "595.038", "total_equity": "421.173", "cash": "136.303", "total_debt": "29.452", "net_debt": "-106.851", "operating_cash_flow": "57.352", "capex_reported": "76.652", "capex_calculated": "-77.708", "free_cash_flow_reported": "-20.356", "free_cash_flow_calculated": "-20.356", "eps": "1.47", "dividend_per_share": "0.30", "ebitda_margin_pct": "30.074506", "ebit_margin_pct": "22.743384", "net_margin_pct": "16.750672", "reported_fcf_margin_pct": "-7.215216", "calculated_fcf_margin_pct": "-7.215216", "roe_pct": "11.220567", "roa_pct": "7.942014", "debt_to_equity": "0.069929", "cash_to_debt": "4.627971", "net_debt_to_ebitda": "-1.259323", "dividend_payout_ratio": null, "revenue_growth_pct": "26.495182", "ebit_growth_pct": "44.587408", "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": "-411.301422", "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated only from published annual-report fields; blanks indicate missing denominators or documented missing/source-limited inputs. dividend_payout_ratio blank: fx_required because dividend_per_share uses CHF/share while eps uses EUR/share; no FX rate was invented or applied.", "capex_reported_basis": "annual_report_reported_metric", "capex_calculated_basis": "operating_cash_flow_statement_cash_outflow", "free_cash_flow_reported_basis": "annual_report_reported_metric", "free_cash_flow_calculated_basis": "operating_cash_flow_plus_capex_calculated", "capex_basis_status": "confirmed_separate_basis", "free_cash_flow_basis_status": "confirmed_separate_basis" }, { "ticker": "PPGN.SW", "company_name": "PolyPeptide Group AG", "sector": "Health Care", "industry": "Peptides / Pharmaceutical Ingredients / CDMO", "fiscal_year": "2022", "reporting_currency": "EUR", "revenue": "280.978", "ebitda": "38.670", "ebit": "12.607", "net_income": "7.767", "total_assets": "575.782", "total_equity": "421.677", "cash": "37.528", "total_debt": "31.724", "net_debt": "-5.804", "operating_cash_flow": "5.460", "capex_reported": "82.985", "capex_calculated": "-78.764", "free_cash_flow_reported": "-73.304", "free_cash_flow_calculated": "-73.304", "eps": "0.24", "dividend_per_share": "0.00", "ebitda_margin_pct": "13.762643", "ebit_margin_pct": "4.486828", "net_margin_pct": "2.764273", "reported_fcf_margin_pct": "-26.088875", "calculated_fcf_margin_pct": "-26.088875", "roe_pct": "1.841931", "roa_pct": "1.348948", "debt_to_equity": "0.075233", "cash_to_debt": "1.182953", "net_debt_to_ebitda": "-0.150091", "dividend_payout_ratio": "0", "revenue_growth_pct": "-0.40691", "ebit_growth_pct": "-80.352217", "eps_growth_pct": "-83.673469", "reported_fcf_growth_pct": "260.110041", "calculated_fcf_growth_pct": "260.110041", "revenue_cagr_3y_pct": "11.51544", "revenue_cagr_5y_pct": null, "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated only from published annual-report fields; blanks indicate missing denominators or documented missing/source-limited inputs.", "capex_reported_basis": "annual_report_reported_metric", "capex_calculated_basis": "operating_cash_flow_statement_cash_outflow", "free_cash_flow_reported_basis": "annual_report_reported_metric", "free_cash_flow_calculated_basis": "operating_cash_flow_plus_capex_calculated", "capex_basis_status": "confirmed_separate_basis", "free_cash_flow_basis_status": "confirmed_separate_basis" }, { "ticker": "PPGN.SW", "company_name": "PolyPeptide Group AG", "sector": "Health Care", "industry": "Peptides / Pharmaceutical Ingredients / CDMO", "fiscal_year": "2023", "reporting_currency": "EUR", "revenue": "320.372", "ebitda": "-5.999", "ebit": "-36.468", "net_income": "-51.440", "total_assets": "689.088", "total_equity": "381.225", "cash": "95.706", "total_debt": "124.782", "net_debt": "29.076", "operating_cash_flow": "36.485", "capex_reported": "54.890", "capex_calculated": "-56.733", "free_cash_flow_reported": "-20.248", "free_cash_flow_calculated": "-20.248", "eps": "-1.56", "dividend_per_share": "0.00", "ebitda_margin_pct": "-1.872511", "ebit_margin_pct": "-11.383017", "net_margin_pct": "-16.056335", "reported_fcf_margin_pct": "-6.320153", "calculated_fcf_margin_pct": "-6.320153", "roe_pct": "-13.493344", "roa_pct": "-7.464939", "debt_to_equity": "0.327319", "cash_to_debt": "0.766986", "net_debt_to_ebitda": "-4.846808", "dividend_payout_ratio": "0", "revenue_growth_pct": "14.020315", "ebit_growth_pct": "-389.267867", "eps_growth_pct": "-750", "reported_fcf_growth_pct": "-72.378042", "calculated_fcf_growth_pct": "-72.378042", "revenue_cagr_3y_pct": "12.83101", "revenue_cagr_5y_pct": null, "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated only from published annual-report fields; blanks indicate missing denominators or documented missing/source-limited inputs.", "capex_reported_basis": "annual_report_reported_metric", "capex_calculated_basis": "operating_cash_flow_statement_cash_outflow", "free_cash_flow_reported_basis": "annual_report_reported_metric", "free_cash_flow_calculated_basis": "operating_cash_flow_plus_capex_calculated", "capex_basis_status": "confirmed_separate_basis", "free_cash_flow_basis_status": "confirmed_separate_basis" }, { "ticker": "PPGN.SW", "company_name": "PolyPeptide Group AG", "sector": "Health Care", "industry": "Peptides / Pharmaceutical Ingredients / CDMO", "fiscal_year": "2024", "reporting_currency": "EUR", "revenue": "336.792", "ebitda": "25.350", "ebit": "-7.364", "net_income": "-19.564", "total_assets": "756.576", "total_equity": "357.244", "cash": "68.277", "total_debt": "104.891", "net_debt": "36.614", "operating_cash_flow": "89.399", "capex_reported": "87.839", "capex_calculated": "-86.968", "free_cash_flow_reported": "2.431", "free_cash_flow_calculated": "2.431", "eps": "-0.59", "dividend_per_share": "0.00", "ebitda_margin_pct": "7.526901", "ebit_margin_pct": "-2.186513", "net_margin_pct": "-5.808927", "reported_fcf_margin_pct": "0.72181", "calculated_fcf_margin_pct": "0.72181", "roe_pct": "-5.476369", "roa_pct": "-2.585861", "debt_to_equity": "0.293612", "cash_to_debt": "0.650933", "net_debt_to_ebitda": "1.444339", "dividend_payout_ratio": "0", "revenue_growth_pct": "5.125292", "ebit_growth_pct": "-79.806954", "eps_growth_pct": "-62.179487", "reported_fcf_growth_pct": "-112.006124", "calculated_fcf_growth_pct": "-112.006124", "revenue_cagr_3y_pct": "6.081476", "revenue_cagr_5y_pct": "10.697775", "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated only from published annual-report fields; blanks indicate missing denominators or documented missing/source-limited inputs.", "capex_reported_basis": "annual_report_reported_metric", "capex_calculated_basis": "operating_cash_flow_statement_cash_outflow", "free_cash_flow_reported_basis": "annual_report_reported_metric", "free_cash_flow_calculated_basis": "operating_cash_flow_plus_capex_calculated", "capex_basis_status": "confirmed_separate_basis", "free_cash_flow_basis_status": "confirmed_separate_basis" }, { "ticker": "PPGN.SW", "company_name": "PolyPeptide Group AG", "sector": "Health Care", "industry": "Peptides / Pharmaceutical Ingredients / CDMO", "fiscal_year": "2025", "reporting_currency": "EUR", "revenue": "389.327", "ebitda": "46.755", "ebit": "8.689", "net_income": "-21.169", "total_assets": "825.959", "total_equity": "340.598", "cash": "74.589", "total_debt": "141.361", "net_debt": "66.772", "operating_cash_flow": "77.510", "capex_reported": "109.978", "capex_calculated": "-108.905", "free_cash_flow_reported": "-31.395", "free_cash_flow_calculated": "-31.395", "eps": "-0.64", "dividend_per_share": "0.00", "ebitda_margin_pct": "12.009185", "ebit_margin_pct": "2.2318", "net_margin_pct": "-5.437332", "reported_fcf_margin_pct": "-8.063915", "calculated_fcf_margin_pct": "-8.063915", "roe_pct": "-6.215245", "roa_pct": "-2.56296", "debt_to_equity": "0.415038", "cash_to_debt": "0.527649", "net_debt_to_ebitda": "1.428125", "dividend_payout_ratio": "0", "revenue_growth_pct": "15.598648", "ebit_growth_pct": "-217.992939", "eps_growth_pct": "8.474576", "reported_fcf_growth_pct": "-1391.44385", "calculated_fcf_growth_pct": "-1391.44385", "revenue_cagr_3y_pct": "11.484392", "revenue_cagr_5y_pct": "11.786428", "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated only from published annual-report fields; blanks indicate missing denominators or documented missing/source-limited inputs.", "capex_reported_basis": "annual_report_reported_metric", "capex_calculated_basis": "operating_cash_flow_statement_cash_outflow", "free_cash_flow_reported_basis": "annual_report_reported_metric", "free_cash_flow_calculated_basis": "operating_cash_flow_plus_capex_calculated", "capex_basis_status": "confirmed_separate_basis", "free_cash_flow_basis_status": "confirmed_separate_basis" }, { "ticker": "LONN.SW", "company_name": "Lonza Group Ltd", "sector": "Health Care", "industry": "Pharmaceutical Manufacturing / CDMO", "fiscal_year": "2015", "reporting_currency": "CHF", "revenue": "3803.0", "ebitda": "780.0", "ebit": "428.0", "net_income": "277.0", "total_assets": "6248.0", "total_equity": "2135.0", "cash": "277.0", "total_debt": "1938.0", "net_debt": "1661", "operating_cash_flow": "741.0", "capex_reported": "264.0", "capex_calculated": "-264.0", "free_cash_flow_reported": "667.0", "free_cash_flow_calculated": "477.0", "eps": "5.3", "dividend_per_share": "2.5", "ebitda_margin_pct": "20.510124", "ebit_margin_pct": "11.254273", "net_margin_pct": "7.283723", "reported_fcf_margin_pct": "17.538785", "calculated_fcf_margin_pct": "12.542729", "roe_pct": "12.974239", "roa_pct": "4.433419", "debt_to_equity": "0.907728", "cash_to_debt": "0.142931", "net_debt_to_ebitda": "2.129487", "dividend_payout_ratio": "0.471698", "revenue_growth_pct": null, "ebit_growth_pct": null, "eps_growth_pct": null, "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": null, "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated only from published annual-report fields; blanks indicate missing denominators or documented missing/source-limited inputs.", "capex_reported_basis": "annual_report_reported_metric", "capex_calculated_basis": "operating_cash_flow_statement_cash_outflow", "free_cash_flow_reported_basis": "annual_report_reported_metric", "free_cash_flow_calculated_basis": "operating_cash_flow_plus_capex_calculated", "capex_basis_status": "confirmed_separate_basis", "free_cash_flow_basis_status": "confirmed_separate_basis" }, { "ticker": "LONN.SW", "company_name": "Lonza Group Ltd", "sector": "Health Care", "industry": "Pharmaceutical Manufacturing / CDMO", "fiscal_year": "2016", "reporting_currency": "CHF", "revenue": "4132.0", "ebitda": "848.0", "ebit": "486.0", "net_income": "301.0", "total_assets": "6828.0", "total_equity": "2355.0", "cash": "274.0", "total_debt": "1860.0", "net_debt": "1586", "operating_cash_flow": "752.0", "capex_reported": "366.0", "capex_calculated": "-366.0", "free_cash_flow_reported": null, "free_cash_flow_calculated": "386.0", "eps": "5.73", "dividend_per_share": "2.75", "ebitda_margin_pct": "20.522749", "ebit_margin_pct": "11.761859", "net_margin_pct": "7.284608", "reported_fcf_margin_pct": null, "calculated_fcf_margin_pct": "9.341723", "roe_pct": "12.781316", "roa_pct": "4.408319", "debt_to_equity": "0.789809", "cash_to_debt": "0.147312", "net_debt_to_ebitda": "1.870283", "dividend_payout_ratio": "0.47993", "revenue_growth_pct": "8.651065", "ebit_growth_pct": "13.551402", "eps_growth_pct": "8.113208", "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": "-19.077568", "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated only from published annual-report fields; blanks indicate missing denominators or documented missing/source-limited inputs.", "capex_reported_basis": "annual_report_reported_metric", "capex_calculated_basis": "operating_cash_flow_statement_cash_outflow", "free_cash_flow_reported_basis": "not_available", "free_cash_flow_calculated_basis": "operating_cash_flow_plus_capex_calculated", "capex_basis_status": "confirmed_separate_basis", "free_cash_flow_basis_status": "confirmed_separate_basis" }, { "ticker": "LONN.SW", "company_name": "Lonza Group Ltd", "sector": "Health Care", "industry": "Pharmaceutical Manufacturing / CDMO", "fiscal_year": "2017", "reporting_currency": "CHF", "revenue": "5105.0", "ebitda": "1153.0", "ebit": "723.0", "net_income": "728.0", "total_assets": "13790.0", "total_equity": "6253.0", "cash": "479.0", "total_debt": "4246.0", "net_debt": "3767", "operating_cash_flow": "863.0", "capex_reported": "451.0", "capex_calculated": "-451.0", "free_cash_flow_reported": null, "free_cash_flow_calculated": "412.0", "eps": "10.7", "dividend_per_share": "2.75", "ebitda_margin_pct": "22.5857", "ebit_margin_pct": "14.162586", "net_margin_pct": "14.260529", "reported_fcf_margin_pct": null, "calculated_fcf_margin_pct": "8.070519", "roe_pct": "11.642412", "roa_pct": "5.279188", "debt_to_equity": "0.679034", "cash_to_debt": "0.112812", "net_debt_to_ebitda": "3.267129", "dividend_payout_ratio": "0.257009", "revenue_growth_pct": "23.547919", "ebit_growth_pct": "48.765432", "eps_growth_pct": "86.736475", "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": "6.735751", "revenue_cagr_3y_pct": null, "revenue_cagr_5y_pct": null, "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated only from published annual-report fields; blanks indicate missing denominators or documented missing/source-limited inputs.", "capex_reported_basis": "annual_report_reported_metric", "capex_calculated_basis": "operating_cash_flow_statement_cash_outflow", "free_cash_flow_reported_basis": "not_available", "free_cash_flow_calculated_basis": "operating_cash_flow_plus_capex_calculated", "capex_basis_status": "confirmed_separate_basis", "free_cash_flow_basis_status": "confirmed_separate_basis" }, { "ticker": "LONN.SW", "company_name": "Lonza Group Ltd", "sector": "Health Care", "industry": "Pharmaceutical Manufacturing / CDMO", "fiscal_year": "2018", "reporting_currency": "CHF", "revenue": "5542.0", "ebitda": null, "ebit": "842.0", "net_income": "563.0", "total_assets": "13921.0", "total_equity": "6290.0", "cash": "461.0", "total_debt": "4062.0", "net_debt": "3601", "operating_cash_flow": "1082.0", "capex_reported": "575.0", "capex_calculated": "-575.0", "free_cash_flow_reported": null, "free_cash_flow_calculated": "507.0", "eps": "7.51", "dividend_per_share": "2.75", "ebitda_margin_pct": null, "ebit_margin_pct": "15.193071", "net_margin_pct": "10.158787", "reported_fcf_margin_pct": null, "calculated_fcf_margin_pct": "9.148322", "roe_pct": "8.950715", "roa_pct": "4.04425", "debt_to_equity": "0.645787", "cash_to_debt": "0.113491", "net_debt_to_ebitda": null, "dividend_payout_ratio": "0.366178", "revenue_growth_pct": "8.560235", "ebit_growth_pct": "16.459198", "eps_growth_pct": "-29.813084", "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": "23.058252", "revenue_cagr_3y_pct": "13.373982", "revenue_cagr_5y_pct": null, "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated only from published annual-report fields; blanks indicate missing denominators or documented missing/source-limited inputs.", "capex_reported_basis": "annual_report_reported_metric", "capex_calculated_basis": "operating_cash_flow_statement_cash_outflow", "free_cash_flow_reported_basis": "not_available", "free_cash_flow_calculated_basis": "operating_cash_flow_plus_capex_calculated", "capex_basis_status": "confirmed_separate_basis", "free_cash_flow_basis_status": "confirmed_separate_basis" }, { "ticker": "LONN.SW", "company_name": "Lonza Group Ltd", "sector": "Health Care", "industry": "Pharmaceutical Manufacturing / CDMO", "fiscal_year": "2019", "reporting_currency": "CHF", "revenue": "5920.0", "ebitda": "1525.0", "ebit": "972.0", "net_income": "646.0", "total_assets": "13841.0", "total_equity": "6565.0", "cash": "505.0", "total_debt": "3540.0", "net_debt": "3035", "operating_cash_flow": "986.0", "capex_reported": "786.0", "capex_calculated": "-786.0", "free_cash_flow_reported": null, "free_cash_flow_calculated": "200.0", "eps": "8.7", "dividend_per_share": "2.75", "ebitda_margin_pct": "25.760135", "ebit_margin_pct": "16.418919", "net_margin_pct": "10.912162", "reported_fcf_margin_pct": null, "calculated_fcf_margin_pct": "3.378378", "roe_pct": "9.840061", "roa_pct": "4.667293", "debt_to_equity": "0.539223", "cash_to_debt": "0.142655", "net_debt_to_ebitda": "1.990164", "dividend_payout_ratio": "0.316092", "revenue_growth_pct": "6.820642", "ebit_growth_pct": "15.43943", "eps_growth_pct": "15.845539", "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": "-60.552268", "revenue_cagr_3y_pct": "12.73371", "revenue_cagr_5y_pct": null, "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated only from published annual-report fields; blanks indicate missing denominators or documented missing/source-limited inputs.", "capex_reported_basis": "annual_report_reported_metric", "capex_calculated_basis": "operating_cash_flow_statement_cash_outflow", "free_cash_flow_reported_basis": "not_available", "free_cash_flow_calculated_basis": "operating_cash_flow_plus_capex_calculated", "capex_basis_status": "confirmed_separate_basis", "free_cash_flow_basis_status": "confirmed_separate_basis" }, { "ticker": "LONN.SW", "company_name": "Lonza Group Ltd", "sector": "Health Care", "industry": "Pharmaceutical Manufacturing / CDMO", "fiscal_year": "2020", "reporting_currency": "CHF", "revenue": "4508.0", "ebitda": "1378.0", "ebit": "901.0", "net_income": "871.0", "total_assets": "14429.0", "total_equity": "6884.0", "cash": "495.0", "total_debt": "3580.0", "net_debt": "3085", "operating_cash_flow": "1130.0", "capex_reported": "889.0", "capex_calculated": "-973.0", "free_cash_flow_reported": null, "free_cash_flow_calculated": "157.0", "eps": "11.68", "dividend_per_share": "2.75", "ebitda_margin_pct": "30.567879", "ebit_margin_pct": "19.98669", "net_margin_pct": "19.321207", "reported_fcf_margin_pct": null, "calculated_fcf_margin_pct": "3.482697", "roe_pct": "12.652528", "roa_pct": "6.036454", "debt_to_equity": "0.520046", "cash_to_debt": "0.138268", "net_debt_to_ebitda": "2.238752", "dividend_payout_ratio": "0.235445", "revenue_growth_pct": "-23.851351", "ebit_growth_pct": "-7.304527", "eps_growth_pct": "34.252874", "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": "-21.5", "revenue_cagr_3y_pct": "-4.060809", "revenue_cagr_5y_pct": "3.459772", "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated only from published annual-report fields; blanks indicate missing denominators or documented missing/source-limited inputs.", "capex_reported_basis": "annual_report_reported_metric", "capex_calculated_basis": "operating_cash_flow_statement_cash_outflow", "free_cash_flow_reported_basis": "not_available", "free_cash_flow_calculated_basis": "operating_cash_flow_plus_capex_calculated", "capex_basis_status": "confirmed_separate_basis", "free_cash_flow_basis_status": "confirmed_separate_basis" }, { "ticker": "LONN.SW", "company_name": "Lonza Group Ltd", "sector": "Health Care", "industry": "Pharmaceutical Manufacturing / CDMO", "fiscal_year": "2021", "reporting_currency": "CHF", "revenue": "5409.0", "ebitda": "1365.0", "ebit": "851.0", "net_income": "2947.0", "total_assets": "16459.0", "total_equity": "9823.0", "cash": "1582.0", "total_debt": "2403.0", "net_debt": "821", "operating_cash_flow": "1217.0", "capex_reported": "1299.0", "capex_calculated": "-1341.0", "free_cash_flow_reported": null, "free_cash_flow_calculated": "-124.0", "eps": "39.65", "dividend_per_share": "3.0", "ebitda_margin_pct": "25.235718", "ebit_margin_pct": "15.733038", "net_margin_pct": "54.483269", "reported_fcf_margin_pct": null, "calculated_fcf_margin_pct": "-2.292476", "roe_pct": "30.001018", "roa_pct": "17.905098", "debt_to_equity": "0.24463", "cash_to_debt": "0.658344", "net_debt_to_ebitda": "0.601465", "dividend_payout_ratio": "0.075662", "revenue_growth_pct": "19.98669", "ebit_growth_pct": "-5.54939", "eps_growth_pct": "239.469178", "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": "-178.980892", "revenue_cagr_3y_pct": "-0.806438", "revenue_cagr_5y_pct": "5.533741", "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated only from published annual-report fields; blanks indicate missing denominators or documented missing/source-limited inputs.", "capex_reported_basis": "annual_report_reported_metric", "capex_calculated_basis": "operating_cash_flow_statement_cash_outflow", "free_cash_flow_reported_basis": "not_available", "free_cash_flow_calculated_basis": "operating_cash_flow_plus_capex_calculated", "capex_basis_status": "confirmed_separate_basis", "free_cash_flow_basis_status": "confirmed_separate_basis" }, { "ticker": "LONN.SW", "company_name": "Lonza Group Ltd", "sector": "Health Care", "industry": "Pharmaceutical Manufacturing / CDMO", "fiscal_year": "2022", "reporting_currency": "CHF", "revenue": "6223.0", "ebitda": "2139.0", "ebit": "1541.0", "net_income": "1218.0", "total_assets": "17356.0", "total_equity": "10665.0", "cash": "1339.0", "total_debt": "2232.0", "net_debt": "893", "operating_cash_flow": "1020.0", "capex_reported": "1872.0", "capex_calculated": "-1872.0", "free_cash_flow_reported": null, "free_cash_flow_calculated": "-852.0", "eps": "16.37", "dividend_per_share": "3.5", "ebitda_margin_pct": "34.372489", "ebit_margin_pct": "24.762976", "net_margin_pct": "19.572553", "reported_fcf_margin_pct": null, "calculated_fcf_margin_pct": "-13.691146", "roe_pct": "11.420534", "roa_pct": "7.017746", "debt_to_equity": "0.209283", "cash_to_debt": "0.59991", "net_debt_to_ebitda": "0.417485", "dividend_payout_ratio": "0.213806", "revenue_growth_pct": "15.048992", "ebit_growth_pct": "81.081081", "eps_growth_pct": "-58.713745", "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": "587.096774", "revenue_cagr_3y_pct": "1.677774", "revenue_cagr_5y_pct": "4.040112", "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated only from published annual-report fields; blanks indicate missing denominators or documented missing/source-limited inputs.", "capex_reported_basis": "annual_report_reported_metric", "capex_calculated_basis": "operating_cash_flow_statement_cash_outflow", "free_cash_flow_reported_basis": "not_available", "free_cash_flow_calculated_basis": "operating_cash_flow_plus_capex_calculated", "capex_basis_status": "confirmed_separate_basis", "free_cash_flow_basis_status": "confirmed_separate_basis" }, { "ticker": "LONN.SW", "company_name": "Lonza Group Ltd", "sector": "Health Care", "industry": "Pharmaceutical Manufacturing / CDMO", "fiscal_year": "2023", "reporting_currency": "CHF", "revenue": "6717.0", "ebitda": "1940.0", "ebit": "880.0", "net_income": "655.0", "total_assets": "16848.0", "total_equity": "9512.0", "cash": "1468.0", "total_debt": "2801.0", "net_debt": "1333", "operating_cash_flow": "1388.0", "capex_reported": "1682.0", "capex_calculated": "-1682.0", "free_cash_flow_reported": null, "free_cash_flow_calculated": "-294.0", "eps": "8.88", "dividend_per_share": "4.0", "ebitda_margin_pct": "28.881941", "ebit_margin_pct": "13.101087", "net_margin_pct": "9.751377", "reported_fcf_margin_pct": null, "calculated_fcf_margin_pct": "-4.376954", "roe_pct": "6.886039", "roa_pct": "3.887702", "debt_to_equity": "0.29447", "cash_to_debt": "0.524099", "net_debt_to_ebitda": "0.687113", "dividend_payout_ratio": "0.45045", "revenue_growth_pct": "7.938293", "ebit_growth_pct": "-42.894225", "eps_growth_pct": "-45.754429", "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": "-65.492958", "revenue_cagr_3y_pct": "14.216929", "revenue_cagr_5y_pct": "3.920629", "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated only from published annual-report fields; blanks indicate missing denominators or documented missing/source-limited inputs.", "capex_reported_basis": "annual_report_reported_metric", "capex_calculated_basis": "operating_cash_flow_statement_cash_outflow", "free_cash_flow_reported_basis": "not_available", "free_cash_flow_calculated_basis": "operating_cash_flow_plus_capex_calculated", "capex_basis_status": "confirmed_separate_basis", "free_cash_flow_basis_status": "confirmed_separate_basis" }, { "ticker": "LONN.SW", "company_name": "Lonza Group Ltd", "sector": "Health Care", "industry": "Pharmaceutical Manufacturing / CDMO", "fiscal_year": "2024", "reporting_currency": "CHF", "revenue": "6574.0", "ebitda": "1695.0", "ebit": "964.0", "net_income": "637.0", "total_assets": "19733.0", "total_equity": "9388.0", "cash": "1111.0", "total_debt": "4710.0", "net_debt": "3599", "operating_cash_flow": "1274.0", "capex_reported": "1417.0", "capex_calculated": "-1417.0", "free_cash_flow_reported": null, "free_cash_flow_calculated": "-143.0", "eps": "8.93", "dividend_per_share": "4.0", "ebitda_margin_pct": "25.783389", "ebit_margin_pct": "14.663827", "net_margin_pct": "9.689687", "reported_fcf_margin_pct": null, "calculated_fcf_margin_pct": "-2.175236", "roe_pct": "6.785258", "roa_pct": "3.228095", "debt_to_equity": "0.501704", "cash_to_debt": "0.235881", "net_debt_to_ebitda": "2.123304", "dividend_payout_ratio": "0.447928", "revenue_growth_pct": "-2.128927", "ebit_growth_pct": "9.545455", "eps_growth_pct": "0.563063", "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": "-51.360544", "revenue_cagr_3y_pct": "6.717974", "revenue_cagr_5y_pct": "2.117835", "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated only from published annual-report fields; blanks indicate missing denominators or documented missing/source-limited inputs.", "capex_reported_basis": "annual_report_reported_metric", "capex_calculated_basis": "operating_cash_flow_statement_cash_outflow", "free_cash_flow_reported_basis": "not_available", "free_cash_flow_calculated_basis": "operating_cash_flow_plus_capex_calculated", "capex_basis_status": "confirmed_separate_basis", "free_cash_flow_basis_status": "confirmed_separate_basis" }, { "ticker": "LONN.SW", "company_name": "Lonza Group Ltd", "sector": "Health Care", "industry": "Pharmaceutical Manufacturing / CDMO", "fiscal_year": "2025", "reporting_currency": "CHF", "revenue": "6531.0", "ebitda": "1970.0", "ebit": "1239.0", "net_income": "-275.0", "total_assets": "17907.0", "total_equity": "7966.0", "cash": "719.0", "total_debt": "4185.0", "net_debt": "3466", "operating_cash_flow": "1156.0", "capex_reported": "1373.0", "capex_calculated": "-1373.0", "free_cash_flow_reported": null, "free_cash_flow_calculated": "-217.0", "eps": "-3.93", "dividend_per_share": "5.0", "ebitda_margin_pct": "30.163834", "ebit_margin_pct": "18.971061", "net_margin_pct": "-4.210687", "reported_fcf_margin_pct": null, "calculated_fcf_margin_pct": "-3.322615", "roe_pct": "-3.452172", "roa_pct": "-1.535712", "debt_to_equity": "0.525358", "cash_to_debt": "0.171804", "net_debt_to_ebitda": "1.759391", "dividend_payout_ratio": "-1.272265", "revenue_growth_pct": "-0.654092", "ebit_growth_pct": "28.526971", "eps_growth_pct": "-144.008959", "reported_fcf_growth_pct": null, "calculated_fcf_growth_pct": "51.748252", "revenue_cagr_3y_pct": "1.6233", "revenue_cagr_5y_pct": "7.695896", "ratio_status": "calculated_from_published_inputs", "notes": "Accounting ratios calculated only from published annual-report fields; blanks indicate missing denominators or documented missing/source-limited inputs.", "capex_reported_basis": "annual_report_reported_metric", "capex_calculated_basis": "operating_cash_flow_statement_cash_outflow", "free_cash_flow_reported_basis": "not_available", "free_cash_flow_calculated_basis": "operating_cash_flow_plus_capex_calculated", "capex_basis_status": "confirmed_separate_basis", "free_cash_flow_basis_status": "confirmed_separate_basis" } ]